Molecular and Structural Characterisation of Epsilon Toxin and Necrotic Enteritis Toxin B: Two Pore-forming Toxins from Clostridium Perfringens by Fernandes da Costa, Sérgio P.
  
 
 
 
 
Molecular and structural characterisation of  
epsilon toxin and necrotic enteritis toxin B:  
two pore-forming toxins from Clostridium perfringens 
 
 
 
 
 
 
Submitted by Sérgio Paulo Fernandes da Costa  
to the University of Exeter as a thesis for the degree of 
Doctor of Philosophy in Biological Sciences 
in November 2013. 
1 
 
Molecular and structural characterisation of epsilon toxin and necrotic enteritis 
toxin B: two pore-forming toxins from Clostridium perfringens 
 
 
 
Submitted by Sérgio Paulo Fernandes da Costa  
to the University of Exeter as a thesis for the degree of 
Doctor of Philosophy in Biological Sciences 
in November 2013. 
 
 
 
This thesis is available for library use on the understanding that it is copyright material 
and that no quotation from the thesis may be published without proper 
acknowledgement. 
 
 
 
I certify that all material in this thesis which is not my own work has been identified and 
that no material has previously been submitted and approved for the award of a degree 
by this or any other University. 
 
 
 
Signature: ………………………………………………………….. 
  
2 
 
  
3 
 
Abstract 
 
Epsilon toxin (Etx) and necrotic enteritis toxin B (NetB) are two pore-forming toxins 
produced by C. perfringens. While Etx has been shown to be the key virulence factor 
for enterotoxemia in goats and sheep, NetB has been associated with the pathogenesis 
of avian necrotic enteritis (NE), a gastro-intestinal disease causing economic damage to 
the poultry industry worldwide. 
The crystal structure of Etx H149A (an Etx variant with 6x reduced toxicity 
relative to wild type toxin) was solved to 2.4 Å and showed that the H149A mutation in 
domain III does not affect organization of the receptor binding region in domain I. The 
Etx H149A structure also revealed a second putative glycan binding site in domain III. 
In addition, site-directed mutagenesis in domain I of Etx H149A affirmed the important 
role of tyrosine residues for toxin binding and demonstrated the capability of Etx 
H149A to be used as a platform for further receptor binding studies in the future. 
The crystal structure of the pore-form of NetB was solved to 3.9 Å and revealed 
high similarities to the Staphylococcus aureus α-hemolysin heptameric structure. 
However, in particular the region thought to interact with the target cell membrane 
showed some interesting divergence in amino acid composition. Site-directed 
mutagenesis within this domain significantly affected binding and toxicity of NetB to 
target cells. Mutagenesis within the ȕ-sandwich domain of NetB revealed important 
amino acid residues for toxin oligomerisation and pore-formation. In order to test NetB 
toxoids as candidate vaccines, a NetB genetic toxoid and a formaldehyde NetB toxoid 
were used to immunise poultry in an in vivo NE disease model. Vaccination with any of 
the two antigens resulted in the induction of specific antibody responses against NetB 
and provided significant protection against disease.  
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1. Aim of introduction 
This PhD thesis deals with the molecular and structural characterisation of two pore-
forming toxins produced by Clostridium perfringens: epsilon toxin (Etx) and necrotic 
enteritis toxin B (NetB). This introduction will first aim to give a general overview on 
the mechanisms of bacterial pathogenicity and then list the most common ways used by 
bacterial toxins that led to the progression of disease in the host organism. In addition, 
the role of Etx in enterotoxemia and the recent association of NetB with avian necrotic 
enteritis will be reviewed. This introduction concludes by listing the aims and objectives 
of this PhD thesis. 
 
2. Mechanisms of bacterial pathogenicity 
The capability of a bacterium to cause disease is generally referred as its relative 
pathogenicity. The degree of pathogenicity is determined by the virulence of the 
bacterial pathogen and its ability to produce virulence factors. A number of mechanisms 
have evolved in pathogenic bacteria that lead to disease in host organisms. While some 
of these mechanisms are commonly used across different bacterial species others are 
very unique to particular pathogens. 
The colonisation of the host is usually the initial step in bacterial infection. 
Adherence of bacteria to host cells can be mediated by virulence factors such as 
adhesins or ligands, bacterial cell-associated compounds with the ability to interact 
specifically with host cell receptors (Niemann et al., 2004), or pili, hair-like structures 
on the surface of bacterial cells facilitating bacterial attachment (Kline et al., 2010). In 
order to survive in the host organism bacteria have evolved strategies to evade host cell 
defence mechanisms. Surface layers such as thick polysaccharide capsules are able to 
mask bacteria and impair phagocytosis and opsonisation by the host immune response 
(Moxon & Kroll, 1990). Important virulence factors for invasion and damage of the host 
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organism are toxins. Bacterial toxins can be classified either as endotoxins or exotoxins 
(Popoff, 2005, Rietschel et al., 1994, Hodgson, 2006). While endotoxins are structural 
components of the bacterial cell envelope and act in close proximity to the bacterium, 
exotoxins are generally secreted by the bacterium and may act remote from the site of 
bacterial growth. However, although endotoxins are not actively released by bacteria 
they may be released after bacterial cell lysis. The archetypical example of an endotoxin 
is lipopolysaccharide (LPS), which is present on the cell wall of Gram-negative bacteria 
(Gronow & Brade, 2001, Trent et al., 2006). The presence of LPS in the circulatory 
blood system of mammals can induce a severe septic shock (Das, 2000). Exotoxins are 
produced by Gram-negative as well as Gram-positive bacteria and are often unique to a 
particular bacterial species. Exotoxins are usually peptides or proteins which are 
secreted by the bacterium into the surrounding medium. However, some bacteria use 
specialised secretion systems to inject their toxins directly into the target host cell 
(Allaoui et al., 1993, Michiels et al., 1990). In general, exotoxins show a high degree of 
specificity against target cells and are more potent than endotoxins. 
 
3. Categorisation of exotoxins 
Exotoxins can be categorised either as intracellular acting toxins or cell surface acting 
toxins according to their mode of action on target cells (Table 1). However, this 
categorisation is not always unambiguous as toxic strategies to enter cells or induce 
disease can be quite similar and have overlapping characteristics. While intracellular 
acting toxins have intracellular targets and may interfere with signalling pathways, e.g. 
modify host cytoskeleton or influence host cell metabolism, cell surface acting toxins 
may bind to receptors on the cell surface and stimulate intracellular signal transduction 
pathways or directly damage the membrane of target host cells (Schmitt et al., 1999).  
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Depending on the mode of action, toxins acting intracellularly can be classified 
into one of the following groups: AB toxins, binary toxins and A-only toxins. Thereby, 
the “A” designation refers to the protein component containing the catalytic (active) part 
and “B” refers to the protein component important for host cell binding and 
translocation of the “A” component across the membrane into the target cell cytosol. 
While the two components are expressed as one protein in the case of AB toxins, binary 
toxins are expressed and secreted by the bacteria as two distinct components (“A” and 
“B”) and get only in contact on the cell surface of host cells to act synergistically. A-
only toxins do not possess a binding/translocation domain and are transported directly 
from the bacterial cell into the host cell via a specific secretion system. Internalisation 
of AB toxins and binary toxins into the host cell is accomplished by a receptor mediated 
endocytosis process. 
Cell surface acting toxins may either bind specifically to cell surface receptors 
and stimulate intracellular signal transduction pathways, like bacterial superantigens, or 
directly damage the membrane of target host cells. Membrane-damaging toxins are 
categorised by their different mode of action as either membrane-perturbing/detergent-
like toxins, toxins that enzymatically hydrolyse membranes or pore-forming toxins.  
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Table 1. Categorisation of exotoxins.  
Representative toxins which will be described in detail in this chapter are indicated in bold. 
Bacterial exotoxins 
Toxins acting intracellularly on cells Toxins acting on the cell surface 
AB Toxins Binary toxins A-only toxins 
Bacterial 
superantigens 
Membrane-damaging toxins 
Clostridium 
difficile  
TcdA, TcdB 
 
C. diphtheria 
diphtheria toxin 
 
C. botulinum 
botulinum toxin 
 
C. botulinum 
C2 toxin 
 
C. perfringens 
iota toxin 
 
Bacillus 
anthracis 
anthrax toxin 
 
Yersinia 
pestis  
Yop toxins 
 
Pseudomonas 
aeroginosa 
exotoxin S 
 
C. botulinum 
C3 toxins 
 
streptococcal 
pyrogenic 
exotoxins 
 
staphylococcal 
enterotoxins 
 
staphylococcal 
toxic shock 
syndrome toxin  
Membrane-
perturbing 
toxins 
Membrane 
hydrolysing 
toxins 
Pore-forming toxins (PFTs) 
Staphylococcus 
aureus  
δ-hemolysin 
 
Apis mellifera 
melittin 
 
Lactococcus 
lactis  
nisin 
C. perfringens  
α-toxin 
 
Listeria 
monocytogenes 
PLC-A 
 
Mycobacterium 
tuberculosis 
PLC 
α-PFTs ȕ-PFTs 
Escherichia coli 
hemolysin E 
 
E. coli  
colicin A 
 
B. thuringiensis  
Cry δ-endotoxin 
Forming  
small pores 
Forming  
large pores 
Aeromonas 
hydrophila 
aerolysin 
 
S. aureus  
α-hemolysin 
 
C. perfringens 
Etx 
 
C. perfringens 
NetB 
C. perfringens 
perfringolysin O 
 
L. monocytogenes 
listeriolysin O 
 
Streptococcus 
pneumoniae 
pneumolysin 
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4. Toxins acting intracellularly on cells 
 
4.1 The clostridial glucosylating toxins – an example of AB toxins 
C. difficile is the major cause of antibiotic-associated diarrhoea and pseudomembranous 
colitis (Bartlett, 2002, Borriello, 1998). The major virulence factors of C. difficile leading to 
disease are TcdA and TcdB (Voth & Ballard, 2005). These two proteins are considered as the 
prototypes of the clostridial glucosylating toxins, which are also termed the large clostridial 
cytotoxins due to the fact that members of this group possess a relatively high molecular 
mass of 250-308 kDa (Busch & Aktories, 2000). 
Clostridial glucosylating toxins show a remarkable amino acid sequence identity (40-
90%) and share a similar cellular uptake mechanism among each other (Figure 1) (von 
Eichel-Streiber et al., 1996). A tripartite structure has been suggested for these toxins: a C-
terminal receptor-binding domain, a N-terminal domain harbouring the catalytic active site 
and a middle domain with hydrophobic properties essential for membrane binding and 
translocation of the catalytic domain into the host cell cytosol (Jank & Aktories, 2008, Jank et 
al., 2007). The clostridial glucosylating toxins bind to specific glycan receptors on the cell 
surface of eukaryotic cells via polypeptide repeats present in the C-terminal domain of these 
toxins (Greco et al., 2006, Ho et al., 2005, Wren, 1991). After binding, the toxin is 
internalised via a cellular endocytosis mechanism (Florin & Thelestam, 1983). Acidification 
of the endosome leads to conformational changes within the translocation domain facilitating 
insertion of the toxin into the endosomic membrane and subsequent translocation of the 
catalytic component into the cytosol of the target cell (Qa'Dan et al., 2000, Barth et al., 2001, 
Pfeifer et al., 2003). The exact mechanism underlying membrane insertion, pore-formation 
and translocation of the “A” component is still enigmatic. However, a pH-decrease within the 
endosome has been shown important to trigger pore-formation (Barth et al., 2001, Giesemann 
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et al., 2006). Once the “A” component, harbouring the glucosyltransferase domain, is 
translocated through the endosomic membrane into the cytosol it is autocatalytically cleaved 
off from the remaining protein (Reineke et al., 2007, Egerer et al., 2007). In the host cell 
cytosol, the catalytic domain glucosylates members of the Rho and Ras superfamily by using 
uridine diphosphate (UDP)-glucose as a co-substrate (Just et al., 1995). Rho and Ras proteins 
are small guanosine triphosphate (GTP)-binding proteins with important functions in several 
cellular processes as they interact with a variety of regulatory proteins involved in the 
maintenance of the actin cytoskeleton, enzyme activation, gene transcription or cell polarity 
(Voth & Ballard, 2005, Schirmer & Aktories, 2004, Jank & Aktories, 2008, Vetter et al., 
2000). Regarding their function in host-pathogen interactions, Rho proteins have vital 
functions in immune and cell defences, such as phagocytosis, cell-cell contact, wound repair, 
epithelial barrier functions or immune cell signalling (Etienne-Manneville & Hall, 2002, 
Burridge & Wennerberg, 2004). 
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Figure 1. The large clostridial glucosylating toxins. (A) Schematic representation of the three domain 
structure. (B) Schematic mode of action. After binding to the target host cell, toxins are internalised via a 
receptor-mediated endocytosis process. Acidification of the endosome leads to the insertion of the translocation 
domain into the endosomic membrane and translocation of the glucosyltransferase domain into the host cell 
cytosol. Here, the catalytic domain glucosylates target proteins by using UDP-glucose as a co-substrate. 
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4.2 The clostridial ADP-ribosylating toxins – an example of binary toxins 
Clostridial toxins categorised into the family of adenosine diphosphate (ADP)-ribosylating 
toxins (ADPRTs) are the C2 toxin from C. botulinum (Fujii et al., 1996, Kimura et al., 1998), 
the C. difficile transferase (Perelle et al., 1997), the iota toxin from C. perfringens (Perelle et 
al., 1993, Stiles et al., 2011) and the C. spiroforme toxin (Popoff et al., 1989). ADPRTs 
function as binary toxins on the cell surface of target cells, meaning that the components “A” 
and “B” are expressed as two separate proteins and only interact with each other on the cell 
surface of the host cell. Prior to this encounter each toxin component remains non-toxic 
(Stiles & Wilkins, 1986a, Stiles & Wilkins, 1986b).  
The most extensively studied ADPRT is the C2 toxin from C. botulinum (Schleberger 
et al., 2006). Prior to binding, the “B” component precursor has to be proteolytically 
activated (Ohishi, 1987, Barth et al., 2000). Subsequently, the “B” monomers oligomerise 
into heptamers and bind to specific glycan receptors on the cell surface of target cells 
(Eckhardt et al., 2000). This allows the binding of the “A” component to the “B” heptameric 
complex, thereby the multimeric “B” complex acts like a docking platform (Barth et al., 
2002). The toxin is then internalised into the cell via a receptor-mediated endocytosis 
mechanism. Acidification of the endosome leads to the insertion of the heptameric “B” 
component into the membrane and subsequent translocation of the catalytic domain into the 
cytosol (Bachmeyer et al., 2001, Simpson, 1989). Once the “A” component is released into 
the cytosol, the catalytic component modifies actin by mono-ADP-ribosylation (Aktories et 
al., 1986). Nicotinamide adenine dinucleotide (NAD) is used as an ADP-ribose substrate, 
whereby the nicotinamide moiety of NAD is released during enzymatic cleavage (Jung et al., 
1993, Tsuge et al., 2008). The major consequence of intracellular actin modification is the 
inhibition of actin filaments assembly and as a consequence the breakdown of the cell 
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cytoskeleton, which finally leads to the collapse of the cell (Reuner et al., 1987, Aktories et 
al., 1986). 
 
4.3 The Yersinia Yop proteins – an example of A-only toxins 
Some Yersinia species are able to deliver a number of plasmid-encoded toxins, named 
Yersinia outer proteins (Yops), directly into the target host cell via a specialised type III 
secretion system (T3SS). All of the human pathogenic Yersinia species (Y. pestis,  
Y. enterocolitica and Y. pseudotuberculosis) encode this T3SS on a virulence plasmid. The 
T3SS consists of three groups of proteins: i) proteins which form the injectisome, the 
continuous channel from the bacterial cytosol to the target cell membrane translocating the 
effector Yops, ii) chaperones which ensure that the effector Yops are correctly folded and 
delivered by the injectisome and iii) six effector Yops named YopE, YopH, YopJ/YopP, 
YopM, YopO/YpkA and YopT (Viboud & Bliska, 2005, Cornelis & Van Gijsegem, 2000).  
YopJ/YopP is an acetyltransferase which induces apoptosis by blocking several signal 
transduction pathways such as mitogen-activated protein kinases or nuclear factor-kappa B 
pathways (Orth, 2002, Mukherjee et al., 2006). YopE is a GTP-ase activating protein able to 
inactivate proteins of the Rho pathway, such as Rho, Rac and Cdc42, causing actin 
depolymerisation and inhibition of phagocytosis (von Pawel-Rammingen et al., 2000). YopT 
is another virulence factor leading to modification of the cytoskeleton and inhibition of 
phagocytosis by modifying Rho-GTPases (Shao & Dixon, 2003). YopH is a tyrosine 
phosphatase inhibiting phagocytosis by targeting peripheral focal adhesions which are 
important for connecting the cytoskeleton with the plasma membrane (Black & Bliska, 1997, 
Persson et al., 1997). Phagocytosis is also inhibited by YopO/YpkA which is a 
serine/threonine protein kinase that interacts with Rho and Rac proteins but also interferes 
with heterotrimeric G proteins important for signal transduction pathways (Navarro et al., 
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2007, Prehna et al., 2006). The cellular function of YopM is not well known and still under 
investigation. 
 
 
5. Toxins acting on the cell surface 
 
5.1 The bacterial superantigens 
Bacterial superantigens induce a massive stimulation of the immune system by binding to 
major histocompatibility class II (MHC II) molecules on the surface of antigen-presenting 
cells and also to the variable elements of T-cell antigen receptors (Figure 2) (Kotzin et al., 
1993). The best-characterised family within this group are the pyrogenic superantigens 
including members such as the staphylococcal enterotoxins (serotypes A-E, G and H), the 
streptococcal pyrogenic exotoxins (A-C and F), the streptococcal superantigen and the 
staphylococcal toxic shock syndrome toxin 1 (TSST-1) (Rago & Schlievert, 1998, Bohach et 
al., 1996, Kotb, 1995, Dinges et al., 2000). 
Interaction of superantigens with immune cells leads to the proliferation of T-cells (up 
to 20% of all T-cells) and a massive release of host cytokines, such as interferons, 
interleukins and tumor necrosis factors, from lymphocytes and monocytes (Stevens, 1997, 
Fast et al., 1989, Ikejima et al., 1984). The high concentrations of cytokines lead to the 
characteristic symptoms caused by the TSST-1, such as fever, rash formation, capillary leak 
and hypotension (Alouf & Muller-Alouf, 2003, Schlievert & Bohach, 2007). 
Superantigens are expressed as precursor molecules with a N-terminal signal 
sequence that is cleaved-off after secretion by the bacterial cell. The mature proteins have 
molecular weights ranging from 20-30 kDa (McCormick et al., 2001). In general, 
superantigens are highly resistant to heat, acids, proteolysis and desiccation (Dinges et al., 
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2000). The crystal structures of several superantigens have been determined and showed 
highly conserved protein architectures among various family members. The superantigen 
structure can be divided into two distinct domains: a N-terminal domain, also called small 
domain, comprised of a ȕ-barrel, and a C-terminal domain, also called large domain, 
consisting of antiparallel ȕ-strands and an α-helix (Mitchell et al., 2000, Brosnahan & 
Schlievert, 2011). 
 
 
 
Figure 2. Schematic representation of the superantigen target.  
Antigen-derived peptide is presented by the antigen-presenting cell. This complex is then recognised by the 
appropriate T-cell. Superantigens cross-link the MHC II molecule from the antigen-presenting cell to the 
variable elements of T-cell receptors and as a result stimulate T-cells.  
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5.2 Membrane-damaging toxins 
Bacterial membrane-damaging toxins (MDTs) were first described by Paul Ehrlich in the late 
19th century. He observed that a bacterial culture fluid containing C. tetani was able to lyse 
erythrocytes in vitro. On account of this finding, the substances responsible for red blood cell 
lysis were initially named hemolysins (Bernheimer, 1996). Nowadays, it is a known that not 
all of the MDTs have the ability to lyse erythrocytes and many MDTs have been shown being 
able to target a range of cell types other than red blood cells. Approximately one-third of all 
the bacterial toxins characterised so far have been identified to act as MDTs (Alouf, 2006, 
Alouf, 2001).  
MDTs play an important role in bacterial pathogenesis by generally disrupting 
membrane integrity of target host cells, followed by swelling and lysis of cells (Bhakdi & 
Tranum-Jensen, 1988, Alouf, 2001). Most MDTs are secreted by the bacteria and diffuse to 
the target cell membrane. However, some MDTs remain associated with the cell surface, such 
as streptolysin S from Streptococcus pyogenes (Calandra & Cole, 1981), or remain in the 
cytoplasm, such as C. perfringens enterotoxin, which is only released upon autolysis of the 
bacterium (Duncan, 1973, McDonel, 1980b). Due to their mode of action, MDTs can be 
classified into three groups: i) toxins with membrane-perturbing/detergent-like activity on 
membranes, ii) toxins with membrane-hydrolysing activity or iii) pore-forming toxins (Rowe 
& Welch, 1994). 
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5.2.1 Membrane-perturbing/detergent-like toxins 
Staphylococcus aureus δ-hemolysin, also called δ-toxin or δ-lysin, is one of the best studied 
examples of a membrane-perturbing/detergent-like toxin. Other examples include melittin 
from Apis mellifera (European honey bee venom) and nisin from Lactococcus lactis 
(Raghuraman & Chattopadhyay, 2007, Buchman et al., 1988).  
The gene encoding δ-hemolysin is part of the S. aureus agr locus (accessory gene 
regulator) that is involved in the regulation of several other S. aureus virulence factors 
(Balaban & Novick, 1995). δ-hemolysin is synthesized as a small 26 amino acid peptide with 
a molecular weight of 2.9 kDa (Fitton et al., 1980). It represents a zero net-charge and is 
mostly hydrophobic (Kantor et al., 1972). In organic solvents and membranes it adopts an 
amphipathic α-helical conformation (Tappin et al., 1988). δ-hemolysin binds non-specifically 
to membranes and is active against a number of cells: it exhibits hemolytic activity against a 
wide range of erythrocytes and shows limited antimicrobial activity against bacteria, such as 
Legionella pneumophila (Kreger et al., 1971, Verdon et al., 2008). Membrane interactions 
are mediated via hydrophobic and electrostatic interactions (Talbot et al., 2001). δ-hemolysin 
shows a concentration-dependent activity: at low toxin concentrations it forms small ion 
channels in membranes, while at high concentrations it acts in a detergent-like manner, 
solubilising the membrane (Bechinger & Lohner, 2006, Thelestam & Mollby, 1975, Pokorny 
& Almeida, 2004, Mellor et al., 1988, Kerr et al., 1995). The efficiency of δ-hemolysin is 
lipid-composition dependent as it has been shown that δ-hemolysin is preferentially located 
within liquid-disordered membrane domains, which, in contrast to liquid-ordered membrane 
domains, have low levels of sphingomyelin and cholesterol (Pokorny & Almeida, 2005, 
Pokorny et al., 2006). 
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5.2.2 Membrane-hydrolysing toxins 
The bacterial phospholipase C (PLC) family is one of the best studied toxin family with the 
capacity to enzymatically hydrolyse membranes. Members of this family can be found across 
different bacterial species, such as phosphatidylcholine-PLC from Bacillus cereus, PLC from 
Mycobacterium tuberculosis, Listeria monocytogenes PLC-A, α-toxin from C. perfringens, 
PLC from C. bifermentans or Ȗ-toxin from C. novyii (Gilmore et al., 1989, Titball, 1993, 
Vazquez-Boland et al., 1992). Most of the PLC family members show a significant sequence 
homology among each other (approximately 30%), particularly within their N-terminal 
regions (up to 250 amino acids). This protein region has been shown to harbour the catalytic 
site of the toxin (Naylor et al., 1998, Hough et al., 1989, Vazquez-Boland et al., 1992, Titball 
& Rubidge, 1990). In addition, some PLCs possess a C-terminal region (up to 120 residues) 
that has been shown to mediate binding of the toxin to the cell membrane (Titball et al., 
1993). In particular, this is the case for the three clostridial PLC members. However, not all 
of the PLC family members possess an additional C-terminal domain for membrane 
interaction. As a consequence, these PLCs have been shown to be non-toxic and are not able 
to hydrolyse phospholipids (Otnaess et al., 1977, Geoffroy et al., 1991). 
 
5.2.2.1 The C. perfringens α-toxin 
The α-toxin from C. perfringens is one of the most prominent members of the PLC family 
and is responsible for a variety of severe diseases in animals and humans (Titball et al., 1999, 
Bunting et al., 1997, Titball, 1993). The α-toxin gene is encoded on the chromosome and 
present in all of the five C. perfringens toxinotypes (McDonel, 1980a). In humans, α-toxin is 
the major virulence factor for causing gas gangrene. This observation is supported by the fact 
that mutants without the α-toxin gene did not cause disease and vaccination with an α-toxin 
toxoid was able to provide partial protection against disease (Williamson & Titball, 1993, 
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Awad et al., 1995). Interestingly, the α-toxin was the first toxin ever described to have 
enzymatic activity (Macfarlane & Knight, 1941). The toxin is a zinc-containing 
phospholipase with the ability to hydrolyse cell membrane phospholipids, preferentially 
phosphatidylcholine and sphingomyelin. The phospholipid cleavage reaction leads to the 
release of a head group which is linked to a phosphate and a diacylglycerol group, in the case 
of phosphatidylcholine, or a ceramide group, in the case of sphingomyelin (Nagahama et al., 
1996a, Krug & Kent, 1984). 
Elucidation of the α-toxin crystal structure revealed that the protein is composed of 
two domains (Figure 3) (Naylor et al., 1998, Eaton et al., 2002): a N-terminal domain 
harbouring the catalytic site (Nagahama et al., 1997), consisting of nine α-helices, and a C-
terminal domain essential for membrane interaction (Alape-Giron et al., 2000, Nagahama et 
al., 2002, Jepson et al., 1999), consisting of eight antiparallel ȕ-sheets which form a ȕ-
sandwich motif. The two domains are connected with each other via a flexible linker region. 
The C-terminal domain shows high similarity to C2-domains, which can be found in 
eukaryotic proteins. C2-domains have been shown to be involved in signal transduction 
pathways and possess a Ca2+ and/or phospholipid binding domain (Naylor et al., 1998, 
Guillouard et al., 1997, Nalefski & Falke, 1996). Zinc ions, located within the N-terminal 
domain, play a key function for the efficiency of the catalytic reaction. Amino acids involved 
in coordinating the correct position of zinc and calcium ions within the protein have been 
shown to be important for toxin activity (Titball & Rubidge, 1990, Nagahama et al., 1995, 
Nagahama et al., 1996b, Young et al., 1991). The two loops present in the N-terminal domain 
have been found to be crucial for the transformation between an open (substrate accessible) 
and a closed (substrate inaccessible) conformation of the toxin. A recent study identified that 
an exposed loop (residues 72-93) within this region is able to specifically interact with 
ganglioside GM1 (Oda et al., 2012).  
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Figure 3. Protein structure of C. perfringens α-toxin (closed form).  
The N-terminal domain is coloured in blue (residues 1-245) and the C-terminal domain in green (250-370). In 
addition, the two loop regions within the N-terminal domain are highlighted in red and two zinc positions are 
pointed out by black spheres within the catalytic site of the toxin. Reprinted from Eaton and co-workers, with 
permission from Elsevier (Eaton et al., 2002). 
 
Following membrane-binding, α-toxin induces the degradation of phosphatidylcholine 
and sphingomyelin, leading to membrane disruption. However, impairment of cell integrity is 
not the only effect of this toxin on the host. The generated phospholipid degradation products 
induce a variety of signal transduction pathways, favouring survival and spreading of  
C. perfringens within the host. For instance, diacylglycerol has been shown to be an 
important intracellular second messenger molecule that stimulates a variety of cell processes 
such as activation of endogenous protein kinase C (PKC) and sphingomyelinase (Sakurai et 
al., 2004). PKC triggers platelet activation factors that lead to platelet aggregation in infected 
areas (Sugahara et al., 1976, Kald et al., 1994). In addition, PKC is able to hydrolyse several 
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other membrane-bound phospholipases leading to increased levels of arachidonic acid and as 
a consequence, leukotrienes, thromboxanes and prostaglandins are generated, molecules that 
have important roles in inflammation processes. These factors contribute to local 
inflammation and induce inflammatory changes that influence various host defence 
mechanisms, for instance the contraction of blood vessels, impaired phagocytosis or platelet 
aggregation (Stevens et al., 1997, Bunting et al., 1997, Samuelsson, 1983, Gustafson & 
Tagesson, 1990). 
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5.2.3 Pore-forming toxins 
The pore-forming toxins (PFTs), with over 85 members described to date, form the largest 
group within the family of membrane-damaging toxins (Alouf, 2001). In general, PFTs are 
secreted by the bacterium as water-soluble monomers, diffuse to their target cell, insert into 
the host cell membrane and lead to cell lysis by pore-formation (Anderluh & Lakey, 2008).  
Membrane binding is mediated by the interaction with a specific cell surface 
component. This may be a lipid, lipid derivative, carbohydrate or proteinaceous receptor. 
After binding to the cell surface, PFTs assemble into a membrane-spanning oligomeric pore 
complex causing membrane permeabilisation and consequent cell lysis (Bhakdi & Tranum-
Jensen, 1988, Gouaux, 1997).  
The interaction of PFTs with membranes is one of the most fascinating processes: the 
transition of a water-soluble, mostly hydrophilic protein into a membrane-integrated protein 
in a highly hydrophobic environment. Two main strategies have been developed to manage 
this task: Toxins may either bury hydrophobic residues within the water-soluble form or 
generate hydrophobic surfaces by undergoing major conformational changes from the water-
soluble to the membrane-inserted form. In both cases, specific transmembrane regions are 
necessary in order to cross the membrane and form a pore. 
PFTs are classified by their pore-formation mechanism as either α- or ȕ-PFTs 
(Gouaux, 1997, Parker & Feil, 2005). While α-PFTs are α-helical proteins that form pores by 
inserting amphipathic α-helices into the membrane, ȕ-PFTs insert ȕ-sheets into the membrane 
in order to form a membrane spanning ȕ-barrel. Thereby, one (small PFTs) or more ȕ-
hairpins (large PFTs) of each individual toxin can insert into the target membrane (Geny & 
Popoff, 2006, Gouaux, 1997, Parker & Feil, 2005, Parker et al., 1989, Parker et al., 1994). 
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5.2.3.1 α-PFTs 
Members of the α-PFTs family show very different three dimensional protein structures and 
the size of the formed pore complex varies considerably. In most of the cases, these toxins 
possess an elongated protein structure rich in α-helical domains. Thereby, hydrophobic 
residues of membrane-penetrating amphipathic α-helices are buried against the protein core 
while in the water-soluble form. Upon interaction with the membrane bilayer these residues 
get surface exposed and line the pore in the transmembrane form. 
 
5.2.3.1.1 The Escherichia coli hemolysin E –  
first solved multimeric structure of an α-PFT 
The E. coli hemolysin E (HlyE), also known as cytolysin A (ClyA) or silent hemolysin A 
(SheA), is a major virulence factor for E. coli mediated pathogenicity (delCastillo et al., 
1997, Ludwig et al., 2004, Oscarsson et al., 1999). The crystal structures of its water-soluble 
and its transmembrane form have been determined (Ludwig et al., 1995, Wallace et al., 2000, 
Mueller et al., 2009). HlyE-like hemolysins can also be found within the Shigella and 
Salmonella genera (Hunt et al., 2010). 
The crystal structure of the water-soluble monomer revealed an elongated protein 
formed by a bundle of four helices (Figure 4 left) (Wallace et al., 2000). An additional helix 
at the C-terminus of the toxin forms the so called tail subdomain. At the other end of the 
protein, a subdomain called the ȕ-tongue is present. The ȕ-tongue consists of a short  
ȕ-hairpin rich in solvent exposed hydrophobic residues (delCastillo et al., 1997). The pore 
structure of HlyE showed an octameric pore with an inner diameter of about 25-30 Å (Figure 
4 middle, right) (Mueller et al., 2009, Oscarsson et al., 1999, Ludwig et al., 1999, Ludwig et 
al., 1995). More interestingly, it revealed the molecular re-arrangements needed for the 
transition from the water-soluble monomer to the transmembrane HlyE pore. Initially, it was 
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suggested that the ȕ-tongue subdomain would be responsible for forming the pore. However, 
Mueller et al. showed that the α-helix located at the opposite end of the protein, the tail 
subdomain, flips downwards and penetrates the membrane to form the transmembrane α-
helix. Although the ȕ-tongue also inserts into the membrane, after transformation to a short α-
helix, its primary function lies in the correct positioning of the tail domain and triggering 
pore-formation. Mutagenesis of amino acid residues within the ȕ-tongue have been shown to 
decrease the toxin hemolytic activity (Atkins et al., 2000). So far, no lipid-preference or 
proteinaceous receptor has been identified for HlyE. 
 
 
 
Figure 4. Protein structure of E. coli hemolysin E.  
(Left) Soluble monomeric form. (Middle) Monomeric form in the dodecameric assembly (Right). The ß-tongue 
is highlighted in black and the pore-forming domain in blue. The transition of the soluble toxin to the 
dodecameric assembly results in rearrangements of the ß-tongue and the pore-forming domain. Reprinted from 
Iacovache and co-workers, with permission from Elsevier (Iacovache et al., 2010). 
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5.2.3.2 β-PFTs 
The ȕ-PFTs form a membrane spanning ȕ-barrel structure that consists of individual ȕ-
hairpins from the assembled monomers. Whereas small ȕ-PFTs form pores ranging from 1-3 
nm in diameter, generally by oligomerisation of 6-8 monomers, large ȕ-PFTs are able to form 
pores with a diameter of up to 50 nm via the assembly of 35-50 monomers (Heuck et al., 
2001, Tweten et al., 2001, Shepard et al., 2000).  
 
5.2.3.2.1 The aerolysin-like β-PFTs family 
Aerolysin is a major virulence factor of the Aeromonas family causing gastrointestinal 
diseases, meningitis, wound infections and septicaemia in humans (Janda & Abbott, 1998, 
Leclerc et al., 2002, Altwegg & Geiss, 1989). Aerolysin is the best-characterised member of 
related toxins classified into the aerolysin-like PFTs family. Other members of this family 
include enterolobin from the Brazilian tree Enterolobium contortisiliquum (Sousa et al., 
1994, Bittencourt et al., 2003), C. septicum α-toxin (Ballard et al., 1995), lectin from the 
mushroom Laetiporus sulphurous (Mancheno et al., 2005), insecticidal toxins such as mtx 
from B. sphaericus (Charles et al., 1996) or parasporin-2 from B. thuringiensis (Akiba et al., 
2009), lysenin from the earthworm Eisenia fetida (De Colibus et al., 2012) or C. perfringens 
Etx and enterotoxin (Briggs et al., 2011, Kitadokoro et al., 2011, Cole et al., 2004). 
 
5.2.3.2.1.1 The A. hydrophila aerolysin -  
the first solved monomeric protein structure of a β-PFT 
Aerolysin is expressed as a 52 kDa prototoxin with a N-terminal signal peptide for secretion 
into the extracellular medium via the type II secretion system (Fivaz et al., 2001a). The 
secreted inactive proaerolysin is proteolytically activated by proteases such as trypsin, α-
chymotrypsin or furin and lead to the removal of a 41-43 long peptide at the C-terminus 
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(Abrami et al., 1998a, Howard & Buckley, 1985, van der Goot et al., 1992). Proaerolysin and 
activated aerolysin preferentially associate as dimers in solution (van der Goot et al., 1993, 
Barry et al., 2001). However, for interaction with cell membranes the dimers have to 
dissociate into monomers (Fivaz et al., 1999). GPI-anchored proteins have been shown to be 
the binding targets for the aerolysin toxin (Nelson et al., 1997, Fivaz et al., 1999, Diep et al., 
1998, Abrami et al., 1998b, MacKenzie et al., 1999). GPI-anchored proteins are ubiquitous 
molecules on the cell surface of eukaryotes and prevalently accumulate in regions called 
detergent-resistant membrane domains (DRMs) (Harder & Simons, 1997). Concentration of 
aerolysin in DRMs facilitates oligomerisation and subsequent formation of a heptameric pore 
complex (Wilmsen et al., 1992, Moniatte et al., 1996, Tsitrin et al., 2002, Abrami & van der 
Goot, 1999). The aerolysin pore leads to cell death by inducing cell membrane depolarisation. 
However, massive membrane disruption might not be the only effect in order to cause cell 
damage and involve more complex mechanism such as triggering a variety of cellular events 
as a consequence of the selective permeabilisation of small ions through the toxin pore, such 
as potassium or calcium (Krause et al., 1998, Abrami et al., 1998b). In baby hamster kidney 
cells, aerolysin has been shown to cause vacuolation of the endoplasmic reticulum (ER) by 
the interaction with GPI-anchored proteins (Abrami et al., 1998b). In human granulocytes, 
aerolysin has been shown to be involved in G-protein dependent cell-activation and release of 
calcium from the ER (Krause et al., 1998). In T-cells, sublytic concentrations of aerolysin 
have been shown to trigger apoptosis by pore-formation and resulting calcium influx (Nelson 
et al., 1999).  
The monomeric structure of aerolysin from A. hydrophila was the first solved protein 
structure of a ȕ-PFT (Figure 5) (Parker et al., 1994). The aerolysin monomer appears as a 
bilobal L-shaped molecule with a small N-terminal lobe (domain 1) and a large lobe formed 
by domains 2-4. Domains 1 and 2 play a significant role in
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receptor binding (MacKenzie et al., 1999, Fivaz et al., 2001a, Green & Buckley, 1990), while 
domains 3 and 4 are important for oligomerisation and insertion of the toxin into the target 
cell membrane (Rossjohn et al., 1998, Lesieur et al., 1999, Wilmsen et al., 1991, Vandergoot 
et al., 1993).  
The channel-forming region is located in domain 3 and consists of an amphipathic 
loop of around 20-25 amino acids (Iacovache et al., 2006). For membrane insertion, the 
amphipathic hairpin extends away from the molecule core towards the membrane and 
interacts with neighbouring loops in order to form a transmembrane ȕ-barrel configuration. 
The insertion process is particularly driven by a central hydrophobic stretch within the 
amphipathic loop that, once inserted in the membrane, lines the aerolysin pore and anchors 
the 14-stranded ȕ-barrel into the membrane. A pre-condition for triggering membrane 
penetration is the proteolytic cleavage of the C-terminal peptide in domain 4 during toxin 
activation. This reaction induces key conformational changes facilitating toxin 
oligomerisation and membrane insertion (Cabiaux et al., 1997, Parker et al., 1994). Thus, 
uncleaved, the C-terminal peptide might stabilise the momomeric form and prevent toxin 
oligomerisation. 
Despite limited amino acid sequence homology across members of the aerolysin-like 
PFTs family (e.g. Etx shows a sequence similarity of under 14% to aerolysin), the three 
dimensional protein structures show high structural similarity (Figure 5) (Cole et al., 2004, 
Mancheno et al., 2005, Briggs et al., 2011, Kitadokoro et al., 2011, Akiba et al., 2009). 
However, in contrast to aerolysin, the other members of this family consist of only three 
domains. The lowest structural similarities amongst these toxins are observed in domain 1 
(domains 1 and 2 in aerolysin), the highest structural similarities in domains 2 and 3 (domains 
3 and 4 in aerolysin). This is due to the fact that domain 1 (domains 1 and 2 in aerolysin) 
mediates receptor specificity and plays an important role in toxin-cell interactions 
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(MacKenzie et al., 1999). Domain 2 and 3 show similar functions to those observed in 
aerolysin and play a key role in membrane insertion and oligomerisation of these toxins 
(Knapp et al., 2009, Miyata et al., 2001, Melton-Witt et al., 2006, Melton et al., 2004, Kokai-
Kun et al., 1999). To date, no multimeric crystal structures from members of the aerolysin-
like PFTs family are available. However, whereas aerolysin, α-toxin and Etx have been 
suggested to form a heptameric pore, lectin may form a hexameric pore arrangement 
(Mancheno et al., 2005, Wilmsen et al., 1992, Moniatte et al., 1996, Melton et al., 2004, 
Ballard et al., 1993, Miyata et al., 2002, Degiacomi et al., 2013).  
 
 Figure 5. Protein structures of members of the aerolysin-like β-PFTs family.  
The N-terminal membrane-interacting region and other non-related regions are coloured cyan, domains 
important for oligomerisation and membrane interaction are coloured in pale green and pink, and the 
characteristic ȕ-hairpin which inserts into the membrane in red. Reprinted from Bokori-Brown and co-workers, 
with permission from John Wiley and Sons (Bokori-Brown et al., 2011).  
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5.2.3.2.2 The α-hemolysin-like β-PFTs family 
The α-hemolysin (αHL) from S. aureus has been associated with the pathogenesis of a variety 
of human diseases such as skin/soft tissue infection, sepsis and pneumonia (Fritz et al., 2013, 
Kolata et al., 2011, Adhikari et al., 2012). αHL has been considered as the prototype of the 
αHL-like ȕ-PFTs family which also comprise the Ȗ-hemolysin and leukocidins from S. aureus 
(Yamashita et al., 2011), Vibrio cholerae cytolysin (De & Olson, 2011), B. cereus hemolysin 
II and cytotoxin K (Baida et al., 1999, Lund et al., 2000, Miles et al., 2002) and NetB, ȕ- and 
δ-toxins from C. perfringens (Manich et al., 2008, Keyburn et al., 2008). 
 
5.2.3.2.2.1 S. aureus α-hemolysin -  
the first solved multimeric protein structure of a β-PFT 
S. aureus αHL is secreted as a 34 kDa water-soluble monomer that does not need any 
proteolytic activation for its toxic activity (Tweten et al., 1983). After binding to target cells, 
the toxin assembles into a heptameric pore complex leading to cell permeation and 
consequent cell lysis (Bhakdi & Tranum-Jensen, 1991, Menestrina et al., 2001, Valeva et al., 
1997). In contrast to aerolysin, a so called pre-pore complex is formed whereby the 
monomers are non-covalently associated with each other, arranged in a ring-like structure but 
do not yet cross the membrane (Walker & Bayley, 1995, Walker et al., 1995, Valeva et al., 
1996). Thus, the pore-formation process of αHL is commonly described as a four-step 
process: i) secretion of the water-soluble monomer, ii) membrane-bound monomer, iii) 
membrane-bound heptamer and iiii) heptameric pore complex.  
The membrane-spanning αHL pore leads to influx of small ions, such as Ca2+ and K+, 
and small molecules with a molecular cutoff of around 4 kDa (Gouaux et al., 1994). 
Disintegrin and metalloprotease 10 have been identified as specific cell receptors for αHL 
mediated cytotoxicity (Wilke & Wardenburg, 2010, Inoshima et al., 2011). The toxin can 
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target a wide range of cells such as human erythrocytes, thrombocytes and T-cells (Bhakdi et 
al., 1988, Gouaux et al., 1997, Jonas et al., 1994). However, αHL is also able to form pores 
on artificial liposomes (Watanabe et al., 1987, Belmonte et al., 1987) and been been shown to 
have increased affinity to a variety of lipids such as cholesterol and phosphatidylcholine 
(Thay et al., 2013, Valeva et al., 2006, Schwiering et al., 2013, Galdiero & Gouaux, 2004). 
Receptor-assisted cytotoxicity may be most relevant at low-toxin concentrations where a 
high-affinity receptor is most useful to induce disease.  
The heptameric αHL pore complex was the first elucidated PFT structure in a pore-
conformation (Song et al., 1996, Gouaux, 1998) (Figure 6). The oligomeric αHL protein 
structure can be divided into three domains: cap, rim and stem (Iacovache et al., 2010, 
Gouaux, 1997, Parker & Feil, 2005). The cap domain is rich in ȕ-sheets and is involved in 
monomer-interactions while the rim domain is located at the bottom of the cap and involved 
in cell binding. The cap and rim domains form the core of the protein. The stem domain 
consists of a glycine-rich ȕ-hairpin with alternating hydrophilic and hydrophobic amino acid 
residues. In the monomeric form, the ȕ-hairpin is folded against the protein core. However, 
during membrane insertion, a transmembrane ȕ-barrel is formed by the unfolding of 
individual ȕ-hairpins into the membrane and thus, the heptameric lytic pore complex 
spanning the lipid bilayer is formed by a 14-stranded ȕ-barrel. The N-terminal latch protrudes 
from each monomer and interacts with the neighbouring protomers around the entrance of the 
channel in order to stabilise the heptameric complex (Malghani et al., 1999, Song et al., 
1996). The αHL pore has been suggested to be slightly anion selective (Menestrina, 1986).  
In recent years, three-dimensional protein structures of several other members of the 
αHL-like PFTs family have been determined, such as LukF and Ȗ-hemolysin from  
S. aureus, δ-toxin from C. perfringens or cytolysin from Vibrio cholerae, and revealed high 
structural similarities among each other (Olson et al., 1999, Huyet et al., 2013, Pedelacq et 
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al., 1999, Guillet et al., 2004, De & Olson, 2011, Yamashita et al., 2011). Whereas αHL 
assembles into a homo-heptamer, the bicomponent leukotoxins (Ȗ-hemolysin and 
leukocidins) form hetero-oligomeric pores by the synergistic association of two distinct and 
independently secreted proteins (Kaneko & Kamio, 2004, Montoya & Gouaux, 2003). The 
stoichiometry of these hetero-oligomeric pores is still under debate and varies from 6-8 
monomers (Sugawara et al., 1997, Sugawara-Tomita et al., 2002).  
 
 
 
Figure 6. Protein structure of the S. aureus αHL heptamer.  
(A) Side view of the αHL heptamer. One monomer is shown in a darker shade with the N- and C-termini 
labelled. The cap, rim and stem domains of the toxin and the putative location of the membrane bilayer is 
indicated. (B) Cytoplasmatic view of the αHL heptamer. (C) Isolated monomer from the heptameric αHL 
structure. The amino latch, triangle region, rim, ȕ-sandwich and stem domains are labelled. The ȕ-sandwich 
forms the backbone of the monomer and the triangle region bridges the ȕ-hairpins and the monomer core. 
Reprinted from Gouaux and co-workers, with permission from Elsevier (Gouaux, 1998).  
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5.2.3.2.3 Cholesterol-dependent cytolysins – the large β-PFTs 
The cholesterol-dependent cytolysins (CDCs) form a large group of water-soluble, 
monomeric, single-chain toxins with an average molecular weight of 50-80 kDa (Heuck et 
al., 2001, Harris et al., 2010, Alouf et al., 2006). The members of the CDC family are widely 
spread over different genera of Gram-positive bacteria. The best studied members of this 
group being perfringolysin O from C. perfringens, streptolysin O from S. pyogenes, 
pneumolysin from S. pneumoniae and listeriolysin O from L. monocytogenes. Recently, 
CDCs have also been identified in Gram-negative bacteria (Hotze et al., 2013). Two main 
characteristics make the CDC family so unique: CDCs depend on cholesterol for their 
activity and monomer oligomerisation (35-50) lead to the formation of very large, membrane 
embedded, pore-forming complexes with up to 350 Å in diameter (Tweten et al., 2001, 
Heuck et al., 2010, Giddings et al., 2003, Shatursky et al., 1999). 
The genes of the CDCs are present on the bacterial chromosome and possess high 
amino acid sequence similarity among each other (40-80%) (Parker & Feil, 2005, Heuck et 
al., 2010). The sequence similarity is particularly high within the C-terminus where the so 
termed undecapeptide is located, an eleven amino acid long region rich in tryptophan residues 
(ECTGLAWEWWR) and important for interaction with target cells (Tweten et al., 2001, 
Shannon et al., 2003). Worth mentioning in this context is that the cysteine residue located in 
the undecapeptide gave the CDCs the former designation of sulfhydryl or thiol-activated 
cytolysins due to the fact that their activity could be repressed by sulfhydryl group blocking 
agents and recovered by thiols and other reducing agents (Iwamoto et al., 1987). Although 
the cysteine residue is not necessarily required for cytolytic activity, as some members do not 
possess this residue such as pyolysin (Billington et al., 1997), it plays a key role for the 
biological activity of many CDCs as mutations at this position tend to decrease cytolytic 
activity (Saunders et al., 1989, Pinkney et al., 1989).  
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In general, CDCs are produced as water-soluble monomers and released by the 
bacterium via the type 2 secretion system into the extracellular medium. Exceptions being 
some CDCs produced by the Streptococcus genus, such as pneumolysin, that lack a signal 
peptide for bacterial secretion (Walker et al., 1987). The mechanism by which pneumolysin 
is secreted by the bacterium is still not well understood (Johnson, 1977, Price & Camilli, 
2009, Balachandran et al., 2001, Mitchell et al., 1997). For most of the CDCs, membrane 
cholesterol acts as a binding receptor. Binding to cholesterol triggers rearrangements in the 
protein structure that facilitate oligomerisation of the monomers and formation of a so called 
pre-pore complex (Hotze et al., 2002, Hotze et al., 2001). Once the pre-pore complex is 
formed, a concerted conformational change leads to the unfurling of membrane-spanning ȕ-
hairpins in each monomer and to the formation of a large ȕ-barrel transmembrane pore 
(Shatursky et al., 1999). Membrane cholesterol have been shown to be important for the 
conversion of the pre-pore to the pore complex (Soltani et al., 2007b, Soltani et al., 2007a, 
Giddings et al., 2003, Ramachandran et al., 2004, Shatursky et al., 1999). Some CDCs, such 
as intermedilysin from S. intermedius, have been shown to use human CD59 as cell receptors 
(Giddings et al., 2004, Gelber et al., 2008). However, membrane cholesterol has still been 
identified to be important for CD59 mediated binding and pore-formation (LaChapelle et al., 
2009, Giddings et al., 2003).  
It is not yet fully understood why CDCs necessarily form such enormous pores as a 
smaller pore would be absolutely sufficient to cause cell lysis. Several studies suggest that 
CDCs might trigger a number of cellular effects other than pore-formation to cause cell lysis 
(Gekara et al., 2007, Rose et al., 2001, Cockeran et al., 2001, Cockeran et al., 2002, Fickl et 
al., 2005, Bernatoniene et al., 2008, Baba et al., 2002). For instance, some S. pneumoniae 
strains have been shown to produce only a non-hemolytic toxin, due to a mutation in the 
pneumolysin gene, but were still able to cause disease (Kirkham et al., 2006, Jefferies et al., 
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2007). As the formed pore is big enough to translocate proteins, it has been suggested that 
bacteria might use this system even for protein translocation (Madden et al., 2001, Shatursky 
et al., 1999). 
 
5.2.3.2.3.1 C. perfringens perfringolysin O –  
the first crystal structure of a large β-PFT 
Perfringolysin O (PFO) from C. perfringens is a prototypical member of the CDC family. 
The crystal structure of the soluble form of PFO was the first solved protein structure of a 
large ȕ-PFT and led to an increased general understanding of the reaction mechanisms of 
CDCs (Rossjohn et al., 1997). The elucidated protein structure revealed an elongated shape 
consisting of 4 domains (Figure 7). The characteristic CDC undecapeptide and 3 hydrophobic 
loops are located in domain 4 (C-terminal domain) and play key roles for membrane 
recognition and binding to target cells (Nakamura et al., 1995, Heuck et al., 2003, Nakamura 
et al., 1998, Ramachandran et al., 2002). The predicted model of action is that domain 4 
anchors the protein to the cell surface, whereby the elongated toxin monomers are orientated 
approximately perpendicular to the surface of the lipid bilayer (Ramachandran et al., 2005, 
Czajkowsky et al., 2004). This initiates molecular rearrangements facilitating monomer-
monomer interactions and oligomerisation of the monomers into a pre-pore complex (Hotze 
et al., 2002, Hotze et al., 2001, Ramachandran et al., 2004, Shepard et al., 2000). Thereby, 
monomers form large circles or arcs on the membrane surface and oligomeric assemblies can 
comprise of up to 50 monomers (Olofsson et al., 1993, Czajkowsky et al., 2004). Once the 
pre-pore complex is formed, major conformational changes in domain 3 lead to unfolding of 
6 α-helices into 2 transmembrane ȕ-hairpins in each PFO monomer and subsequently 
penetrate the membrane to form the lumen of a large ȕ-barrel pore (Shepard et al., 1998). 
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In recent years, protein structures have been solved of intermedilysin from  
S. intermedius, anthrolysin O from B. anthracis and suilysin from S. suis (Polekhina et al., 
2005, Bourdeau et al., 2009, Xu et al., 2010). Using cryo-electron microscopy and PFO as a 
model, a pore structure has also been determined for pneumolysin from S. pneumoniae 
(Tilley et al., 2005). Collectively, this data revealed that the structural backbone is mostly 
conserved across members of the CDC family, thus suggesting a similar mechanism for pore-
formation. 
 
 
 
Figure 7. Protein structure of C. perfringens PFO.  
The four domains and the tryptophan-rich motif are indicated. Reprinted from Rossjohn and co-workers, with 
permission from Elsevier (Rossjohn et al., 1997). 
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6. Enterotoxemia  
Enterotoxemia is an enteric C. perfringens infection leading to severe disease in sheep, goats 
and calves and to a lesser extent in horses and deer (Songer, 1996). In sheep, enterotoxemia is 
also known as pulpy kidney or overeating disease. Etx, which is produced by C. perfringens 
toxinotypes B and D, has been identified as the main virulence factor causing enterotoxemia 
and intoxication of animals may result in rapid death (Uzal & Songer, 2008, Uzal, 2004). As 
treatment of severe enterotoxemia is difficult, preventive animal vaccination has been the 
most successful strategy to reduce occurrence of disease (Titball, 2009). 
 
6.1 Clinical signs of enterotoxemia 
Enterotoxemia has been well characterised in sheep and goats and may occur as an acute, 
subacute or chronic form (Uzal & Songer, 2008). While acute and subacute disease can arise 
rapidly without any premonitory signs and lead to mortality within a short time period, 
chronic disease may persist for long time periods and either lead to death or result in 
recovery. Clinical signs include diarrhea, hemorrhagic enterocolitis, abdominal discomfort, 
convulsions and neurological manifestations (Popoff, 1984, Finnie, 2004, Blackwell et al., 
1991, Uzal et al., 2002, Uzal et al., 2004). High glucose blood levels and presence of glucose 
in the urine are also characteristic signs for enterotoxemia (Gardner, 1973). 
At necropsy, pulmonary and cardiac edema may be found (Uzal et al., 2004). In 
addition, lesions, focal degeneration and softening of cerebral tissue may be observed 
(Buxton et al., 1981, Finnie, 1984, Buxton & Morgan, 1976, Uzal et al., 1997). Etx can often 
be detected in intestinal contents and pericardial fluids (Uzal, 2004, Layana et al., 2006, Uzal 
et al., 2003). 
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6.2 Predisposing factors for enterotoxemia 
Predisposing factors for enterotoxemia have in common to disrupt the microbial balance in 
the gut favouring overproliferation of C. perfringens. This is mostly due to overeating or 
sudden diet changes, often of poorly digestible carbohydrates, which result in the passage of 
large amounts of nutrients into the gut but may also be triggered by parasite infections (Uzal 
& Kelly, 1996, Elliott, 1984). High numbers of C. perfringens result in the production of Etx 
which is able to perforate the intestinal barrier, pass into the bloodstream and circulate to 
various organs where it is able to cause severe tissue damage (Miyakawa & Uzal, 2003, 
Goldstein et al., 2009). 
 
6.3 The epsilon toxin gene 
The epsilon toxin gene (etx) encodes a 296 amino acid protein and includes a N-terminal 
signal peptide for secretion. Only minor nucleotide differences were observed between the 
etx genes present in C. perfringens toxinotypes B (etxB) and D (etxD) (Havard et al., 1992). 
While a nucleotide variation at position 762 does not result in a change of the amino acid 
sequence, another nucleotide variation at position 962 leads to the translation of a different 
codon. Thus, as etxB encodes for a serine at that position, etxD encodes for a tyrosine. In 
addition, the promoter sequences of both genes are not identical and show differences in the 
putative -35 and -10 binding regions suggesting that expression of etxB and etxD may be 
regulated differently in C. perfringens toxinotypes B and D. 
 
6.4 Production of Etx 
Etx is secreted as a relatively inactive prototoxin with a predicted molecular mass of 33 kDa 
(Hunter et al., 1992). For activation, the prototoxin is cleaved proteolytically by proteases 
which are either provided by the host, as trypsin or chymotrypsin, or by the bacterium itself, 
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as λ-protease (Bhown & Habeerb, 1977, Minami et al., 1997). Depending on the protease 
involved, different peptide fragment lengths are removed from the N- and C-terminal ends of 
the protein. Activation by trypsin and chymotrypsin, which leads to the removal of 13 amino 
acids at the N-terminus and 29 amino acids at the C-terminus, leads to an approximately 
1000-fold increase in toxicity and a LD50 of 50-65 ng/kg in mice (Worthington & Mulders, 
1977, Minami et al., 1997, Miyata et al., 2001). Cleavage by trypsin only, whereby 22  
C-terminal residues are removed, results in a LD50 of 320 ng/kg in mice (Minami et al., 
1997). Proteolytic cleavage by λ-toxin leads to the removal of 10 amino acids at the N-
terminus and 29 amino acids at the C-terminus, resulting in an active Etx with a LD50 of  
110 ng/kg in mice (Minami et al., 1997). 
 
6.5 Molecular mode of action of Etx 
Etx has been suggested to assemble into a high molecular weight complex after binding to 
target cell membranes (Petit et al., 1997, Nagahama et al., 1998). Cleavage of the C-terminus 
has been shown to be crucial for toxin oligomerisation and formation of a pore complex 
(Miyata et al., 2001). Prior to pore-formation, evidence for a pre-pore stage has been shown 
by Robertson and co-workers (Robertson et al., 2011). Pore-formation leads to swelling and 
blebbing of cells as a result of an increased membrane permeability, in particular leading to 
an efflux of K+ and influx of Na+ and Cl- ions into the cell (Petit et al., 1997, Petit et al., 
2001). The subsequent collapse of membrane integrity results in rapid cell lysis (Petit et al., 
2003). 
One of the best studied cell types relative to Etx mediated cytotoxicity is the Madin-
Darby canine kidney cell line (MDCK) (Knight et al., 1990, Petit et al., 1997, Nagahama et 
al., 1998). A mouse kidney cell line (mpkCCDcl4), a human renal adenocarcinoma cell line 
(ACHN) and a renal leiomyoblastoma human cell line (G-402) have also been identified to be 
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susceptible against Etx (Chassin et al., 2007, Ivie et al., 2011, Shortt et al., 2000). This 
particular high specificity to a very few cell types in vitro raises the question if Etx requires a 
specific binding partner on the target cell surface. Previous studies showed that Etx did not 
show a specific lipid preference but prevalently accumulated in regions called detergent 
resistant membrane domains (DRMs) (Miyata et al., 2001, Petit et al., 2001). These regions 
have been found to be the favoured interaction locations also for other PFTs, such as 
aerolysin from A. hydrophila or perfringolysin O from C. perfringens (Waheed et al., 2001, 
Fivaz et al., 2001b). Although a specific cell receptor has not been identified for Etx yet, 
several studies indicate that a glycoprotein may be involved in binding to target cell surfaces 
(Nagahama & Sakurai, 1992, Dorca-Arevalo et al., 2012). Recently, Ivie et al. showed that 
Etx was able to bind to O-linked glycans of the extracellular domain of human hepatitis A 
virus cellular receptor 1 (HAVCR1) (Ivie et al., 2011, Ivie & McClain, 2012). However, if 
this may represent the physiological receptor also for other cells is not known. 
 
6.6 Structure of Etx 
The crystal structure of monomeric Etx shows high similarities with aerolysin from  
A. hydrophila, despite the fact that sequence similarity is under 14% (Figure 5) (Cole et al., 
2004). As for most of the members of the aerolysin-like PFTs family, the Etx structure 
revealed an elongated shape consisting of three domains. While domain 1 plays an important 
role for toxin-cell interactions, the second domain of Etx features the ȕ-hairpin and has a key 
role in membrane insertion (Knapp et al., 2009, Fivaz et al., 2001a, Cole et al., 2004, Ivie & 
McClain, 2012, Bokori-Brown et al., 2013). The third domain has been shown to be 
important for toxin oligomerisation (Miyata et al., 2001). Although a multimeric crystal 
structure has not been determined for Etx yet, a heptameric pore complex has been suggested 
(Miyata et al., 2002). 
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6.7 Prevention of disease 
A number of vaccines are commercially available to prevent C. perfringens associated 
enterotoxemia (Titball, 2009). The most common strategy being immunisation of 
formaldehyde-inactivated C. perfringens culture filtrates (Lobato et al., 2010). However, as 
effectiveness has been reported to be variable, alternative immunisation strategies have been 
tested (Blackwell & Butler, 1992, Uzal & Kelly, 1998). Immunisation of a recombinant 
variant form of Etx (H106P) with reduced cytotoxicity has shown induction of specific 
antibody responses and protected animals against a 1000-fold LD50 challenge of wild type 
toxin (Oyston et al., 1998). Etx I51C/A114C and V56C/F118C have also been shown to lack 
detectable cytotoxicity against MDCK cells and may potentially be used as dominant-
negative inhibitors (Pelish & McClain, 2009). Monoclonal antibodies against Etx have 
effectively been shown to neutralise Etx induced cytotoxicity towards cultured cells 
(McClain & Cover, 2007) and to be protective against an Etx challenge in mice (El-Enbaawy 
et al., 2003, Percival et al., 1990). Recently, three small molecule inhibitors (N-
cycloalkylbenzamide, furo [2,3-b] quinoline and 6H-anthra [1,9-cd] isoxazol) have also been 
identified to inhibit Etx mediated cytotoxicity (Lewis et al., 2010). 
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7. Necrotic enteritis 
Necrotic enteritis (NE) is a severe gastro-intestinal disease manifesting in gross lesions within 
the intestines of poultry and causing significant costs to the poultry industry worldwide 
(Parish, 1961, Cooper & Songer, 2010, Keyburn et al., 2008). In 2000, the economic impact 
of this disease was estimated to be in the order of 2bn US dollars per year (Sluis, 2000, 
Castanon, 2007). It is assumed that intensive farming practices in modern poultry rearing 
developed alongside the general use of antimicrobial growth promoters in feedstuffs and thus, 
as an unintended consequence, the functioning of these farming practices heavily depend on 
the addition of antibiotics. These supplements controlled diseases such as NE, although this 
was not the sole intention for their addition to feedstuffs. In the EU, the addition of 
antimicrobial growth promoters to feedstuffs has been banned since 2006 (Leung et al., 
2011). Thus, as an effect of regulations limiting the addition of antimicrobial growth 
promoters, NE is re-emerging and the incidence of disease is certain to increase over the next 
few years. 
 
7.1 Clinical signs of NE 
NE can occur either as an acute or as a mild clinical form. Acute NE typically leads to high 
mortality rates during the last weeks of the broilers rearing period (week 5-6). Disease can 
arise without any previous signs and cause mortality in a couple of hours (Wijewanta & 
Senevirtna, 1971, Helmboldt & Bryant, 1971). The mild clinical form of NE is more chronic 
and induces intestinal damage. Diseased animals show reduced performance parameters such 
as less feed intake, decreased digestion and absorption of feedstuffs and consequently 
reduced weight gain over time (Elwinger et al., 1992, Kaldhusdal et al., 2001). The mild 
clinical form is the most prevalent form of NE in the poultry production industry and mostly 
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responsible for the associated economical losses as it may go undetected and remain 
untreated (Dahiya et al., 2006). 
At necropsy, macroscopic lesions can be found primarily at the mucosal surface of the 
small intestines (Figure 8). Tissue damage can range from small necrotic foci to extensive 
necrosis. Mucosal surfaces are often covered by a so called pseudomembrane consisting of 
loosely adhered damaged tissue and aggregation of bacterial cells (Gazdzinski & Julian, 
1992). However, other organs such as kidneys or liver may also get effected (Eleazer & 
Harrell, 1976, Al-Sheikhly & Truscott, 1977a, Al-Sheikhly & Truscott, 1977b, Olkowski et 
al., 2006). In addition, blood vessels have been found to be congested with morphologically 
abnormal erythrocytes.  
 
 
Figure 8. NE lesions within the small intestines of chicken.  
Clinical signs can range from small/ medium necrotic foci (A) to extensive necrosis (B) of the mucosal intestinal 
surface. Reprinted from Van Immerseel and co-workers, with permission from Elsevier (Van Immerseel et al., 
2009). 
58 
 
7.2 Predisposing factors for NE 
A number of predisposing factors for developing NE have been identified which influence 
the gut environment of the host organism and favour the growth of NE-inducing  
C. perfringens strains. C. perfringens proliferates in high numbers and starts production of 
extracellular toxins, resulting in severe tissue damage and leading to the characteristic NE 
clinical picture. 
The nature of the feedstuff is the key predisposing factor for NE. Poor digestible diet, 
such as non-starch polysaccharides and protein-rich feed with low lipid content, lead to ideal 
growth conditions for C. perfringens in the gut (Branton et al., 1987, Riddell & Kong, 1992, 
Palliyeguru et al., 2010). Stress is another important factor able to induce NE by influencing 
the composition of the bacterial flora. Stress can be provoked by sudden diet changes, high-
density animal housing conditions or extreme environmental temperatures (McDevitt et al., 
2006, Burkholder et al., 2008). Mucosal damage of the gut, caused by some organisms such 
as Eimeria species, has often been reported before or during outbreaks of NE in the field 
(Williams, 2005, Helmboldt & Bryant, 1971, Broussard et al., 1986). Co-infection of  
C. perfringens with various Eimeria species have been shown to synergistically induce NE in 
animals (Al-Sheikhly & Alsaieg, 1980, Gholamiandehkordi et al., 2007, Williams et al., 
2003, Park et al., 2008). Eimeria species are able to cause mucosal damage as part of their 
pathogenic lifestyle by lysing mucosal cells and inducing mucin production (Collier et al., 
2008). The released cell nutrients and mucin can be used as substrates by C. perfringens. The 
consequences of tissue damage lead to exposure of extracellular matrix molecules that can be 
used by C. perfringens for adhesion and colonisation of the intestinal gut (Martin & Smyth, 
2010). A correlation between high C. perfringens counts in the intestines and diseased 
animals has also been shown (Kaldhusdal et al., 1999, Pedersen et al., 2008). However, 
although this might be a useful indicator, and precondition for inducing NE, each case should 
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be looked at carefully as high numbers of C. perfringens are not necessarily found only in 
diseased animals (Mikkelsen et al., 2009). The molecular makeup of C. perfringens strains in 
the gut is another essential factor for inducing NE (Shojadoost et al., 2012). Molecular typing 
of C. perfringens isolates from healthy and diseased animals showed that, in contrast to 
healthy animals, diseased animals carried a particular C. perfringens strain (Engstrom et al., 
2003, Nauerby et al., 2003). It has been suggested that NE-inducing C. perfringens strains 
produce bacteriocins in order to inhibit intra-species growth of non-NE strains in the gut 
(Barbara et al., 2008, Timbermont et al., 2009). As a consequence, an almost clonal NE-
inducing C. perfringens population is able to solely proliferate in the gut. This is supported 
by the observation that C. perfringens isolates across birds within a diseased flock show a  
C. perfringens population with very low genetic diversity (Gholamiandekhordi et al., 2006). 
 
7.3 Toxins inducing NE 
Initially, it was suggested that α-toxin from C. perfringens was the major virulence factor for 
causing NE but experiments with an α-toxin mutant showed that this strain was still virulent 
and able to cause disease (Keyburn et al., 2006, Al-Sheikhly & Truscott, 1977b). In addition, 
NE-inducing C. perfringens isolates did not show higher α-toxin production levels relative to 
isolates from healthy animals (Gholamiandekhordi et al., 2006). 
NetB is a toxin produced by C. perfringens toxinotype A strains and has been shown 
to play a major role in the pathogenesis of NE (Al-Sheikhly & Truscott, 1977b, Kaldhusdal et 
al., 1999). This is supported by the fact that a netB mutant was not capable of causing NE, 
whereas the wild type strain and the complemented mutant were (Keyburn et al., 2008). In 
addition, almost all C. perfringens isolates from NE-cases possessed the netB gene (Cooper 
& Songer, 2009, Chalmers et al., 2008, Martin & Smyth, 2009). NetB has been classified as 
new member of the αHL-like ȕ-PFTs family. NetB shares significant sequence homology to 
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other family members such as 38% identity with the  
ȕ-toxin from C. perfringens, 40% identity with C. perfringens δ-toxin and 31% with αHL 
from S. aureus (Manich et al., 2008, Keyburn et al., 2008). NetB has been shown to display 
cytotoxic activity against LMH cells, a Leghorn chicken hepatocellular carcinoma cell line, 
by inducing cell rounding and cell lysis (Keyburn et al., 2008). 
However, there is also accumulating evidence that other virulence factors, such as the 
large cytotoxin TpeL, play a role in disease (Coursodon et al., 2012). Olkowski et al. have 
shown that C. perfringens strains isolated from NE field cases produced an elevated level of 
proteolytic factors such as collagenolytic enzymes which are able to damage extra-cellular 
matrix proteins and cellular junctions, thus contributing to tissue necrosis (Olkowski et al., 
2008). The production of these virulence factors might explain the reported ability of some 
netB-negative strains of C. perfringens to cause NE (Keyburn et al., 2008, Cooper & Songer, 
2010, Martin & Smyth, 2009). 
Comparative genomics of C. perfringens isolates from NE-cases with non NE-
virulent C. perfringens strains led to the identification of 31 open reading frames unique to 
NE-strains (Lepp et al., 2010). These sequences were clustered into three distinct, highly 
conserved pathogenicity loci of 42 kb, 11.2 kb and 5.6 kb. In addition, it was shown that two 
of the pathogenicity loci, including the largest locus harbouring the netB gene, were plasmid 
encoded. These new identified genes may represent novel potential NE-associated virulence 
factors important for causing NE. 
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7.4 The netB gene 
The netB gene encodes a 322 amino acid protein including a N-terminal 30 amino acid signal 
peptide for secretion. In its mature form, the NetB protein has an estimated molecular mass of 
33 kDa. Sequencing netB genes from 23 NE-virulent C. perfringens isolates from Australia, 
Belgium, Canada and Denmark revealed that the netB gene sequence is highly conserved 
(Keyburn et al., 2010). Only six isolates showed one amino acid modification. However, this 
amino acid change did not alter in vitro NetB activity. A different study sequencing 27 netB-
positive C. perfringens isolates verified that only minor nucleotide variations were present 
and showed no amino acid alterations in the netB gene promoter region (Abildgaard et al., 
2010). 
 
7.5 Production of NetB 
NetB production is regulated by the VirSR two-component signal transduction system 
(Cheung et al., 2010). Mutation of the virR gene significantly reduced the production of 
NetB. In addition, DNA-binding sequences for the VirR response regulator have been found 
upstream of the netB gene and purified VirR was able to bind to these regions. The VirSR 
two-component system in C. perfringens is a global regulatory network for housekeeping 
genes and virulence factors such as perfringolysin O, α-toxin and collagenases, and has been 
suggested to be quorum sensing-dependent (Banu et al., 2000, Okumura et al., 2008, Shimizu 
et al., 2002, Ohtani et al., 2010, Ohtani et al., 2009). Thus, NetB production could be cell-
density regulated and produced only when the C. perfringens population reaches a certain 
threshold in the host gut.  
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7.6 Prevention of disease 
Initial trials on devising a vaccine against NE focused on the use of α-toxin from  
C. perfringens as an antigen. Immunisation studies with α-toxin have been identified to 
partially protect chicken from developing NE (Cooper et al., 2009, Kulkarni et al., 2010, 
Kulkarni et al., 2007). It has been shown that animals with high α-toxin titres showed lower 
mortality rates during the production period than those with low titres (Heier et al., 2001). 
Immunisation with either C. perfringens crude toxoids (Saleh et al., 2011) or culture 
supernatants (Lanckriet et al., 2010) can also provide significant but incomplete protection 
against experimental NE. In addition, immunogenic proteins from C. perfringens have been 
evaluated as sub-unit vaccines including glyceraldehyde-3-phosphate dehydrogenase, 
pyruvate-ferredoxin oxidoreductase, fructose 1,6-biphosphate-aldolase and a hypothetical 
protein (Kulkarni et al., 2007). Immunisation with any of these sub-units provided partial 
protection against experimental NE. Oral immunisation with an attenuated Salmonella 
enterica serovar Typhimurium vaccine vector expressing fructose 1,6-biphosphate-aldolase, 
the carboxy-terminal domain of α-toxin, or a hypothetical protein induced protective 
responses against NE in chicken (Zekarias et al., 2008, Kulkarni et al., 2008). Partial 
protection against NE has also been reported after immunisation with C. perfringens large 
cytotoxin TpeL, endo-beta-N-acetylglucosaminidase or phosphoglyceromutase (Jiang et al., 
2009). A more recent study in which α-toxin, NetB, pyruvate-ferredoxin oxidoreductase and 
elongation factor-Tu were compared as protective antigens concluded that NetB and 
pyruvate-ferredoxin oxidoreductase given with ISA71 adjuvant provided the most enhanced 
protective immunity (Jang et al., 2012). In summary, a variety of antigens have been tested as 
vaccine candidates against NE so far but complete protection has not been observed.  
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8. Aims and objectives of this PhD thesis 
Etx has been shown to be the key virulence factor for enterotoxemia in goats and sheep. 
Immunisation efficiency of commercially available vaccines based on formaldehyde-
inactivated C. perfringens has been shown variable in the past. Understanding the Etx 
binding mechanism may help in devising new strategies to neutralise toxin activity. Thus, in 
order to pave the way for future receptor binding studies on Etx, one aim of this study was to 
establish an expression system for Etx in E .coli. In order being able to work with a less toxic 
protein, a suitable less toxic variant of Etx with similar structural characteristics relative to 
wild type toxin had to be identified. 
NetB has been associated with the pathogenesis of NE. However, little is known on 
the structural and molecular basis of NetB toxicity. Moreover, there is no NetB based vaccine 
available to immunise animals against NE so far. Therefore, the second aim of this study was 
to characterise the structural and biophysical properties of NetB and to test potential genetic 
vaccines in an in vivo chicken NE model. 
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Abstract 
 
Clostridium perfringens epsilon toxin (Etx) is a pore-forming toxin responsible for a 
severe and rapidly fatal enterotoxemia of ruminants. The toxin is classified as a category 
B bioterrorism agent by the U.S. Government Centres for Disease Control and 
Prevention, making work with recombinant toxin difficult. To reduce the hazard posed 
by work with recombinant Etx, we have used a variant of Etx that contains a H149A 
mutation (Etx-H149A), previously reported to have reduced, but not abolished, toxicity. 
The 3D structure of H149A prototoxin shows that the H149A mutation in domain III 
does not affect organisation of the putative receptor binding loops in domain I of the 
toxin. Surface exposed tyrosine residues in domain I of Etx-H149A (Y16, Y20, Y29, 
Y30, Y36 and Y196) were mutated to alanine and mutants Y30A and Y196A showed 
significantly reduced binding to MDCK.2 cells relative to Etx-H149A that correlated 
with their reduced cytotoxic activity. Thus, our study confirms the role of surface 
exposed tyrosine residues in domain I of Etx in binding to MDCK.2 cells and the 
suitability of Etx-H149A for further receptor binding studies. In contrast, binding of all 
of the tyrosine mutants to ACHN cells was similar to that of Etx-H149A, suggesting 
that Etx can recognise different cell surface receptors. In support of this, the crystal 
structure of Etx-H149A identified a glycan ( -octyl-glucoside) binding site in domain 
III of Etx-H149A, which may be a second receptor binding site. These findings have 
important implications for developing strategies designed to neutralise toxin activity. 
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Introduction 
 
Epsilon toxin (Etx) is a pore-forming toxin and is produced by Clostridium perfringens 
strains belonging to toxinotypes B and D.1 These strains are responsible for 
enterotoxemia, which affects mainly sheep but also occurs in goats and cattle, and 
results in heavy economic losses.2,3 The disease is also known as overeating disease as it 
is often triggered by feeding on carbohydrate-rich food, leading to disruption of the 
microbial balance in the intestine and consequent proliferation of C. perfringens, 
leading to overproduction of Etx.4 
By an unknown mechanism, Etx crosses the gut wall, enters into the 
bloodstream and is disseminated to several organs, in particular to the kidneys and the 
brain, where intoxication results in fluid accumulation due to increased permeability of 
blood vessels.4 There is also evidence that Etx acts directly on the brain,5-7 targeting 
glutamatergic neurons8 and stimulating glutamate release. This may explain some of the 
neurological symptoms often associated with the disease in sheep, such as loss of 
coordination and seizures.3,9,10 
Etx is secreted by C. perfringens as a prototoxin (P-Etx), which consists of 296 
amino acids with a molecular weight of 32,981 Da.11 The prototoxin is activated, with 
carboxy-terminal and amino-terminal peptides removed, by proteolytic cleavage in the 
gut, either by digestive proteases of the host, such as trypsin and chymotrypsin,12 or by 
-protease produced by C. perfringens.13,14 
The crystal structure of P-Etx has been determined15 and reveals mainly -
sheets, which are organised into three functional domains. Domain I at the N-terminus 
contains the suggested receptor interaction region,15,16 domain II contains an 
amphipathic ȕ-hairpin, which is predicted to play a role in membrane insertion, and 
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domain III at the C-terminus contains the C-terminal peptide, which has to be removed 
for activation.  
The mechanism of pore-formation by Etx is not well understood and the current 
pore-formation model is based on studies of other ȕ-pore-forming toxins (ȕ-PFTs), such 
as aerolysin from Aeromonas hydrophila.17 Like aerolysin, Etx binds to detergent-
resistant microdomains (DRMs) of lipid rafts.18-20 Both P-Etx and Etx can accumulate 
within DRMs but only activated toxin can oligomerise and form a heptameric complex. 
Heptameric complexes of Etx have been identified in rat synaptosomal, MDCK and 
mpkCCDcl4 cell membranes.21-23 The final step of pore formation might involve 
unfolding of the amphipathic ȕ-hairpin in domain II and subsequent insertion of the 
toxin into the membrane, usually leading to rapid cell death.  
Etx is unique among -PFTs as it shows high cell specificity and potency. 
Relatively few cell lines are susceptible to the toxin and most in vitro studies on Etx 
have been carried out using the highly susceptible Madin-Darby Canine Kidney 
(MDCK) cell line.24,25 Other toxin-sensitive cell lines include the mouse kidney cell line 
mpkCCDcl423 and the recently identified human renal adenocarcinoma cell line 
ACHN.26 Because of its high potency, and the potential to use Etx as a bioterrorist 
weapon, the toxin is classified as a category B bioterrorism agent by the U.S. 
Government Centres for Disease Control and Prevention.27 
In view of the high potency of Etx, the aim of this study was to identify a 
platform that provided a reduction in the hazard associated with the genetic 
manipulation of recombinant C. perfringens epsilon toxin in E. coli whilst allowing 
receptor binding studies. For this platform we selected the H149A variant of Etx 
(numbering corresponds to prototoxin without the 13 amino acids N-terminal peptide), 
which reduces toxicity 6-fold in MDCK cells and 67-fold in mice.28 This study has 
confirmed the role of tyrosine residues in domain I of Etx in binding to MDCK cells and 
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has also revealed that additional receptor binding regions appear to play a role in 
toxicity of Etx. 
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Materials and methods 
 
Cell culture 
MDCK.2 cells (ATCC-LGC Standards, Teddington, UK) and ACHN cells (ECACC, 
Salisbury, UK) were routinely cultured in Eagle's Minimum Essential Medium (EMEM; 
ATCC-LGC Standards, Teddington, UK) supplemented with 10% Foetal Bovine Serum 
Gold (PAA, Pasching, Austria) at 37°C in a humidified atmosphere of 95% air/5% CO2. 
The culture medium was replaced every 2-3 days. Cells were routinely detached by 
incubation in trypsin/EDTA and split as appropriate (typically 1:6 dilutions).   
 
Cloning of recombinant epsilon prototoxin P-Etx-H149A 
The etxD gene encoding epsilon prototoxin with the H149A mutation (P-Etx-H149A) 
was subcloned from plasmid pCl028 into the expression vector pET-26b(+) (Merck, 
Darmstadt, Germany) using NcoI and XhoI restriction sites. This fused the N-terminal 
end of P-Etx-H149A to the PelB leader peptide without the 13 N-terminal residues 
(KEISNTVSNEMSK) while the C-terminal end of P-Etx-H149A was fused to a 
polyhistidine (6 x His) affinity tag to aid purification of recombinant P-Etx-H149A (Fig. 
1). The recombinant plasmid expressing P-Etx-H149A is termed pET26-b(+)/P-Etx-
H149A. All amino acid numbering corresponds to prototoxin with the 13 amino acids 
N-terminal peptide sequence removed (PDB ID: 1UYJ), unless otherwise stated. 
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Site-directed mutagenesis 
Mutations were introduced into the gene encoding P-Etx-H149A using the QuikChange 
Lightning Site-Directed Mutagenesis Kit (Agilent Technologies, Inc. Santa Clara, US) 
according to the manufacturer’s instructions. Synthetic oligonucleotide primer pairs 
(Eurofins MWG Operon, Ebersberg, Germany) were used to change each tyrosine 
codon to an alanine codon. To create Tyr mutants, plasmid pET26-b(+)/P-Etx-H149A 
served as template. The presence of the intended mutations was verified by DNA 
sequencing (Source BioScience, Cambridge, UK).   
 
Expression and purification of P-Etx-H149A and its derivatives 
For expression of P-Etx-H149A and its derivatives, recombinant plasmids were 
transferred into E. coli Rosetta 2 (DE3) cells (Merck, Darmstadt, Germany) and 
expression of P-Etx-H149A and its derivatives was induced using the autoinduction 
system as described by Studier29. In brief, cells (100 ml) were grown in ZYM-5052 
autoinducing medium supplemented with 50 μg/ml kanamycin and γ4 μg/ml 
chloramphenicol and cultured at γ7˚C for γ h at γ00 rpm, then for a further β4 h at β0˚C, 
300 rpm.  
For protein purification, cells were harvested by centrifugation and 2 g of cell 
pellet was lysed by 10 ml BugBuster™ Protein Extraction Reagent (Merck, Darmstadt, 
Germany) containing 10 l rlysozyme™ (1 KU/ l) (Merck, Darmstadt, Germany) and 
10 l Benzonase® Nuclease (25 U/ l) (Merck, Darmstadt, Germany). The cell 
suspension was incubated on a rotating mixer for 25 min at room temperature and 
centrifuged at 16,000 x g for 20 min at 4 C to separate soluble and insoluble fractions. 
The supernatant was loaded onto a His GraviTrap column (GE Healthcare Life 
Sciences, δittle Chalfont, UK) following the manufacturer’s guidelines. In brief, His-
tagged proteins were bound to the affinity column using a buffer composed of 20 mM 
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sodium phosphate, 500 mM NaCl, 20 mM imidazole, pH 7.4. The column was washed 
with a buffer composed of 20 mM sodium phosphate, 500 mM NaCl, 60 mM imidazole, 
pH 7.4. Recombinant prototoxin was eluted in a buffer composed of 20 mM sodium 
phosphate, 500 mM NaCl, 500 mM imidazole, pH 7.4. All purification steps were 
carried out at 4 C. For buffer exchange and sample clean up, prototoxin containing 
eluate was applied to a PD-10 Desalting Column (GE Healthcare Life Sciences, Little 
Chalfont, UK) and eluted in 10 mM phosphate buffer, 2.7 mM potassium chloride,  
137 mM NaCl, pH 7.4. Protein concentrations were determined using the BCA assay 
(Fisher Scientific UK Ltd, Loughborough, UK).  
The purity of P-Etx-H149A and its derivatives was confirmed by SDS-PAGE. 
Proteins were resolved by 4-12% Bis-Tris NuPAGE gels (Invitrogen Ltd., Paisley, UK) 
using Surelock Xcell apparatus (Invitrogen Ltd., Paisley, UK ) and NuPAGE MES SDS 
running buffer (Invitrogen Ltd., Paisley, UK). All samples were heated prior to loading 
at 70 C for 10 min in NuPAGE LDS sample buffer (Invitrogen Ltd., Paisley, UK). Gels 
were run at 200 V for 45 min. After electrophoretic separation, proteins were visualised 
by SimplyBlue staining (Invitrogen Ltd., Paisley, UK). The Perfect Protein™ Marker 
10-225 kDa (Merck, Darmstadt, Germany) was used as the molecular weight standard.  
 
Crystallisation and data processing 
For crystallisation experiments a modified construct of P-Etx-H149A was used with a 
TEV cleavable N-terminal His-tag and a Factor Xa cleavage (IEGR) site engineered in 
between amino acids K260 and K261, which allows potential activation of P-Etx-
H149A by Factor Xa. Purification of P-Etx-H149A was carried out using standard metal 
affinity chromatography followed by removal of the N-terminal His-tag by TEV 
protease. A final size exclusion chromatography step was performed using a 120 ml 
Superdex S-200 column equilibrated with 20 mM Tris pH 7.5, 150 mM NaCl and 1 mM 
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DTT. Recombinant P-Etx-H149A was concentrated to 16 mg/ml using a 10 kDa cut-off 
Amicon concentrator (Merck, Darmstadt, Germany). Crystals were obtained using the 
hanging drop method in 0.85 M ammonium dihydrogen phosphate and 0.5% (w/v)  
-octyl-glucoside (ȕ-OG). Data were collected on a Rigaku Saturn 944 CCD detector 
mounted onto a Rigaku Micromax X-ray generator. Data were indexed and integrated 
and scaled with D*TREK.30 Molecular replacement was carried out using Phaser MR31 
as part of the CCP4 package32 using the wild type structure (PDB ID: 1UYJ) as a search 
model. Refinement was carried out using Refmac 5,33 and manual building and real 
space refinement was performed using COOT34. Model validation was calculated using 
Molprobity35 and PyMOL36 was used for visualisation and figure preparation. 
 
Activation of P-Etx-H149A and its derivatives by trypsin 
Purified recombinant P-Etx-H149A and its derivatives were activated with trypsin, 
TPCK treated from bovine pancreas (Sigma-Aldrich Company Ltd., Gillingham, UK), 
which removes the C-terminal peptide sequence, together with the His-tag (Fig. 1). 
Trypsin was prepared in PBS and added to recombinant prototoxin at 1:100 (w/w) ratio 
and incubated at room temperature for 1 h. Protease Inhibitor Cocktail, EDTA-Free 
(Fisher Scientific UK Ltd, Loughborough, UK) was added to the digest to inhibit 
trypsin in the samples. Removal of the C-terminal peptide sequence was assessed by 
SDS-PAGE. 
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Protein thermal shift assay 
Thermostability of P-Etx-H149A and its derivatives was assessed by mixing purified 
recombinant prototoxin (0.25 mg/ml) with 240x SYPRO Orange dye (Sigma) in 
triplicate and fluorescence was monitored using a StepOnePlus quantitative PCR 
machine (Applied Biosystems) with a 1% thermal gradient from 25 C to 99°C. 
Fluorescence data was analysed by the Protein Thermal Shift Software (Applied 
Biosystems) to calculate the melting temperature (Tm) using the Boltzmann method. 
 
Cytotoxicity assay 
The cytotoxic activity of trypsin-activated Etx-H149A and its derivatives towards 
MDCK.2 and ACHN cells was determined by measuring the amount of lactate 
dehydrogenase (LDH) released from the cytosol of lysed cells into the cell culture 
medium using the CytoTox 96 nonradioactive cytotoxicity assay kit (Promega, 
Southampton, UK) according to the manufacturer’s protocol. In brief, a two-fold 
dilution series of each activated toxin (ranging from 10 M to 0.15 nM) was prepared in 
PBS and added to cells seeded into 96-well plates (3 x 104 cells/well). Following 
incubation at 37°C for 3 h, cell culture medium (50 l) was harvested from cell 
monolayers, transferred to a fresh 96-well enzymatic assay plate and 50 μl of 
reconstituted substrate mix was added to each well. The plate was incubated for 30 min 
at room temperature, protected from light. Absorbance was measured at 490 nm using a 
Model 680 Microplate Reader (Bio-Rad Laboratories Ltd., Hemel Hempstead, UK). 
The absorbance values for each sample were normalized by subtracting the absorbance 
value obtained for the culture medium from untreated cells. The toxin dose required to 
kill 50% of the cell monolayer (CT50) was determined by nonlinear regression analysis, 
fitting a variable slope log (dose) vs. response curve, constraining F to a value of 50 
(logCT50=logCTF - (1/HillSlope)*log(F/(100-F)). 
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On-Cell Western assay 
On-Cell Western assay was used to measure binding of P-Etx-H149A and its derivatives 
to MDCK.2 and ACHN cells. Black 96-well microtiter plates were seeded with 3 x 104 
cells/well in EMEM medium containing 10% foetal bovine serum. To allow cells to 
attach, plates were incubated overnight at 37°C in a humidified atmosphere of  
95% air/ 5% CO2. The next day, plates were washed with PBS and cells were incubated 
with purified recombinant prototoxin (10 M) for 1 h at 37°C in a humidified 
atmosphere of 95% air/ 5% CO2. For background control, triplicate wells were 
incubated with PBS only. Unbound toxin was removed by washing cell monolayers 
three times with PBS. Cells were then fixed with 4% formaldehyde at room temperature 
for 20 min. After washing the cell monolayers with PBS three times, cells were blocked 
for 1.5 h using Odyssey blocking buffer (LI-COR Biosciences, Lincoln, NE, USA). 
Bound prototoxin was detected with mouse anti-His Tag monoclonal antibody 
(Invitrogen Ltd., Paisley, UK) and IRDye 800CW goat anti-mouse IgG (H + L) 
antibody (LI-COR Biosciences, Lincoln, USA) at 1:500 dilution each. Plates were 
imaged at 800 nm using the Odyssey CLx infrared imaging system (LI-COR 
Biosciences, Lincoln, USA) to quantify the amount of fluorescent signal. The 
fluorescent signal from wells treated with prototoxin was normalised to that of wells 
treated with PBS only and the binding activity of each tyrosine mutant was expressed as 
the fold-change in fluorescence intensity relative to P-Etx-H149A. 
 
Statistical analysis 
To compare the means of protein thermal shift, On-Cell Western and cytotoxicity data, 
One-way ANOVA analysis followed by Dunnett’s post test ( : p<0.001, : p<0.01) 
was carried out using the GraphPad Prism software 5.01 (GraphPad Software, La Jolla, 
USA). In all analyses, a p value of less than 0.01 was considered significant. All data 
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represent the means and standard deviations of three independent experiments 
performed in triplicate. 
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Results 
 
Mutation H149A does not affect P-Etx structure 
To determine the effect of the H149A mutation on the tertiary structure of P-Etx, we 
crystallised recombinant P-Etx-H149A. Initial trials resulted in crystals, which grew in 
the presence of 0.85-1.0 M ammonium dihydrogen phosphate and diffracted to ~3 Å. 
However, the crystals were twinned with >45% twin fractions. In an attempt to reduce 
the degree of twinning, various additives were included in the crystallisation conditions. 
One of the additives, -octyl-glucoside (ȕ-OG), resulted in crystals with lower twin 
fractions, and which diffracted to 2.4 Å. They belonged to the P3 spacegroup with unit 
cell dimensions of a = 123.70 Å, b = 123.70 Å, c = 127.31 Å, and α = ȕ = 90°, Ȗ = 120°. 
The asymmetric unit (ASU) contained four P-Etx-H149A molecules, four ȕ-OG 
molecules and four ordered phosphates. Due to the higher resolution of the P-Etx-
H149A data compared to the original wild type structure (PDB ID: 1UYJ, 2.6 Å) we 
detected a +1 residue register error in the wild type structure from Ser3 to Gly14.  
Each ȕ-OG molecule is accommodated in a cleft formed between two -sheets 
in domain III of P-Etx-H149A and interacts through hydrogen bonds to Etx (Fig. 2A, 
lower inset). Specifically, the glucose moiety of ȕ-OG forms hydrogen bonds via O5 to 
Thr93 mainchain N and through O2 to Val72 mainchain O. In addition, in chains A and 
B, the Oγ of ȕ-OG forms a hydrogen bond to OE1 of Glu61 in the neighbouring 
asymmetric unit. The alkyl chain of ȕ-OG is in close proximity to Phe92 in all four Etx 
molecules. The four phosphate molecules also form hydrogen bonds to Etx through 
OD1 and OD2 of Asp48, OG of Ser188 and NE2 of Gln85 from the neighbouring ASU. 
Moreover, strong positive density (>3 ) in the Fo-Fc map could be seen near Y29 in all 
four chains in the ASU, and although the size of this density suggests additional bound 
ȕ-OG molecules we could not place ȕ-OG with certainty (data not shown).  
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The P-Etx-H149A structure closely resembles the wild type structure with a C -
C  root mean square deviation (rmsd) of 0.95 Å (Fig. 2B). Small main chain deviations 
occur in domains I, II and III compared to the wild type structure. In domain I, at the 
end of the first -helix near Y29, the C  positions are shifted by 2.20 Å in respect to the 
wild type structure. This may be due to the influence by putative ȕ-OG molecules in this 
region as mentioned above. In addition, a loop between Ser195 and P200 is shifted by 
up to 2.58 Å away from the core of the molecule. In domain II, the membrane-inserting 
ȕ-hairpin is shifted by up to 2.84 Å near Phe135. Finally, in domain III, the -strand 
from V70 to N79 is displaced outwards by up to 2.05 Å in order to accommodate the ȕ-
OG molecule (Fig. 2A, lower inset). Overall, the H149A mutation does not have an 
effect on the prototoxin tertiary structure and does not induce any significant 
conformational changes in the suggested receptor binding loops in domain I. Collection 
and refinement statistics for the crystals are listed in Table 1, and coordinates and 
structure factors have been deposited with the Protein Data Bank (PDB ID: 3ZJX). 
 
Tyrosine mutants in H149A background mimic the binding of tyrosine mutants in 
wild type background  
Surface exposed tyrosine residues in domain I of Etx have recently been reported to 
play a role in binding to MDCK cells.16 To evaluate the suitability of P-Etx-H149A for 
receptor binding studies, we selected six surface exposed tyrosine residues (Y16, Y20, 
Y29, Y30, Y36 and Y196) in domain I for site-directed mutagenesis and replaced each 
one with alanine (Fig. 2A, top inset) to delete the side chain completely, and thus to 
allow a definitive determination of whether the side chain contributed to binding in any 
way. 
All tyrosine mutants showed similar purification (Fig. 3A) and trypsin digestion 
(Fig. 3B) profiles to Etx-H149A, indicating that tyrosine mutations do not affect the 
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folding of the toxin. Purified recombinant P-Etx-H149A and its derivatives have an 
apparent molecular weight of 37 kDa as detected by SDS-PAGE (Fig. 3A). Thermal 
stability assay37 revealed that the Tm of the tyrosine mutants was similar to that of  
P-Etx-H149A (Fig. 3C), providing further evidence that the tyrosine mutants are folded 
correctly. 
On-Cell Western assays were used to evaluate the effect of the tyrosine 
mutations on the binding of P-Etx-H149A to MDCK.2 cells. The binding activity of 
each tyrosine mutant was expressed as the fold-change in fluorescence intensity relative 
to P-Etx-H149A (Fig. 4). Mutants Y30A and Y196A showed significant reduction in 
binding activity relative to P-Etx-H149A (20-fold and 6-fold decrease in fluorescent 
intensity, respectively).  
 
Reduced binding of tyrosine mutants to MDCK.2 cells correlates with their 
reduced cytotoxicity 
Next, we evaluated the effect of the tyrosine mutations on the cytotoxic activity of Etx-
H149A towards MDCK.2 cells by measuring the amount of LDH released from the 
cytosol of lysed cells into the cell culture medium. All tyrosine mutations resulted in 
reduced cytotoxic activity of Etx-H149A towards MDCK.2 cells (Fig 5A), indicated by 
a right shift of the dose response curves relative to Etx-H149A. The dose of each toxin 
that killed 50% of the cells (CT50) was determined by nonlinear regression analysis and 
the cytotoxic activity of each tyrosine mutant was expressed as the fold-change in CT50 
relative to Etx-H149A. Mutants Y30A and Y196A showed significant reduction in 
cytotoxic activity towards MDCK.2 cells relative to Etx-H149A (27-fold and 10-fold 
increase in CT50, respectively) (Fig. 5B and Table 2).  
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Surface exposed tyrosine residues in domain I do not play a role in binding of  
P-Etx-H149A to ACHN cells  
To determine whether surface exposed tyrosine residues in Domain I also play a role in 
binding of Etx to ACHN cells, we tested binding of the tyrosine mutants in H149A 
background to ACHN cells using the On-Cell Western assay. The binding activity of 
each tyrosine mutant was expressed as the fold-change in fluorescence intensity relative 
to P-Etx-H149A. ACHN cells treated with all of the tyrosine mutants showed 
fluorescence similar to that of cells treated with P-Etx-H149A (Fig. 6), indicating that 
surface exposed tyrosine residues in Domain I do not mediate binding of Etx to ACHN 
cells.  
Next, we measured LDH release from ACHN cells exposed to mutants Y30A 
and Y196A, mutants that showed significantly reduced binding and cytotoxic activities 
towards MDCK.2 cells. The results of our cytotoxicity assay revealed that Etx-H149A 
and its derivatives are unable to cause cell lysis in ACHN cells, while wild type Etx was 
able to cause approximately 45% cell lysis at the maximum dose of 10 M tested (Fig. 
7). 
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Discussion 
 
Epsilon toxin is a potent toxin and is classified as a category B bioterrorism agent,38 
making genetic modification of the toxin hazardous. In this study, we showed that the 
H149A mutation does not affect the overall organisation of the putative receptor binding 
loops in domain I. Residue H149 is located in Domain III of Etx in close proximity to 
the tip of the ȕ-hairpin in Domain II. Therefore, the H149A mutation is likely to 
interfere with the conformation changes associated with insertion of the -hairpin into 
the membrane and thus with membrane insertion of the toxin. It has previously been 
shown that creating disulphide bonds between pairs of introduced cysteines (one in the 
-hairpin and one in an adjacent strand) prevented pore formation but not receptor 
binding or oligomerisation of the toxin,39 providing further support that interfering with 
pore-formation of Etx does not affect its receptor binding. 
Our cytotoxicity and binding data show that residues Y30 and Y196 play an 
important role in cell binding and thus, cytotoxicity of Etx towards MDCK.2 cells. All 
of the tyrosine mutants that we have cloned, expressed and purified in H149A 
background were soluble and stable, and our thermal stability analysis indicated that 
these proteins are correctly folded, ruling out the possibility that the reduced binding 
and cytotoxic activities of the tyrosine mutants towards MDCK.2 cells was due to their 
change in structure. The average CT50 for Etx-H149A towards MDCK.2 cells was 400 
ng/ml (12 nM), in agreement with the reported CT50 of 20-300 ng/ml for the more active 
wild type Etx.22,23,25,40 We also showed that tyrosine mutants in H149A background 
mimic the behavior of tyrosine mutants in wild type background,16 confirming the role 
of domain I in binding of Etx to MDCK cells, and thus the suitability of the H149A 
mutant for further receptor binding studies. 
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The human kidney carcinoma cell line, ACHN, has recently been identified to be 
susceptible to Etx26 but the role of surface exposed tyrosine residues in binding of Etx to 
this cell line has not been determined. Using the H149A mutant as a platform to study 
binding of tyrosine mutants to ACHN cells we showed that surface exposed tyrosine 
residues in domain I of Etx do not mediate binding of Etx to ACHN cells, suggesting 
that alternative amino acids within the toxin contribute to binding of Etx to these cells. 
The crystal structure of P-Etx-H149A also identified a glycan ( -octyl-glucoside) 
binding site in domain III of Etx-H149A, suggesting the presence of a secondary 
binding site in Etx in this region. Recent evidence also indicates the presence of a 
secondary binding site for lysenin, a sphingomyelin-specific pore-forming protein,41 in a 
location similar to the ȕ-OG binding site in Etx.  
The results of our cytotoxicity assay also revealed that ACHN cells are more 
resistant to Etx induced cell lysis than MDCK.2 cells. Wild type Etx in ACHN cells was 
only able to cause up to 45% cell lysis, even at the maximum dose of 10 M tested, 
while a dose of wild type Etx approximately 10,000-fold less is able to cause 50% cell 
lysis in MDCK.2 cells,22,23,25,40 suggesting that the mechanism of Etx-induced 
intoxication in ACHN and MDCK cells is different. Several lines of evidence suggest 
that Etx-induced cytotoxicity differs in different cell lines. In particular, Chassin et al.23 
reported that Etx-induced intracellular Ca2+ rise and ATP depletion-mediated rapid cell 
death in mpkCCDcl14 cells occurred even under conditions that prevented toxin 
oligomerisation and pore formation, providing evidence that pore formation is not the 
only way Etx manifests its cytotoxicity. The differences in relative sensitivity of 
MDCK.2 and ACHN cells to Etx are likely to be due to the differences in the mode of 
action of Etx on these two cell lines, probably due to the ability of Etx to recognise 
different targets on the cell surface of different cells.  
 106 
 
There is no evidence for a single receptor for epsilon toxin. Studies using 
MDCK cells suggest that binding of Etx is mediated by O-linked oligosaccharides as 
removal of O-glycans by ȕ-elimination reduced binding of Etx to these cells.42 Other 
studies implicated that interaction of Etx with target cells is mediated by the O-linked 
glycans of the extracellular domain of the human hepatitis A virus cellular receptor 
(HAVCR1).16,26 Although disrupting expression of HAVCR1 in MDCK and ACHN 
cells led to increased resistance to Etx-induced cytotoxicity,26 providing good evidence 
that both of these cell lines express HAVCR1, no direct evidence exists that the toxin 
binds to HAVCR1 on these cells. Furthermore, studies using synaptosomal fractions 
isolated from rat brain indicate that the receptor for Etx in the brain is a 
sialoglycoprotein.43 In this study, we provide further indirect evidence that Etx binds to 
glycans by identifying a ȕ-OG binding site in-between two ȕ-sheets in domain III. In 
addition, a second unidentified ligand, likely to be ȕ-OG, was found in the proximity of 
Y29 in domain I, providing further circumstantial evidence for the role of domain I in 
glycan binding. 
In conclusion, the present study confirmed the role of surface exposed tyrosine 
residues in binding of Etx to MDCK.2 cells and demonstrated the suitability of the 
H149A mutant for further receptor binding studies. However, we found no evidence that 
surface exposed tyrosine residues in domain I mediate binding of Etx to ACHN cells, 
suggesting that Etx recognises different targets on the cell surface of different cells. 
These findings have important implications for developing strategies designed to 
neutralise the activity of this potent toxin.  
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Tables 
 
 
Table 1. X-ray data collection and refinement statistics. 
 P-Etx-H149A  
Data collection  
Space group P3 
Cell dimensions   
    a, b, c (Å) 123.70, 123.70, 127.31 
 ( )  90, 90, 120 
Resolution (Å) 21.56-2.40 (2.49-2.40)a 
Rmerge 0.061 (0.435) 
I/ I 12.3 (1.2) 
Completeness (%) 100.0 (99.9) 
Redundancy 3.70 (2.25) 
 
 
Refinement  
Resolution (Å) 21.56-2.4 
No. reflections 85072 
Rwork/ Rfree (%) 24.6-27.5 
No. atoms  
    Protein 8448 
    Ligand/ion 100 
    Water 459 
B-factors (Å2)  
    Protein 54.5 
    Ligand 48.2 
    Water 47.0 
RMS deviations  
    Bond lengths (Å) 0.01 
    Bond angles ( ) 1.33 
a Values in parentheses are for highest-resolution shell. 
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Table 2. The reduced binding ability of the tyrosine mutants correlates with their reduced ability to 
bind to MDCK.2 cells.  
The binding activity of each Tyr mutant was expressed as the fold-change in fluorescence intensity 
relative to P-Etx-H149A as determined in Figure 4. The cytotoxic activity of single tyrosine mutants was 
expressed as the fold-change in CT50 relative to Etx-H149A as determined in Figure 5B. 
 
Etx-H149A 
mutant 
Mean fold-change in CT50 
relative to Etx-H149A 
Mean fold-change in fluorescence intensity 
relative to P-Etx-H149A 
Y30A 27.8  7.3  -20.7  4.5  
Y196A 9.1  2.1  -6.0  2.6  
Y36A 5.7  2.6 -3.7  1.5 
Y29A 4.1  2.2 -3.3  0.6 
Y16A 3.5  2.9 -1.7  0.6 
Y20A 2.5  1.3 -1.3  0.6 
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Figures 
 
 
 
 
Figure 1. Schematic representation of recombinant C. perfringens epsilon prototoxin P-Etx-H149A. 
The amino acid sequences around the processing sites are shown. Amino acid numbering for H149A 
corresponds to prototoxin without the 13 amino acids N-terminal peptide sequence (PDB ID: 1UYJ). 
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Figure 2. Structure of C. perfringens epsilon prototoxin P-Etx-H149A. 
(A) Cartoon representation of the prototoxin coloured according to domain. The likely membrane-
inserting -hairpin is coloured red. The C-terminal peptide is coloured in yellow and situated near the 
pink oligomerisation domain. Top inset shows the receptor binding region and the positions of the 
mutated tyrosines. The lower inset shows the location of A149 (blue spheres), the bound -OG ligand and 
interacting residues. (B) Superposition of wild type prototoxin (PDB ID: 1UYJ, grey) with P-Etx-H149A 
(blue). Asterisks indicate the areas of highest RMS C -C  deviation. 
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Figure 3. Recombinant tyrosine mutants in H149A background are folded correctly. 
Inactive prototoxins (A) and trypsin activated toxins (B) were separated by SDS-PAGE and visualized by 
Coomassie staining. Arrows indicate the positions of monomeric epsilon prototoxins and trypsin activated 
toxins, respectively. (C) Thermo-stability of P-Etx-H149A and its derivatives were determined by the 
Boltzmann method using the Protein Thermal Shift software (Applied Biosystems). 
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Figure 4. Effect of tyrosine substitutions on the binding of P-Etx-H149A to MDCK.2 cells. 
The binding of tyrosine mutants to MDCK.2 cells was determined by the On-Cell Western assay. 
Statistically significant differences between P-Etx-H149A and tyrosine mutant proteins are indicated by 
asterisks. 
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Figure 5. Effect of the tyrosine mutations on the cytotoxic activity of Etx-H149A towards MDCK.2 
cells.  
(A) The cytotoxic activity of trypsin-activated toxins towards MDCK.2 cells was determined by 
measuring the release of LDH from lysed cells. (B) The dose of each toxin that killed 50% of the cells 
(CT50) was determined and cytotoxic activity of tyrosine mutants was expressed as the fold-change in 
CT50 relative to Etx-H149A. Statistically significant differences between Etx-H149A and tyrosine mutant 
proteins are indicated by asterisks. 
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Figure 6. Effect of the tyrosine mutations on the binding of P-Etx-H149A to ACHN cells. 
The binding of tyrosine mutants to ACHN cells was determined by the On-Cell Western assay.  
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Figure 7. Effect of tyrosine substitutions on the cytotoxicity of Etx-H149A towards ACHN cells.  
The cytotoxic activity of trypsin-activated toxins towards ACHN cells was determined by measuring the 
release of LDH from lysed cells. Results were normalised to the signal from cells treated with PBS only 
(0% lysis) and cells treated with 0.9% (v/v) Triton X-100 (100% lysis). 
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Abstract 
 
NetB is a pore-forming toxin produced by Clostridium perfringens and has been 
reported to play a major role in the pathogenesis of avian necrotic enteritis, a disease 
that has emerged due to the removal of antibiotics in animal feedstuffs. Here we present 
the crystal structure of the pore-form of NetB solved to 3.9 Å. The heptameric assembly 
shares structural homology to the Staphylococcal -hemolysin. However, the rim 
domain, a region that is thought to interact with the target cell membrane shows 
sequence and structural divergence leading to the alteration of a phosphocholine binding 
pocket found in the staphylococcal toxins. Consistent with the structure we show that 
NetB does not bind phosphocholine efficiently but instead interacts directly with 
cholesterol leading to enhanced oligomerisation and pore formation. Finally we have 
identified conserved and non-conserved amino acid positions within the rim loops that 
significantly affect binding and toxicity of NetB. These findings present new insights 
into the mode of action of these pore-forming toxins enabling the design of more 
effective control measures against necrotic enteritis and providing potential new tools to 
the field of bionanotechnology. 
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Introduction 
 
For decades, antibiotics have been added to animal feedstuffs, leading to enhanced 
weight gain and more efficient conversion of feed into body mass (1). However, there 
are concerns that the addition of antibiotics to animal feedstuffs contributes to the 
spread of antibiotic resistance. Consequently, the use of antibiotics as growth promoters 
has been banned in some countries (2). The reduction in the use of antibiotic growth 
promoters has had some unexpected consequences. Worryingly, some infectious 
diseases have become more widespread in livestock and are now emerging diseases. 
One of these diseases is necrotic enteritis in poultry, caused by the bacterium 
Clostridium perfringens. Acute necrotic enteritis is characterised by a sudden increase 
in flock mortality and at necropsy necrotic foci are found in the intestinal mucosa. 
Chronic disease, which does not result in death, is less easily diagnosed (3-5). This form 
of the disease results in reduced weight gain in poultry (6, 7) and is likely to cause the 
greatest economic losses (8). The full impact of the reduction in antibiotic growth 
promoters on the incidence of necrotic enteritis is not yet known. However, it has been 
estimated that the current cost of necrotic enteritis to the international poultry industry is 
approximately 2 billion US dollars a year (9, 10).  
Recently, a newly discovered toxin from C. perfringens, termed NetB (Necrotic 
Enteritis Toxin B-like), has been shown to play a major role in disease (11). The mode 
of action of this toxin is not fully understood but Keyburn and co-workers have shown 
that based on osmotic protection assays (11), NetB appears to form pores of 
approximately 1.7 nm diameter in Leghorn chicken hepatocellular carcinoma cells 
(LMH). Importantly, a netB mutant of C. perfringens was unable to cause gut lesions in 
experimentally infected poultry (11). On the basis of limited sequence homology with 
other bacterial toxins, NetB is likely to be a member of the ȕ-pore forming toxin  
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(ȕ-PFT) family. Respectively, NetB shares 30% and 25% sequence identity to 
Staphylococcus aureus -hemolysin ( HL) and -hemolysin ( HL) component B (HlgB 
or LukF), and 38% and 40% sequence identity to the  and į toxins of C. perfringens 
(Sup. Fig. 1). The heptameric structure of one of the most widely studied ȕ-PFT,  
S. aureus HL, was determined over 15 years ago (12) and was, until recently, the only 
high-resolution structure of a ȕ-PFT in the membrane-inserted form. The ring-shaped 
complex resembles a mushroom with the cap forming the extracellular domain and the 
stem forming the membrane-spanning region, in which each subunit contributes one ȕ-
hairpin. More recently, the structures of the bi-component, hetero-octameric complex of 
HL from S. aureus (13) composed of four copies of LukF and Hlg2 (HlgA), and the 
cholesterol-requiring Vibrio cholerae cytolysin toxin (VCC) (14) were also determined 
by X-ray crystallography. Both toxins feature architectures common to αHδ and 
demonstrate how distantly related toxins from different organisms adopt a similar pore-
forming architecture. 
Although NetB appears to form pores in target cell membranes, little is known 
about the molecular basis of toxicity, which hinders our ability to devise effective 
control measures against necrotic enteritis. In this study, we report the crystal structure 
of the heptameric complex of NetB in detergent, which likely represents the membrane-
inserted pore-form. The active toxin adopts a similar conformation to αHδ but displays 
important differences in the membrane binding region and the pore lumen that may 
influence its specificity and channel forming properties. In addition, we identified 
residues critical for NetB binding and toxicity and have shown that cholesterol is 
important for NetB activity. This work will provide the basis for the development of 
vaccines against necrotic enteritis and furthers our understanding of the mechanisms 
employed by this family of PFTs. 
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Material and methods 
 
Molecular cloning of the netB gene 
Bacterial genomic DNA from C. perfringens strain 56 (15) was isolated with the 
Wizard Genomic Purification Kit (Promega) and used as a template to amplify the netB 
gene (UniProt accession number: A8ULG6) which was subsequently cloned into the 
pBAD expression vector to generate recombinant pBAD-NetB. Thereby, NetB is 
expressed as a 331 amino acid protein without its native signal peptide, a N-terminal 
His-tag to facilitate affinity purification, and an XpressTM-tag epitope for detection. In 
addition, the following NetB mutants were designed by site-directed mutagenesis: 
K77A, Y78A, Y79A, Y187A, H188A, Y191A, R200A, Y202A, W257A, E258A and 
W262A. Mutants were made with the QuikChange II site-directed mutagenesis Kit 
(Stratagene) and verified by sequencing. 
 
Expression and purification of NetB in E. coli 
E. coli carrying the pBAD-NetB vector was grown to an optical density (OD595 nm) of 
0.5 and expression of NetB was induced for 6 h by adding arabinose at a final 
concentration of 0.02% (w/v). Bacterial cells were harvested by centrifugation and cells 
lysed enzymatically by using BugBuster reagent (Novagen). NetB protein was purified 
by His-bind chromatography columns (GE Healthcare) according to the manufacturer’s 
instructions. Subsequently, the protein was dialysed into Tris-buffered saline (TBS) by 
using PD-10 desalting columns (GE Healthcare) and protein concentrations were 
measured with a UV-Vis spectrophotometer (Pierce). Protein integrity was assessed by 
UV and CD measurements at the Biomolecular Spectroscopy Centre, King’s College 
London, UK.  
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On-cell WesternTM Blotting 
Binding ability of NetB to a chicken hepatocellular carcinoma epithelial cell line (LMH; 
ATTC: CRL-2117) was addressed by an On-cell WesternTM assay using the Odyssey 
CLx infrared imaging system (Li-Cor). δεH cells were grown in Waymouth’s εB 
752/1 medium (Invitrogen) supplemented with 10% fetal calf serum at 37°C in a 5% 
CO2 incubator to 70-80% confluency on 96-well plates and fixed with 4% 
formaldehyde for 20 min at room temperature. After washing three times with TBS, 
cells were incubated with NetB or TBS only, as negative control, for 10 min at 37°C. 
Cells were then washed three times with TBS and blocked by using the Odyssey 
blocking buffer for 1.5 h at room temperature. Cells were then incubated with an anti-
Xpress antibody (Invitrogen; 1:1,000) overnight at 4°C. After washing three times with 
TBS, IRdye 800CW goat anti-mouse (Li-Cor; 1:800) secondary antibody was added 
and cells were incubated for 1 h at room temperature. Cells were washed three times 
with TBS and fluorescence measured by the Odyssey CLx infrared scanner. 
 
Cytotoxic effect of NetB on LMH cells 
The cytotoxicity of NetB on LMH cells was evaluated with the CytoTox96 kit 
(Promega). LMH cells were grown on 96-well plates as described above and incubated 
with two-fold serial dilutions of NetB in Waymouth’s medium for β h at γ7°C. Control 
cells were incubated with Waymouth’s medium to determine either the base line (0%) 
or total cell lysis (100%), the latter achieved by freezing and thawing of the cells. 
Cytotoxicity is shown as percentage relative to the controls. 
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Hemolysis assay 
Hemolysis assays with NetB were performed using human or chicken red blood cells 
(hRBCs, cRBCs). At first, erythrocytes were washed three times with TBS buffer. The 
final stock suspension was prepared by resuspending RBCs in TBS at 15% (v/v), 
obtaining a concentration of approximately 4.6 x 106 cells/ml. Two-fold dilution series 
of NetB were made in a 96-well microtiter plate and RBCs were then added to each well 
leading to molar concentrations of NetB ranging from β0 nε to 5 με. The extent of 
hemolysis was monitored by measuring absorption at 595 nm for 1 h at room 
temperature with the iMark microplate reader (Bio-Rad) and using the Microplate 
Manager 6.0 software (Bio-Rad). For selected mutants, additional measurements were 
taken at 2, 4, and 24 h at a molar concentration of 5 με. The controls consisted of TBS 
as the negative control for 0% hemolysis, and 2% (v/v) Triton X-100 as the positive 
control for 100% hemolysis. Data are shown either as the median cytotoxic dose (CT50) 
for causing 50% hemolysis within 1 h or as the degree of hemolysis after 2, 4, and 24 h 
compared to the controls. 
 
Liposome preparation and NetB oligomer isolation 
To induce oligomerisation of NetB, lipid vesicles containing egg phosphatidylcholine 
(Egg PC), egg phosphatidylglycerol (Egg PG), lysamine-rhodamine B labeled 
phosphatidylethanolamine (PE) and cholesterol were prepared. Lipids dissolved in 
ethanol (Avanti polar lipids) were mixed at the appropriate ratio and dried under a 
nitrogen stream. To ensure no residual solvent remained, lipids were further dried in a 
vacuum desiccator for 1 h. Lipids were hydrated by addition of buffer (20 mM Tris pH 
8.0, 150 mM NaCl) and frozen in liquid nitrogen. Lipid suspensions were then thawed 
at 37 C and the freeze-thaw process repeated two more times. The lipid suspensions 
were then extruded 21 times through a 100 nm diameter filter using an Avanti lipid 
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extruder. Liposomes were used fresh or frozen at -80 C until further use. NetB was 
mixed with liposomes at a protein to lipid weight ratio of 2:1 and incubated at 37 C for 
1 h to allow oligomerisation. In most cases monomeric NetB was removed by 
ultracentrifugation at 100,000 x g for 45 minutes at 4 C using a Beckman TLA 110 
rotor. NetB was then extracted in buffer containing 20 mM Tris pH 7.5, 150 mM NaCl 
and detergent (1% (w/v) octyl ȕ-D-glucopyranoside ( -OG), 5 mM 
lauryldimethylamine-oxide (LDAO), 40 mM hexaethylene glycol monodecyl ether 
(C10E6) or 1 mM pentaethylene glycol monooctyl ether (C8E5)). Unsolubilised 
material was removed by ultracentrifugation as before. As a final step, detergent 
solubilized NetB oligomer was passed over a 25 ml Superose 6 size-exclusion column. 
During this step the majority of lipid associated with NetB was removed as judged by 
the color of the fractions; fractions containing solublised lipid eluted immediately after 
NetB and were pink in color due to rhodamine labeled PE. NetB oligomer was then 
concentrated to 15-18 mg/ml for crystallisation using an Amicon  
100 kDa cut-off concentrator. The color of the concentrated protein also indicated the 
presence of some lipids still associated with NetB.  
 
Oligomerisation and calcein release assays 
Lipid vesicles composed of dioleoylphosphotidylcholine (DOPC), Egg PG and varying 
amounts of cholesterol were prepared as described above. To measure NetB 
oligomerisation, liposomes (1 mM lipid) or deoxycholic acid (6 or 12 mM) or 2-methyl-
2,4-pentanediol (MPD) (10-30% v/v) were mixed with NetB monomer (7 M) and 
incubated at 37 C for 1 h. Samples were then mixed with SDS sample loading buffer 
and run on 4-12% Bis-Tris SDS-PAGE gels without sample heating or boiling. Gels 
were Coomassie stained and digitized using standard procedures. Quantification of 
monomer reduction was performed using the gel analysis tools in Image J (16). For 
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calcein release experiments, liposomes were prepared using the procedures described 
above but lipid films were hydrated using a 75 mM calcein solution in 50 mM Tris pH 
8.0, 150 mM NaCl, and liposomes were separated from excess calcein after extrusion 
by passage over 15 ml CL-4B sepharose resin. To measure pore formation, NetB was 
incubated with liposomes of varying lipid composition at 37 C for 1 h. Calcein release 
was measured using a FluoroMax-3 fluorometer (Jobin Yvon Horiba) with an excitation 
and emission wavelength of 495 nm and 515 nm, respectively. Calcein release (%) was 
calculated as, 
Calcein release %= (Ffinal-F0)/(Fmax-F0) x 100 
 
where Ffinal is the fluorescence measured after incubation with the toxin, F0 is the 
background fluorescence in the absence of toxin and Fmax is the fluorescence after 
addition of 1% (v/v) Triton X-100. 
 
Protein lipid overlay assay 
SphingostripsTM (Echelon Biosciences) were blocked for 1 h at room temperature in 
TBS-milk (10 mM Tris pH 8.0, 150 mM NaCl, 1% (w/v) milk). Membranes were then 
washed three times in TBS and NetB, Clostridium perfringens enterotoxin (CPE) or 
tobacco etch virus protease (TEV) were added at a final concentration of 5 g/ml in 
TBS and left for 16 h at room temperature with gentle shaking. Subsequently 
membranes were washed three times in TBS and incubated with primary anti-His6 
antibodies (GE healthcare) at a 1:3000 dilution in TBS-milk for 2 h at room 
temperature. Membranes were washed three times again and incubated for 1 h with 
secondary HRP-conjugated goat anti-mouse antibodies diluted 1:2500 in TBS-milk. 
Membranes were developed using 4-chloro-1-napthol.  
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Crystallisation and data processing 
NetB oligomer was crystallised initially using the sitting drop method in 12% (w/v) 
PEG 4000, 100 mM sodium cacodylate pH 6.5. However, these crystals were too small 
for diffraction studies. Optimisation using a combination of limited trypsin proteolysis 
and the addition of the additive detergent polyethylene glycol dodecyl ether (Thesit® 
part of the Hampton detergent screen) led to crystals which diffracted to ~4 Å. Data 
were collected on a Rigaku Saturn 944 CCD detector mounted onto a Rigaku Micromax 
X-ray generator. Data were indexed and integrated with Mosflm (17) and scaled using 
SCALA (18) as part of the CCP4 (19) package. Molecular replacement was carried out 
using Phaser MR (20) and the HL heptamer structure (PDB ID: 7AHL) as a search 
model. The initial model refined using Phenix (21) with NCS, Ramachandran and 
secondary structure restraints, and increased weighting on stereochemical terms. At the 
final stages Ramachandran restraints were released. Manual building and real space 
refinement was performed using COOT (22), and model validation was calculated using 
Molprobity (23). PyMOL (24) was used for visualisation and electrostatic potential 
surface rendering. A model with all side-chains present was used for electrostatic 
potential calculation even when side-chain density was not visible in the electron 
density map. Data collection and refinement statistics are shown in Table 1. 
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Results 
 
Mutations within the rim domain of NetB affect binding and toxicity 
NetB shares approximately 30% identity with HL, the prototypical member of this 
family of small ȕ-PFTs. Sequence comparisons with other members of this family 
indicate that a number of residues identified as critical for function among the 
Staphylococcal members are also present in C. perfringens NetB, į and  toxins (Sup. 
Fig. 1). In this study, site-directed mutagenesis was used to determine whether mutation 
of key residues along the rim loops, assumed to be involved in cell binding, would 
affect NetB function 
First, NetB was evaluated for cytotoxicity towards LMH cells. The median 
cytotoxic dose (CT50) of NetB towards LMH cells was determined as 800 nM (Sup. Fig. 
2). Figure 1A shows the morphological effects of NetB on LMH cells. The left panel 
demonstrates the epithelial and dendritic-like growth of untreated cells. Treatment with 
purified NetB (800 nM, 1 h) caused rapid cell blebbing and swelling (right panel), 
whereas longer incubation periods led to total cell lysis. The binding ability of NetB to 
LMH cells was analysed using an On-cell WesternTM assay. Figure 1B shows binding of 
each mutant relative to wild type NetB. Mutants Y191A, R200A, W257A and W262A 
showed significantly reduced binding compared to wild type toxin, with mutant W262A 
having the lowest affinity to the cells. Subsequently, the three NetB mutants showing 
the lowest affinity in the On-cell WesternTM assay (Y191A, R200A, and W262A) were 
tested for their abilities to cause lysis of LMH cells at 4, 8, or 16 M concentrations 
(Fig. 1C). All 3 mutants showed reduced cytotoxicity relative to wild type NetB, with 
W262A showing the highest decrease. 
In addition, the hemolytic activity of NetB was evaluated by incubating the toxin 
with either human red blood cells (hRBCs) or chicken red blood cells (cRBCs). Figure 
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1D shows the CT50 values of the NetB variants on hRBCs. However, CT50 values of 
mutants Y191A, R200A, W257A, and W262A could not be determined as they only 
caused incomplete hemolysis within 1 h, even at 5 µM concentrations. Therefore, these 
mutants were incubated with hRBCs for an extended period and degree of hemolysis 
was monitored at 2, 4, and 24 h (Fig. 1E). Again, mutants Y191A, R200A, W257A and 
W262A showed the most significant decrease in activity relative to wild type NetB. In 
addition, mutants Y78A, Y187A, H188A and Y202A also showed a significant increase 
in CT50 values. When cRBCs were tested for hemolysis, the CT50 value of the wild type 
was more than 3-fold lower as compared to hRBCs (Fig. 1F). Furthermore, the CT50 of 
the mutants Y191A, R200A, W257A and W262A could now be measured as they 
caused complete hemolysis within the 1 h timeframe. However, their activity was 
significantly lower than of wild type toxin. 
In summary, replacement of conserved residues along the rim loops of NetB 
(Y191, R200, W257, and W262) had the most dramatic effect on NetB cell binding and 
toxicity. In addition, due to the broader dynamic range of the hemolysis assay, it could 
be shown that non-conserved residues such as Y78, Y187, H188, and Y202 also play a 
role in NetB function. 
 
NetB oligomerises and forms discrete pores on cholesterol rich vesicles 
NetB is secreted as a water-soluble monomer that is thought to oligomerise on the target 
cell surface prior to pore-formation (11). When overexpressed in E. coli, NetB 
accumulates in the cytoplasm in its monomeric form and can be purified by standard 
metal-affinity chromatography. In order to promote assembly of the oligomer, we tested 
the effect of detergents, amphiphiles and lipids on the oligomeric state of NetB. 
Addition of the ionic detergent deoxycholate above the critical micelle concentration 
(cmc) (6 or 12 mM) or 2-methyl-2,4-pentanediol (MPD) (10-30% v/v) did not produce 
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SDS-resistant oligomers (Fig. 2A). However, the presence of 20-30% (v/v) MPD did 
affect NetB, evidenced by the reduction of the monomer and a smeary appearance in 
these lanes (Fig. 2A, lanes 2-3). MPD may be causing NetB to form aggregates that 
cannot enter the gel. These findings are in contrast to αHδ, which assembles into the 
membrane-inserted form upon addition of deoxycholate (25) or MPD above 20% (v/v) 
(26). Next, liposomes composed of the pure, unsaturated lipid 
dioleoylphosphotidylcholine (DOPC), egg phosphatidylglycerol (Egg PG) and 
cholesterol were evaluated for their ability to promote NetB oligomerisation. The 
efficiency of oligomerisation was assessed by incubating NetB and liposomes at a molar 
ratio of 350:1 (NetB:liposomes) and monitoring the reduction of monomer on SDS-
PAGE. In the absence of cholesterol, 85% of the total protein was in the monomeric 
form, indicating that NetB had only partially oligomerised (Fig. 2B, lane 2). The 
monomer fraction decreased to 65%, 35% and 10% of the total protein input in the 
presence of 0.1, 0.2 and 0.5 molar ratio of cholesterol, respectively (Fig. 2B, lanes 3-5). 
The decrease of monomer was also accompanied by a corresponding increase of SDS-
resistant oligomers. Thus, the inclusion of cholesterol promoted NetB oligomerisation 
with an almost linear dependence.  
To further investigate the role of cholesterol and to test if oligomerisation of 
NetB corresponds to the formation of productive pores, we used small unilamellar 
vesicles loaded with the self-quenching fluorophore calcein (RH = 8 Å, (27)). Liposomes 
were subjected to increasing amounts of NetB monomer and incubated at 37 C for 1 h. 
The total fluorescence was then measured as an indicator of calcein release (pore 
formation) and normalised against 100% calcein release using Triton X-100. As seen in 
Figure 2C, vesicles without cholesterol promoted pore formation by NetB only at high 
protein concentration and resulted in ~30% calcein release. However, the inclusion of 
cholesterol increased pore-formation in a dose dependent way. For example, vesicles 
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with 50 Mol% cholesterol allowed 10 times more calcein release than vesicles with  
10 Mol% cholesterol (at 1 M NetB). Cone-shaped lipids, such as cholesterol, promote 
the transition of the bilayer to the inverted hexagonal phase, which may facilitate toxin 
insertion (28). To investigate whether the shape of the phospholipids is important for 
NetB insertion, vesicles containing 50 Mol% egg phosphatidylethanolamine (Egg PE), 
also a cone-shaped lipid, were tested for pore formation. As seen in Figure 2C, these 
vesicles did not readily promote pore formation.  
We reasoned that the effect of cholesterol on NetB activity might be due to a 
better exposure of the phosphocholine headgroups of DOPC which may act as a 
receptor for the toxin. This would concentrate the toxin on the membrane surface 
allowing it to oligomerise and insert more efficiently as reported previously for HL 
(29). In order to determine if NetB can bind to a specific lipid moiety we performed a 
simple protein lipid overlay assay. Membranes spotted with 100 pmol of various lipids 
(SphingostripsTM) were incubated with NetB bearing an N-terminal hexahistidine tag 
and binding specificity was probed using anti-His6 antibodies. Surprisingly NetB bound 
to cholesterol but not to phosphotidylcholine (Fig. 2D). Some binding was also seen to 
the glycosphingolipid sulfatide but to a lesser extent. No binding of NetB was observed 
to sphingomyelin. Negative controls using C. perfringens enterotoxin (Fig. 2E) and 
tobacco etch virus protease (Fig. 2F) revealed no binding to cholesterol but some 
binding to sulfatide, as seen for NetB. 
In order to confirm that NetB was forming discrete pores and that calcein was 
not being released as a result of liposome fragmentation, NetB-liposome mixtures were 
observed by transmission electron microscopy. Negatively stained specimens showed 
ring-shaped structures protruding from the liposomes, which measured approximately 
10 nm in diameter (Fig. 2G). Furthermore, the liposome size distribution seemed 
unaffected by NetB as compared to lipid only controls (Sup. Fig. 3). Collectively, these 
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results indicate that NetB produces discrete pores of at least 1.6 nm in diameter, and 
although NetB is able to oligomerise and form pores in the presence of PC vesicles 
alone, at lower NetB concentrations inclusion of cholesterol increases the conversion to 
oligomer and pore formation by almost an order of magnitude. Finally the lipid overlay 
assay clearly shows that NetB is able to bind directly to cholesterol in the absence of 
any other lipids. 
 
Solubilisation and crystallisation of the NetB oligomer 
A range of non-ionic and zwitterionic detergents were tested for their abilities to 
solubilise and maintain the oligomers of NetB, which were observed in lipid vesicles, in 
micellar solution. Lauryldimethylamine-oxide (δDAO), octyl ȕ-D-glucopyranoside ( -
OG) and hexaethylene glycol monodecyl ether (C10E6) efficiently solubilised the NetB 
assemblies, indicated by a sharp oligomer peak on size-exclusion chromatography (Sup. 
Fig. 4). In contrast, the detergent pentaethylene glycol monooctyl ether (C8E5) resulted 
in a broad elution profile and led to NetB precipitation immediately after elution. 
Interestingly, residual lipids from the liposomes were still associated with NetB even 
after size-exclusion chromatography (see experimental procedures). Detergents that 
efficiently solubilised NetB were then used for crystallisation trials. Only NetB 
solubilised in C10E6 yielded crystals that diffracted beyond 12 Å. Crystal quality was 
improved by the addition of an additive detergent and limited proteolysis using trypsin, 
which resulted in the removal of the first 20 residues from the N-terminus as determined 
by N-terminal sequencing. The best crystals belonged to the spacegroup C2 (unit cell 
dimensions; a = 313 Å, b = 168 Å, c = 160 Å, α = 90°, ȕ = 109.4°, Ȗ = 90°) and 
diffracted to ~4 Å. εolecular replacement using the αHδ heptamer (PDB ID: 7AHδ) 
resulted in a single solution with two heptamers in the asymmetric unit and a solvent 
content of 71%. The presence of 14-fold non-crystallographic symmetry (NCS) 
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produced maps in which most of the protein chain could be built and the side-chains 
could be placed with an accuracy that is unusually high for this resolution (Sup. Fig 5). 
Although trypsin removed the first 20 residues, electron density was only visible from 
residue 25. 
 
Structure of NetB and pore assembly 
Each NetB monomer contains 15 -strands accounting for 53% of the polypeptide, 
whilst the remainder is made up of one 310–helix, one short -helix and random coil. As 
with HL (12), NetB can be divided into 3 main domains: -sandwich, rim and stem 
(Fig. 3A). The -sandwich domain consists of two -sheets composed of strands 1, 2, 3, 
6, 11 and 5, 9, 10, 12, 14, 15, respectively, and a single -helix. Strands 5 and 12 extend 
into the lower part of the molecule, and these strands, along with strands 4 and 13, the 
310–helix and considerable random coil, make up the rim domain. The stem domain 
contains the long, curved amphipathic hairpin (strands 7 and 8), which is connected to 
the -sandwich domain through two short coils, forming a triangle region similar to that 
in other membrane-inserted -PFTs (12, 13). As described above, the first 20 N-
terminal residues were removed by trypsin and therefore, the amino-latch equivalent 
region which latches on to the adjacent subunit in αHδ (12), is not present in the NetB 
structure. A NetB monomer shares the highest structural similarity with į toxin from  
C. perfringens (PDB ID: βYGT). Superposition of a NetB monomer with į toxin results 
in a root mean square deviation (rmsd) of 1.2 Å (C -C ) by secondary structure 
matching (19), even though the į toxin structure represents the water-soluble monomer 
without the stem extended. Superposition with the S. aureus αHδ monomer results in an 
rmsd of 1.55 Å. Figure 3B illustrates the structural conservation between NetB and 
HL. With the exception of two small -strands which are absent in NetB (αHδ strands 
11 and 12, Sup. Fig. 1), secondary structure elements are largely conserved between the 
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two toxins. Areas of small structural deviation to αHδ exist in all three domains. For 
example, loop positions in the -sandwich domain between strands 5 and 6 and strands 
11 and 12 deviate from the corresponding loops in HL. Strand 15 in HL, which spans 
the rim and -sandwich domains, is composed of two separate strands (13 and 14) in 
NetB. Finally, while the NetB stem domain adopts a similar curvature to HL, the turn 
at the cytoplasmic end bends inwards towards the pore lumen in NetB.  
The most interesting differences between the two toxins lie in the area that 
constitutes the rim loops (Fig. 3C). In particular, a loop after strand 10 (V176-I184) is 
shorter than that of HL (N172-R184) and does not contain an equivalent to W179, a 
residue important for lipid binding in HL and LukF (W177) (12, 30, 31). In addition, 
strand 4 in NetB lies ~6 Å closer to the 7-fold axis, accounting for a smaller heptamer 
diameter compared to the HL heptamer (see below).  
A NetB oligomer is composed of seven monomers arranged in a ring that 
measures 90 Å in diameter and 95 Å along the 7-fold non-crystallographic symmetry 
axis (Fig. 3D, 3E). Thus, the NetB heptamer is slightly more compact than the HL 
(100 Å x 100 Å) (12), HL (114 Å x 93 Å) (13) and VCC (135 Å x 140 Å) (14) 
assemblies. Each monomer buries a total surface area of approximately 4200 Å2 and 
forms extensive hydrogen bond networks and a number of salt bridges on both 
interfaces, including K41 (positional equivalent to H35 in HL), which forms a salt 
bridge to D164 of the neighboring molecule. The seven -sandwich domains form the 
cap of the mushroom-shaped heptamer, whilst the stem domains form the 14-strand -
barrel pore. Each -hairpin extends from K114 and ends at P155, with a G-K-T tri-
peptide forming a turn at the cytoplasmic side of the pore. The amphipathic composition 
of the -hairpin is illustrated in Sup. Fig. 1. The predicted trans-membrane region spans 
from I121 to V146 with Ile, Tyr, Val, Ala, and Gly residues exposed to the bilayer, 
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whilst the lumen of the pore consists of uncharged polar residues, glycines and a single 
charged residue, E132, at the cytoplasmic entrance of the pore. Two aromatic residues, 
Y123 on strand 7 and Y144 on strand 8, form an aromatic belt at the upper side of the 
pore, similar to VCC (14) and some outer membrane proteins (32), and could reside at 
the hydrophobic core-polar headgroup interface of the outer bilayer leaflet. The distance 
from the cytoplasmic entrance of the pore to the aromatic belt is ~27 Å, and ~35 Å to 
the predicted start of the trans-membrane region. A surface representation of the pore 
coloured by electrostatic potential, as calculated by PyMOL (24), exemplifies the 
hydrophobic nature of the trans-membrane region (Fig. 4A). Examination of the charge 
distribution in the pore lumen reveals two distinct negatively charged areas on either 
entrance of the -barrel pore (Fig. 4B). The extracellular side is lined by D116 and 
E153, whilst E132 lines the cytoplasmic entrance. The two negatively charged areas in 
the NetB pore might influence the selectivity of ions across the membrane. The pore 
measures approximately 26 Å in diameter (C -C ), similar to the pores of other 
members of this family (12-14).  
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Discussion 
 
Necrotic enteritis is an emerging infectious disease in poultry causing huge economic 
losses to the livestock industry worldwide. NetB, a novel toxin produced by  
C. perfringens, appears to play a key role in the disease. Here, we present the crystal 
structure of the oligomeric form of NetB, which to our knowledge, is the first near-
atomic resolution structure of a Clostridial -PFT in the pore state. The heptameric 
structure, which displays high structural similarity to the Staphylococcal toxin HL, 
reveals conservation of many of the key residues that are important for function in this 
family of -PFTs but displays differences that may have evolved separately in the 
Clostridial counterparts.  
Binding to the membrane surface of the target cell in this family of PFTs is 
mediated through the rim domain. This domain contains loops rich in aromatic residues 
that are proposed to interact with the outer leaflet of the bilayer and, in the case of VCC, 
these loops may extend further into the membrane and help to destabilize it (14). 
Residues W179 and R200 in HL (equivalent to W177 and R198 in LukF), which are 
located within the rim loops, are essential for toxin function (33, 34) and form a 
phospholipid binding pocket (Fig. 5A) that has been captured interacting with 
phosphatidylcholine analogues and amphiphilic groups in several crystallographic 
structures (12, 13, 26, 30, 31). High resolution crystallographic studies of HL in 
complex with glycerolphosphocholine showed that R200 forms a water-mediated 
hydrogen bond to the phosphate while W179 contacts the quaternary ammonium group 
through cation-  interactions (30). In NetB, mutation of R200 to alanine leads to a 
significant reduction of binding and toxicity, confirming the importance of this residue 
in host cell interactions. However, a W179 equivalent is not present in NetB or in the 
other Clostridial toxins (Sup. Fig. 1) and the equivalent rim loop in NetB is shorter. 
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Therefore, this lipid-binding residue and consequently, the phosphocholine binding 
pocket, are lost in NetB (Fig. 5B). This suggests that NetB and possibly the other 
Clostridial toxins may bind to the host membrane through alternative interactions. In 
support of this hypothesis are three lines of evidence. Firstly, the protein lipid overlay 
assay and the calcein release experiments indicate that NetB does not interact efficiently 
with phosphatidylcholine or sphingomyelin, both of which have a phosphocholine 
headgroups. Secondly, the same assays indicate that NetB interacts directly with 
cholesterol and pore formation is enhanced by its presence in bilayers. Thirdly, the 
monomeric form of į toxin from C. perfringens, which is closely related to NetB and 
has specificity for ganglioside GM2, has recently been crystallised in the presence of 
glycerol that mimics the phospholipid groups (PDB ID: 2YGT). One of the glycerol 
molecules forms hydrogen bonds with residues 199-202, including R200, while Y201 
interacts with the glycerol backbone. In NetB, Y202 may facilitate a similar interaction 
due to its proximity to R200 and this would explain the reduced hemolytic activity of 
NetB Y202A (Fig. 1D). Interestingly tyrosines at this position are only conserved in the 
Clostridial toxins. Thus the Clostridial and Staphylococcal members of this family of -
PFTs may bind to host membranes using different mechanisms and involving 
interactions with different lipids.  
Tyrosine at position 191 is conserved across this toxin family and in its 
equivalent substitution in C. perfringens  toxin (Y203F) increases the median lethal 
dose in mice by more than 2-fold (35). This study has shown that residue Y191 affects 
host-cell binding and consequently, cytotoxicity of NetB. A reduction in membrane 
binding may explain the reduced toxicity of  toxin mutant Y203F. On the neighbouring 
rim loop that extends the furthest towards the membrane, W257 and W262 are also 
involved in cell binding. Substitution to alanine at either position severely reduces NetB 
binding to LMH cells, significantly reduces hemolysis on cRBCs and almost abolishes 
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hemolysis on hRBCs (Fig. 1). These residues are highly conserved in -PFTs of  
S. aureus and C. perfringens and in LukF, W257A abolishes binding to hRBC (33). 
The role of the lipid bilayer composition in the function of pore forming toxins 
has been extensively studied (28, 36-39). Cholesterol modulates the fluidity of lipid 
bilayers and promotes a liquid-ordered state intermediate between the gel and liquid-
crystalline states at temperatures below the specific melting temperature (Tm) of the 
lipid (40). This property has been implicated in the function of HL (37). It has also 
been suggested that cholesterol may allow the optimal orientation of phosphocholine 
headgroups for toxin interaction (29, 36). Valeva and co-workers (29) suggested that 
clustering of phosphocholine headgroups in cholesterol-sphingomyelin containing lipid 
rafts may act as a high-affinity receptor for HL by exposing more of the 
phosphocholine headgroups. The same study showed that cholesterol depletion of rabbit 
erythrocytes significantly reduced the sensitivity to HL and this was attributed to the 
disruption of clustered sphingomyelin in lipid rafts (29). It was also hypothesised that 
cholesterol may interact directly with HL (36) even though it is not a cholesterol-
dependent cytolysin (CDC). Moreover, cholesterol, which has a similar overall structure 
to deoxycholate, a detergent that induces oligomerisation of HL, may facilitate the 
conformational changes that occur during the insertion process (26). In the case of HL 
it was shown that toxin function was not affected by membrane fluidity but was 
influenced by the physical properties of the phospholipid (shape and length) and the 
presence of cholesterol (38). As shown here, NetB activity is also influenced by 
cholesterol. Liposomes composed of 90 Mol% DOPC and no cholesterol did not readily 
induce oligomerisation of NetB, and calcein release occurred only at higher protein 
concentration. Vesicles composed mostly of DOPC (Tm= -20 C) should exist in the 
liquid-crystalline state at the experimental temperatures (>23 C). Thus, membrane 
fluidity is not the sole factor affecting NetB pore formation. The inclusion of cholesterol 
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up to 50 Mol% enhanced oligomerisation and calcein release by almost 10-fold. In 
addition, we showed that it is not the conical shape of cholesterol that confers the 
bilayer susceptibility to NetB. Finally we show that NetB is able to interact with 
cholesterol directly in the absence of other lipids. These potentiating properties of 
cholesterol may reflect a toxin-receptor interaction. At high NetB concentrations, 
enough monomers may be in close proximity that even weak and transient toxin-
membrane interactions may suffice to promote oligomerisation. However, at low 
protein concentrations, stronger interactions for toxin binding are required and may be 
provided by cholesterol directly. Therefore, although NetB does not belong to the 
classical CDC family, like VCC, its activity is dependent on cholesterol. Although the 
exact role of membrane cholesterol in NetB function needs to be investigated further, it 
is clear from this study that it plays a key role in the ability of the toxin to oligomerise 
and form functional pores. These results may reflect the differences in affinity to target 
cells in vivo and suggest that the different susceptibility of cells to this family of toxins 
may be attributed to the composition of the cytoplasmic membrane in addition to a 
putative protein receptor.  
Charged residues in the proximity of the pore entrance and along the pore lumen 
can affect the ion selectivity and function of this family of -PFTs (41-43), and much 
effort has been placed in altering the physicochemical properties of these channels for 
use in nanotechnology (44, 45). In HL, the cytoplasmic entrance contains two 
aspartates (D127 and D128), both of which form salt bridges with K131 of the 
neighboring molecule (12). In addition, E111 on the extracellular side of the HL pore 
is involved in a salt bridge with K147. Thus, the overall charge of the HL pore is 
neutral with a slight anion selectivity, which is attributed to K147 lying closer to the 
lumen center than E111 (43). In HL (HlgA-HlgB) the removal of a single positive 
charge in the pore lumen (HlgA K108) significantly increases the conductance and 
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cation selectivity of the channel (41). The entrances from both sides of the NetB pore 
are lined with acidic residues (D116, E153 and E132) forming two distinct negatively 
charged belts (Fig. 4B). Given the influence of charged residues on ion selectivity and 
the absence of any compensating positive charges we expect the NetB pore to be cation 
selective.  
In conclusion, the structure of NetB, along with the identification of residues 
important for binding and toxicity will facilitate the development of vaccines against 
necrotic enteritis, as well as provide the framework for future studies on this group of 
related pore-forming toxins. Finally, NetB could provide a new set of tools for the field 
of nanotechnology, which will benefit greatly by the availability of a molecular 
structure in the active form. 
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Tables 
Table 1. Data collection and refinement statistics of the NetB structure. 
 Native NetB 
Data collection  
Space group C2 
Cell dimensions   
    a, b, c (Å) 313.23, 168.04, 160.46  
 ( )  90, 109.4, 90 
Resolution (Å) 27.71-3.9 (4.039-3.9)* 
Rmerge 0.344 (0.685) 
I/ I 3.7 (2.0) 
Completeness (%) 97.4 (97.0) 
Redundancy 3.7 (3.7) 
Refinement  
Resolution (Å) 27.71-3.9 
No. reflections 63875 
Rwork/ Rfree 28.3/30.8 
No. atoms  
    Protein 27960 
    Ligand/ion 0 
    Water 0 
B-factors  
    Protein 74.40 
RMS deviation  
    Bond lengths (Å) 0.003 
    Bond angles ( ) 0.83 
  
* Values in parentheses are for highest-resolution shell.  
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Figures 
 
 
 
Figure 1. Morphological damage of LMH cells induced by NetB and functional analysis of NetB rim 
mutants.  
(A) Untreated cells (left panel) and cells incubated with NetB (800 nM, 1 h, right panel). Cell swelling 
and blebbing induced by NetB can be seen on the right panel. (B) Binding to LMH cells. Cells were 
grown on 96-well plates and incubated with NetB (βγ μM) for 10 min at 37°C. Degree of binding is 
shown relative to wild type NetB (100%). Graph represents data from four replicates in three independent 
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experiments (data are means ± SEM; n=3). Asterisks indicate a statistically significant difference  
(*: p<0.05; **: p<0.01; ***: p<0.001; 1-way ANOVA) relative to wild-type NetB. (C) Cytotoxic effect of 
NetB on LMH cells. Cells were grown on 96-well plates and incubated with two-fold serial dilutions of 
NetB for 2 h. Cytotoxicity is shown relative to the signal of untreated (0%) and lysed cells (100%). Graph 
represents data from three replicates in three independent experiments (data are means ± SEM; n=3). 
Asterisks indicate a statistically significant difference (*: p<0.05; **: p<0.01; ***: p<0.001; 2-way 
ANOVA) relative to wild-type NetB. (D-F) Hemolysis of human (hRBCs) or chicken red blood cells 
(cRBCs). (D) Two-fold dilution series of NetB were incubated with hRBCs for 1 h at 37°C. The cytotoxic 
dose to lyse 50% of the cells (CT50) was determined within the given time period. Graph represents data 
from three independent experiments (data are means ± SEM; n=3). Asterisks indicate a statistically 
significant difference (***: p<0.001; **: p<0.01; 1-way ANOVA) relative to wild-type NetB. (E) Rim 
mutants Y191A, R200A, W257A, and W262A were incubated with hRBCs at a molar concentration of  
5 με and the degree of hemolysis was determined at β, 4, and β4 h. Hemolysis is shown relative to the 
signal of untreated (0%) and lysed (100%) hRBCs. Graph represents data from three independent 
experiments (data are means ± SEM; n=3). (F) Hemolysis of cRBCs was carried out as described for 
hRBCs and using wild type NetB and mutants Y191A, R200A, W257A and W262A.  
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Figure 2. In vitro oligomerisation and pore forming activity of NetB.  
(A) NetB oligomerisation in the presence of amphiphiles. Monomer (m) and oligomer (o) band positions 
are indicated. Lane 1. NetB plus 10% (v/v) MPD. Lane 2. NetB plus 20% (v/v) MPD. Lane 3. NetB plus 
30% (v/v) MPD. Lane 4. NetB plus 6 mM Deoxycholate. Lane 5. NetB plus 12 mM Deoxycholate.  
(B) NetB oligomerisation in the presence of liposomes. Lane 1: NetB only. Lane 2. NetB plus DPOC:PG 
(9:1). Lane 3. NetB plus DPOC:PG:Cho (8:1:1). Lane 4. NetB plus DPOC:PG:Cho (7:1:2). Lane 5. NetB 
plus DPOC:PG:Cho (4:1:5). SDS-PAGE samples were run without boiling. (C) Calcein loaded liposomes 
of the indicated compositions were incubated with NetB at various concentrations for 1 h at 37 C and the 
% calcein release was measured. (D-E) Protein lipid overlay assay with NetB (D), CPE (E) and TEV (F). 
SphingoStripsTM (Echelon) were incubated with the His6-tagged proteins as described in the methods and 
developed using ani-His6 antibodies. Lipid spots: 1. sphingosine, 2. sphingosine-1-phosphate,  
3. phytosphingosine, 4. ceramide, 5. sphingomyelin, 6. sphingosylphosphorylcholine, 7. lysophosphatic 
acid, 8. myriosine, 9. monosialoganglioside, 10. disiaganglioside, 11. 3-sulfogalactoceramide (sulfatide), 
12. psychosine, 13. cholesterol, 14. lysophosphocholine, 15. phosphatidylcholine, 16. blank. (G) Electron 
microscopy of NetB-liposome mixtures. NetB mixed with liposomes containing cholesterol (50 Mol %). 
Samples were negatively stained with 2% (w/v) aqueous uranyl acetate and observed using a Philips T12 
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transmission electron microscope. The liposomes appear completely decorated with 10 nm ring structures 
whilst some side views are visible at the liposome edges extending above the liposome surface. 
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Figure 3. Crystal structure of NetB.  
(A) Ribbon representation of an isolated NetB subunit. The three domains are colored green ( -sandwich 
domain), blue (rim domain) and yellow (stem domain) and -strands are numbered as described in the 
main text. The N- and C-termini are indicated. (B) Superposition of a NetB subunit to an HL subunit 
(light grey) indicates the overall similarities and differences between the two proteins. (C) Close up view 
of the rim domain. Residues in NetB that were mutated in this study and shown to affect function are 
shown in stick representation. (D, E) Ribbon representation of the NetB assembly (colored as in A) 
viewed from the side (D) and cytoplasmic aspects (E). Residues Y123 and Y144, which form an aromatic 
belt on the stem, are shown in stick representation. The putative borders of the membrane bilayer are 
indicated with the phospholipid headgroups of both leaflets in yellow and the hydrophobic core in grey. 
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Figure 4. Surface charge distribution in NetB.  
Surface electrostatic potential calculated using the PyMOL molecular graphics program showing the 
exterior of the NetB heptamer (A) and a cut-out view revealing the channel’s interior surface (B). White: 
neutral, blue: positive charge, red: negative charge. 
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Figure 5. Phospholipid binding at the NetB rim domain.  
Surface representation of the rim domain of HL (PDB ID: 7AHL) (A) and NetB (B) in the same 
orientation. The phosphocholine binding pocket which is formed by W179 and R200 in HL is absent in 
NetB. Tyrosine 202 in NetB affects binding and toxicity and could be involved directly in lipid binding. 
Arginine 200 in NetB is disordered and thus absent from the model. 
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Supplementary information 
 
 
 
 
Supplementary Figure 1. Sequence alignment of toxins from Clostridium perfringens and 
Staphylococcus aureus.  
Residue numbers for individual proteins are given at the beginning of each line and additionally every 10 
residues for NetB. Filled-in boxes represent identical residues, whereas outlined boxes represent similar 
residues. Residues marked with an asterisk (*) were mutated in NetB for this study. The secondary 
structure is shown for NetB (top) and αHδ (bottom) based on their respective crystallographic structures. 
Key: ȕ=beta-strand, η=γ10 helix, α=alpha-helix. The alignment was performed using CLUSTALW and 
the figure was created using the ESPript 2.2 server (http://espript.ibcp.fr/ESPript/ESPript/). 
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Supplementary Figure 2. Cytotoxic effect of NetB on LMH cells.  
Cells were grown on 96-well plates and incubated with two-fold serial dilutions of NetB for 2 h. Graph 
represents data from six replicates in three independent experiments (data are means ± SEM; n=3). Data 
is shown relative to the signal of untreated (0%) and lysed (100%) cells. The median cytotoxic dose 
(CT50) was determined as 800 nM. 
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Supplementary Figure 3. Transmission electron microscopy of negatively-stained liposomes in the 
absence of NetB.  
The liposomes contain 50 Mol% cholesterol. 
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Supplementary Figure 4. Size exclusion chromatography of detergent solubilised NetB oligomers.  
The four indicated detergents were used to solubilise liposome-bound NetB assemblies and run on a 
Superose-6 size-exclusion column. In the case of C10E6, the monomer was not removed prior to 
solubilisation and can be seen eluting after the oligomer. 
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Supplementary Figure 5. Stereo representation of the 2F(o)-F(c) electron density map of the NetB 
rim and stem regions.  
The map was contoured at 1.0 σ. 
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Abstract 
 
NetB (Necrotic enteritis toxin B) is a recently identified β-pore-forming toxin produced 
by Clostridium perfringens. This toxin has been shown to play a major role in avian 
necrotic enteritis. In recent years, a dramatic increase in necrotic enteritis has been 
observed, especially in countries where the use of antimicrobial growth promoters in 
animal feedstuffs has been banned. The aim of this work was to determine whether 
immunisation with a NetB toxoid would provide protection against necrotic enteritis. 
The immunisation of poultry with a formaldehyde NetB toxoid or with a NetB genetic 
toxoid (W262A) resulted in the induction of antibody responses against NetB and 
provided partial protection against disease. 
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Introduction 
 
Clostridium perfringens (C. perfringens) is a ubiquitous bacterium that is able to 
colonise a variety of different biotopes and it is not unusual to find C. perfringens as a 
commensal in the normal gut microbiota in domesticated animals. However, under 
particular circumstances the bacterium is responsible for severe diseases. These diseases 
are largely a consequence of the actions of toxins on the host [1]. In addition to the four 
toxins used for typing C. perfringens strains (alpha-, beta-, epsilon-, and iota-toxin), the 
bacterium is able to produce a number of other toxins, including enterotoxin and 
perfringolysin O [2, 3]. 
C. perfringens has been shown to cause avian necrotic enteritis (NE), a severe 
gastro-intestinal disease of farmed poultry [4-6]. Until recently, NE has been controlled 
by the addition of antimicrobial growth promoters to feedstuffs. However, in many 
countries national and supranational regulations now limit the addition of antimicrobials 
to animal feeds. Consequently, in these countries, NE is emerging as a disease which is 
of significant economic consequence to the poultry industry [7, 8]. The disease can 
occur in at least two forms. The acute form of NE typically results in mortality during 
the last weeks of rear of broilers (week 5-6). However, many cases of NE are associated 
with relatively mild clinical signs [9-11]. This subclinical form of NE results in 
decreased digestion and absorption of feedstuffs and consequently reduced weight gain 
[12, 13]. At least in Europe it is now believed that the subclinical NE is the most 
frequent form of the disease and causes the greatest economic losses to the poultry 
production industry [14]. 
Although it is clear that C. perfringens is the etiologic agent of NE, a wide range 
of host and pathogen factors can influence the severity of the disease. These factors 
include the nature of the feedstuff, co-infection with various Eimeria species and the 
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molecular makeup of C. perfringens in the gut [15]. Often these factors interact with 
each other, and this has made the development of reliable infection models difficult 
[15]. The molecular basis of virulence of C. perfringens associated with NE is still 
being investigated. However, almost all C. perfringens isolates from cases of NE 
possess the netB gene [4, 16, 17] which encodes necrotic enteritis toxin B (NetB), a β-
pore-forming toxin [6, 18]. Pore formation by NetB can lead to cell lysis by disruption 
of membrane integrity and a netB mutant of C. perfringens is reported to be incapable 
of causing NE [6]. There is also accumulating evidence that other virulence factors, 
such as the TpeL toxin, play a role in disease [19]. The production of these virulence 
factors might explain the reported ability of some netB-negative strains of  
C. perfringens to cause NE [4, 6]. 
Immunisation with either crude toxoids [20] or culture supernatants [21] can 
provide significant but incomplete protection against experimental NE. Although these 
vaccines are simple to prepare they suffer from the limitation that it is difficult to 
configure them for non-invasive dosing, for example by oral delivery. Other workers 
have explored the possibility of a sub-unit which is able to protect against NE, with a 
view towards both improving vaccine efficacy and opening the possibility of oral 
delivery. To date, a range of proteins derived from C. perfringens have been evaluated 
as sub-unit vaccines including alpha-toxin, glyceraldehyde-3-phosphate dehydrogenase, 
pyruvate-ferredoxin oxidoreductase, fructose 1,6-biphosphate-aldolase, or a 
hypothetical protein [22]. Immunisation with any of these sub-units provided partial 
protection against experimental NE. Partial protection against NE has also been reported 
after immunisation with C. perfringens large cytotoxin TpeL, endo-beta-N-
acetylglucosaminidase or phosphoglyceromutase [23]. A more recent study in which 
alpha-toxin, NetB, pyruvate-ferredoxin oxidoreductase and elongation factor-Tu were 
compared as protective antigens concluded that NetB and pyruvate-ferredoxin 
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oxidoreductase given with ISA71 adjuvant provided enhanced protective immunity 
[24]. However, it is unlikely that a licensed vaccine for widespread use could contain 
active toxins. Therefore, there is a need to identify non-toxic variants of these toxins. 
In a previous study, mutational analysis of NetB led to the identification of 
several amino acids important for toxicity [18]. The mutation of tryptophan to alanine at 
position 262 (W262A) resulted in a significant reduction in cytotoxicity towards LMH 
cells, binding to LMH cells and hemolytic activity on red blood cells [18]. The W262A 
mutation is located within the rim domain of NetB, a region mediating binding of the 
toxin to the cell membrane. 
In this study, we investigated whether a formaldehyde NetB toxoid or a NetB 
mutant (W262A) were able to induce protection against experimental NE in poultry. 
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Material and methods 
 
Bacterial strains and plasmids 
Plasmid pBAD (Invitrogen, Paisley, UK) was used as expression vector and E. coli 
TOP10 (Invitrogen, Paisley, UK) as expression host. E. coli strains were grown either in 
Terrific Broth (TB) or Luria-Bertani (LB) agar supplemented with ampicillin  
(100 μg/ml) at γ7°C and shaken at γ00 rpm, where appropriate. 
 
Animals and housing conditions 
Ross 308 broiler chickens were obtained as one-day-old chicks from Vervaeke-Belavi 
Hatchery (Tielt, Belgium, BE3031) and the parent flock had not been vaccinated with 
the commercial Netvax or any other C. perfringens vaccine. All animals were housed in 
the same room. The birds were reared in pens at a density of 27 animals per 1.5 m2 on 
wood shavings. All pens were separated by solid walls to prevent contact between birds 
from different treatment groups. Before the trial, the rooms were decontaminated with 
Metatectyl HQ (Clim’oMedic®, Metatecta, Belgium) and a commercial anticoccidial 
disinfectant (OOCIDE, DuPont Animal Health Solutions, Wilmington, USA). The 
chickens received ad libitum drinking water and feed. A 23 h/1 h light/darkness 
program was applied. The animal experiments were carried out according to the 
recommendations and following approval of the Ethical Committee of the Faculty of 
Veterinary Medicine, Ghent University, Belgium. 
 
Expression and purification of NetB and NetB W262A 
The expression of wild type NetB or NetB W262A, without their native signal peptides 
and with N-terminal His-tags for purification, was carried out in E. coli TOP10 cells 
and purification was carried out as described previously [18]. In summary, the 
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recombinant E. coli carrying the pBAD-NetB expression vector was grown in TB to an 
optical density (OD595nm) of 0.5 and expression of the toxin induced for 6 h by adding 
arabinose at a final concentration of 0.02% (w/v). Bacterial cells were harvested by 
centrifugation, lysed enzymatically using BugBuster (Invitrogen, Paisley, UK), and 
NetB purified by Ni-NTA chromatography columns (GE Healthcare Life Sciences, 
Little Chalfont, UK) according to the manufacturer’s instructions. The protein was 
transferred into Tris-buffered saline (TBS; 20 mM Tris pH 7.5, 150 mM NaCl) using 
PD-10 desalting columns (GE Healthcare Life Sciences, Little Chalfont, UK) and 
protein concentrations measured with a UV-Vis spectrophotometer (Thermo Scientific, 
Cramlington, UK). 
 
Preparation of formaldehyde NetB toxoid 
Wild type NetB was suspended at 400 μg/ml in TBS and formaldehyde added to a final 
concentration of 130 mM. After incubation for 5 days at 37°C, the reaction was stopped 
by the addition of L-lysine (30 mM final concentration) and residual formaldehyde was 
removed by dialysis overnight against TBS by using 10 kDa MWCO Spectra/Por 6 
dialysis tubing (Spectrumlabs, Rancho Dominguez, USA). 
 
SDS-PAGE analysis 
Protein purity was analysed by SDS-PAGE on precast 4-12% acrylamide-bisacrylamide 
gels (Invitrogen, Paisley, UK). Therefore, gels were run in MES running buffer 
(Invitrogen, Paisley, UK) for 45 min at 200V and stained with SimplyBlue (Invitrogen, 
Paisley, UK). The Perfect Protein Marker (Merck, Darmstadt, Germany) was used as a 
protein standard. 
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Cytotoxic activity of NetB and NetB toxoids 
Wild type NetB or NetB toxoids were evaluated for cytotoxicity towards a chicken 
hepatocellular carcinoma epithelial cell line (LMH; ATCC: CRL-2117; ATCC-LGC 
Standards, Teddington, UK) as described previously [18]. Briefly, LMH cells were 
grown on 96-well plates to approximately 70% confluency in Waymouth’s MB 75β/1 
medium (Invitrogen, Paisley, UK) supplemented with 10% fetal calf serum in a 5% CO2 
incubator at 37°C. Subsequently, cells were incubated with 100 µl (0.4 mg/ml) of either 
wild type NetB, formaldehyde NetB toxoid, or NetB W262A for 1 h at 37°C. Effects on 
cell morphology were observed with the Inverso-TC optical microscope (Medline 
Scientific, Chalgrove, UK) and images were taken with the PowerShot S5 IS digital 
camera (Canon, Reigate, UK). 
 
Measurement of antibody to NetB using ELISA 
Antibody responses to NetB toxoids were determined using an enzyme-linked 
immunosorbent assay (ELISA). Three group of 10 one-day-old Ross 308 broiler 
chickens were fed a wheat/rye-based (43%/7.5%) diet, with soybean meal (24.6% and 
25.3% soybean meal in the starter and grower diet respectively) as a protein source [25]. 
On days 3, 9, and 15, animals were each immunised with γ0 μg of either formaldehyde 
NetB toxoid or NetB W262A. Quil-A (50 μg; Brenntag Biosector, Frederikssund, 
Denmark) was used as an adjuvant. The mixture was diluted in PBS to a total volume of 
200 µl, mixed by pipetting and filter-sterilised (0.2 µm pore size). Birds were 
vaccinated subcutaneously in the neck with a 200 µl dose. Controls consisted of a group 
receiving only the Quil-A (50 μg) adjuvant. Serum samples were taken on day 15 (prior 
to third immunisation) and on day 23. 
For each ELISA, assays were performed in triplicate in three independent 
experiments, individual sera in each group were pooled and used at a dilution of 1:20. 
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First, 96-well microtiter plates (Nunc-Immuno Plates – MaxiSorp; Thermo Scientific, 
Cramlington, UK) were coated with 2.5 µg/well of purified NetB overnight at 4°C. 
Plates were washed three times with TBS-T (TBS, Tween 0.05% v/v) and blocked with 
Odyssey blocking buffer (LI-COR Biosciences, Cambridge, UK) for 1 h at room 
temperature. Plates were washed with TBS-T and 100 µl/well of pooled sera was 
incubated for 2 h at room temperature. Bound antibodies were detected using a HRP-
conjugated rabbit anti-chicken IgY (H+L) secondary antibody (1:5,000; Thermo 
Scientific, Cramlington, UK) and the ELISA HRP substrate (680) pack (LI-COR 
Biosciences, Cambridge, UK). Fluorescent intensity was imaged using the Odyssey 
CLX infrared imaging system (LI-COR Biosciences, Cambridge, UK). The 
fluorescence values for each sample were normalised by subtracting the values obtained 
for using TBS as a sample. 
 
In vivo NE model 
The NE model was based on the subclinical in vivo model described previously [25, 
26]. Groups of 25-28 one-day-old Ross 308 broiler chickens were immunised three 
times with either formaldehyde NetB toxoid formulated with Quil-A or NetB W262A 
formulated with Quil-A as described above. Controls consisted of an untreated group 
and a group receiving only the adjuvant. Nobilis Gumboro D 78 vaccine (Schering-
Plough Animal Health, Brussels, Belgium) was given in the drinking water on day 16. 
From day 17 onwards soy bean meal was replaced by fishmeal (30%) as a protein 
source. All groups were challenged orally, using a plastic tube inserted in the crop, on 
days 17, 18, 19 and 20 with a single dose of approximately 4 x 108 cfu of C. perfringens 
strain 56. On day 18, all animals were orally inoculated with a 10 x dose of Paracox-5 
(Schering-Plough Animal Health, Brussels, Belgium) [26]. On days 21, 22, and 23, one-
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third of the birds in each group were euthanised and necropsied. A schematic outline of 
the experimental design is shown in Figure 1. 
 
Assessment of protection 
NE severity was assessed by scoring lesions within the small intestine of each animal 
(duodenum to ileum) as described by Keyburn et al. [27] as follows: 0 = no gross 
lesions; 1 = congested intestinal mucosa; 2 = focal necrosis or ulceration (1-5 foci); 3 = 
focal necrosis or ulceration (6-15 foci); 4 = focal necrosis or ulceration (≥16 foci); 5 = 
patches of necrosis 2-3 cm long; 6 = diffuse necrosis typical of field cases. Animals 
showing lesion scores of 2 or higher were classified as NE positive. 
 
Statistical analysis 
For the in vivo NE model, differences within the occurrence of NE-positive animals 
between the controls and the NetB toxoid vaccinated groups were evaluated by a binary 
logistic regression analysis with the SPSS Statistics software 21.0 (SPSS Inc., Chicago, 
USA). A 2-way ANOVA analysis with the GraphPad Prism software 5.01 (GraphPad 
Software, La Jolla, USA) was used to compare the means of ELISA data. In both 
analysis, a p value of less than 0.01 was considered as significant (***: p<0.001; **: 
p<0.01).
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Results 
 
SDS-PAGE analyses of NetB W262A and formaldehyde NetB toxoid 
Purified NetB W262A was analysed by SDS-PAGE (supplemental Figure 1A). The 
predicted molecular size of monomeric NetB, without its native signal peptide but with 
an N-terminal His-tag, is 37.6 kDa and we observed a major band with an apparent 
molecular size of approximately 38 kDa. A lower abundance protein migrated with a 
molecular weight of greater than 200 kDa and this is likely to be the SDS-resistant 
heptameric form of the toxin [18]. We also prepared a formaldehyde NetB toxoid. The 
toxoid migrated as a high molecular complex on SDS-PAGE (supplemental Figure 1B), 
consistent with the chemical cross-linking of individual proteins. 
 
Cytotoxic activity of NetB and NetB toxoids on LMH cells 
LMH cells were incubated with 0.4 mg/ml wild type NetB or NetB toxoids for 1 h at 
37°C and any morphological changes observed by optical microscopy (supplemental 
Figure 2). Untreated cells showed epithelial and dendritic-like growth (supplemental 
Figure 2A), whereas treatment of cells with purified wild type NetB caused cell 
blebbing and cell swelling (supplemental Figure 2B). Incubation with formaldehyde 
NetB toxoid or NetB W262A did not result in any morphological changes indicative of 
toxicity to LMH cells (supplemental Figure 2C and 2D, respectively). 
 
Measurement of antibody to NetB using ELISA 
We used an ELISA to measure the antibody responses to NetB in immunised chicken 
(Figure 2). Animals immunised with either formaldehyde NetB toxoid or NetB W262A 
showed an increasing antibody response to NetB over the course of the immunisation 
schedule. By day 23 poultry immunised with the toxoids showed significantly higher 
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levels (p<0.001) of circulating antibody than control animals immunised with Quil-A 
alone. In addition, on day 23 animals immunised with the NetB W262A showed 
significantly increased (p<0.01) NetB antibody responses than the group vaccinated 
with the formaldehyde NetB toxoid. 
 
Protection against experimental NE after immunisation with formaldehyde NetB 
toxoid or NetB W262A 
Immunisation with either the formaldehyde NetB toxoid or with NetB W262A reduced 
lesion scores relative to the control groups in poultry experimentally infected with  
C. perfringens (Figure 3A). In the control groups of untreated chickens, or chickens 
dosed with adjuvant only, the mean lesion scores were 1.04 and 1.07, respectively. In 
contrast, animals immunised with the formaldehyde NetB toxoid showed a mean lesion 
score of 0.33 and animals immunised with NetB W262A a mean lesion score of 0.25. 
There was also a reduced occurrence of NE-positive chicken in vaccinated groups 
compared with control groups (Figure 3B). In the non-vaccinated and the adjuvant only 
immunised groups 48% of the birds were NE-positive, whereas in animals vaccinated 
with formaldehyde NetB toxoid or NetB W262A only 15% and 11% of animals were 
NE-positive, respectively. 
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Discussion 
 
In broilers, acute NE is often evidenced as a sudden increase in flock mortality during 
the last weeks of the rearing period (week 5-6) and at necropsy large necrotic foci and 
extensive necrosis are found at the mucosal surface of the gut. The infection model we 
have used in our study reflects the subclinical form of disease. In our model 
approximately 50% of the control animals develop focal lesions which are typical of the 
lesions seen in field cases of subclinical NE. We do not observe massive necrosis of the 
gut which is associated with acute disease. In previous studies we have used this model, 
in some cases with minor modifications, to evaluate the effect of feed additives, 
vaccines or antibiotics on disease or to perform studies on the pathogenesis of NE [21, 
26, 28-30]. 
Recently, we have solved the heptameric pore-forming structure of NetB and 
determined the roles of selected amino acids mediating binding and toxicity to target 
cells [18]. The NetB mutant (W262A) showed the greatest reduction in binding and 
toxicity, relative to wild type NetB. Cytotoxicity of wild type NetB and NetB W262A 
on LMH cells was tested via the release of lactate dehydrogenase (LDH) into the culture 
medium [18]. Wild type NetB caused LDH release and the median cytotoxic dose 
(CT50) was 800 nM. In contrast, LDH release could not be detected after incubation of 
cells with NetB Wβ6βA, even at a concentration of 4 μM [18]. 
This study was conducted to test NetB W262A or a formaldehyde NetB toxoid 
for their potential to induce an immune response able to protect chicken against the 
subclinical form of NE. Vaccination with either antigen increased the antibody response 
to NetB, relative to the control groups. In addition, antibody levels to NetB were 
significantly higher on day 23 for the NetB W262A immunised group than for the 
formaldehyde NetB toxoid vaccinated group. As expected, control chickens did not 
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have high levels of antibody to NetB on days 15 and 23 of our study. We recorded an 
induced protection after immunisation with either of the NetB toxoids in our NE disease 
model. However, a direct comparison with protection studies carried out by other 
researchers with different antigens is difficult, due to differences in the immunisation 
regimens and disease models used. 
Although our findings are encouraging, the vaccination schedule we have 
reported here would not be suitable for widespread use in poultry flocks. The lifespan of 
broiler poultry is typically 4 to 8 weeks and using our immunisation schedule we could 
not detect a significant increase in serum NetB antibody at 15 days post immunisation. 
Protection of younger animals might be achieved by the vaccination of breeder hens 
with the subsequent transfer of maternal antibody to eggs [31, 32], by in ovo 
immunisation [33, 34], or using a vaccine delivery system that results in a rapid 
development of immunity [35]. 
We could not demonstrate complete protection of poultry after immunisation 
with either NetB W262A or the formaldehyde NetB toxoid. It is possible that NetB 
variants with mutations in other residues might lead to higher levels of protection. 
However, our findings that immunisation with either NetB W262A or the formaldehyde 
toxoid induced broadly similar levels of protection suggests that it is more likely that 
delivery with a different adjuvant or by a different route is required for improved 
protective immunity. If NetB is directly responsible for the gut lesions seen in diseased 
animals, then it is possible that immunisation by a route that would induce a mucosal 
antibody response would provide increased protection against NE. Immunisation with 
an attenuated strain of Salmonella enterica serovar Typhimurium expressing NetB 
W262A could result in the induction of mucosal antibody which would then protect the 
gut mucosal surface from the toxin. The use of a Salmonella-vectored vaccine might 
also allow a single dose of vaccine to be given – an important consideration when 
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immunising poultry flocks. Previously, other workers have expressed C. perfringens 
fructose-biphosphate-aldolase, pyruvate-ferredoxin oxidoreductase, hypothetical 
protein, or alpha-toxoid in attenuated strains of Salmonella enterica serovar 
Typhimurium and have reported the induction of protective immunity against 
experimental NE [36, 37]. These Salmonella based vaccines have been given to poultry 
orally and immunisation resulted in both serum and mucosal antibody responses to the 
C. perfringens antigens [36, 37]. 
Alternatively, we have previously reported the expression of alpha-toxoid on the 
surface of Bacillus subtilis spores, and these spores have been shown to be 
immunogenic in mice, inducing mucosal antibody responses after oral dosing [38]. The 
immunogenicity of the recombinant spores in poultry has not been investigated. 
However, B. subtilis spores have been shown to be effective as competitive exclusion 
agents in poultry, limiting colonisation of the gut by C. perfringens [39]. Oral dosing 
with B. subtilis spores expressing NetB W262A might therefore offer short term 
benefits as the spores act as competitive exclusion agents and also induce protective 
antibody responses in the longer term. 
An alternative approach to devising an NE vaccine that provides more complete 
protection against disease might lie in using a combination of protective antigens, such 
as NetB toxoid with alpha-toxoid, glyceraldehyde-3-phosphate dehydrogenase, 
pyruvate-ferredoxin oxidoreductase, fructose 1,6-biphosphate-aldolase, hypothetical 
protein, elongation factor-Tu, TpeL, endo-beta-N-acetylglucosaminidase, or 
phosphoglyceromutase which have all been shown to provide partial protection against 
disease. 
In conclusion, this study demonstrates that a formaldehyde NetB toxoid or NetB 
W262A could be used in subsequent work to devise a vaccine to control NE. Compared 
to the production method of formaldehyde NetB toxoid, the NetB W262A mutant is 
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easily produced in E. coli. In addition, toxoiding using formaldehyde can show batch to 
batch variation and reversion to toxicity has been reported in other bacterial toxins in 
the past [40, 41]. Furthermore, it is important to minimise any free formaldehyde in 
vaccine preparations to avoid possible side effects [42]. As a NetB formaldehyde toxoid 
might suffer from these problems, the use of a NetB mutant would allow a more reliable 
and simple production of a vaccine. However, further work is required to establish how 
such a toxoid vaccine could be effectively delivered, suitable for use in the poultry 
industry.  
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Figures 
 
 
 
Figure 1. Experimental design of the in vivo NE model. 
Animals were immunised with formaldehyde NetB toxoid or NetB W262A on days 3, 9, and 15 post-
hatching and infected with C. perfringens strain 56 on days 17, 18, 19, and 20. Animals were culled, 
necropsied, and scored for lesions within the small intestines on days 21, 22, or 23. 
  
177 
 
 
Figure 2. Measurement of antibody to NetB using ELISA. 
Chicken were immunised with either formaldehyde NetB toxoid, NetB W262A or the Quil-A adjuvant 
alone, on days 3, 9, and 15. Sera were taken on day 15 (prior to third immunisation) and on day 23. The 
graph represents data from three replicates in three independent experiments (data are the means ± SEM; 
n=3). Asterisks indicate a statistically significant difference (***: p<0.001; 2-way ANOVA analysis) 
relative to the Quil-A immunised control. 
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Figure 3. In vivo NE model. 
(A) Lesion scores of individual broiler chickens. According to severity, lesions in the small intestine were 
scored from 0 (no gross lesions) to 6 (diffuse necrosis). Individual broiler chickens are marked as (+). n = 
number of animals. (B) NE-positive chickens. Animals with lesion scores of 2 or higher were classified as 
NE-positive. Black bars represent the SEM. Groups not sharing the indicated letters are significantly 
different (p<0.01) according to the binary logistic regression analysis. 
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Supplementary information 
 
 
 
Supplementary Figure 1. SDS-PAGE of NetB toxoids. 
(A) NetB W262A. Lane 1: protein marker (molecular mass is indicated in kDa at the side); lane 2: 
purified NetB W262A. (B) Formaldehyde NetB toxoid. Lane 1: protein marker (molecular mass is 
indicated in kDa at the site); lane 2: formaldehyde NetB toxoid. 
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Supplementary Figure 2. Cytotoxicity of NetB and NetB toxoids on LMH cells. 
LMH cells were incubated with 0.4 mg/ml of NetB for 1 h at 37°C. Panel A shows the dendritic-like 
morphology of untreated LMH cells. Incubation of cells with wild type NetB induced cell swelling and 
cell blebbing (panel B). Treatment of cells with formaldehyde NetB toxoid (panel C) or NetB W262A 
(panel D) did not cause any morphological changes. 
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Abstract 
 
Necrotic enteritis toxin B (NetB) is a β-pore-forming toxin produced by Clostridium 
perfringens and has been identified as a key virulence factor in the pathogenesis of 
avian necrotic enteritis, a disease causing significant economic damage to the poultry 
industry worldwide. In this study, site-directed mutagenesis was used to identify amino 
acids that play a key role in NetB oligomerisation and pore-formation. NetB K41H 
showed significantly reduced toxicity towards LMH cells and human red blood cells 
relative to wild type toxin and was unable to oligomerise and form lytic pores on 
liposomes. In addition, our data indicate that NetB N251A might form alternative 
multimeric assemblies relative to the heptameric assemblies formed by wild type NetB. 
Variant forms of NetB with reduced toxicity may have the potential to be used as 
genetic toxoid vaccines against necrotic enteritis in the future. 
  
188 
 
Introduction 
 
Necrotic enteritis toxin B (NetB) is a recently identified β-pore-forming toxin (β-PFT) 
produced by Clostridium perfringens (Keyburn et al., 2008). This toxin has been 
identified as a major virulence factor in avian necrotic enteritis (NE). According to an 
estimation in the year 2000, NE is causing an economic damage of around 2 billion US 
dollars a year to the poultry industry worldwide (Sluis, 2000). 
In a previous study, the crystal structure of the NetB heptamer was solved and 
showed high similarity to the heptamer formed by Staphylococcus aureus alpha-
hemolysin (αHL) (Savva et al., 2013), the prototypic member of the related αHL-like β-
PFTs family. Proteins belonging to this family are organised into three main domains 
according to their structure and function: rim, stem and -sandwich. The rim domain is 
essential in mediating binding of the toxin to the target cell membrane, the stem domain 
consists of the characteristic β-hairpin involved in the penetration of the toxin into the 
membrane and formation of the transmembrane β-barrel structure. The -sandwich 
domain, rich in β-strands, forms the protein backbone with key functions in toxin 
oligomerisation (Song et al., 1996, Yamashita et al., 2011, Olson & Gouaux, 2005). 
In general, pore-formation of αHL-like β-PFTs is suggested to occur as a four-
step process: i) secretion of a water-soluble monomeric toxin by the bacterium, ii) 
binding of the monomer to the membrane, iii) assembly of the membrane-bound 
monomers into a multimer and iiii) formation of a membrane-spanning β-barrel pore-
structure (Valeva et al., 1997, Gouaux, 1998, Gouaux et al., 1997). Extensive 
mutagenesis studies on αHL have led to the identification of several amino acid residues 
important for toxin oligomerisation and pore-formation (Kawate & Gouaux, 2003, 
Walker & Bayley, 1995). A pre-pore stage, in which the αHL heptamer is fully 
assembled but does not penetrate the membrane, has also been well defined (Valeva et 
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al., 1997, Fang et al., 1997, Walker et al., 1995). Like αHL, NetB has been suggested to 
oligomerise into a heptameric structure on the target cell surface upon pore formation 
(Savva et al., 2013, Keyburn et al., 2008). However, the assembly mechanism is still 
not well understood.  
This study was conducted to gain information on the functional roles of selected 
amino acids in NetB oligomerisation and pore-formation. Therefore, we have not only 
selected amino acids which are conserved across αHL-like β-PFTs but also amino acids 
which, on the basis of the heptameric NetB crystal structure, we believe play critical 
roles in toxicity but are not conserved across αHL-like β-PFTs. 
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Materials and methods 
 
Expression and purification of wild type NetB 
Expression of wild type NetB was carried out as described previously in E. coli TOP10 
cells (Savva et al., 2013). In summary, E. coli cells carrying the pBAD-NetB expression 
vector were grown in terrific broth (TB) supplemented with ampicillin (100 μg/ml) at 
37°C and shaken at 300 rpm. For protein expression, cultures were induced for 6 h by 
adding arabinose to a final concentration of 0.02% (w/v) at an optical density (OD595nm) 
of 0.5. Bacterial cells were harvested by centrifugation, lysed enzymatically using 
BugBuster (Novagen), and NetB was purified by Ni-NTA chromatography columns 
(GE Healthcare) according to manufacturer’s instructions. The protein was dialysed into 
Tris-buffered saline (TBS; 20 mM Tris pH 7.5, 150 mM NaCl) using PD-10 desalting 
columns (GE Healthcare) and protein concentrations were measured with a UV-Vis 
spectrophotometer (Pierce).  
 
Design and purification of variant forms of NetB 
The following variant forms of NetB were made by site-directed mutagenesis: K41H, 
K71A, P155A, D156C, D250A and N251A. Mutants were made with the QuikChange 
II site-directed mutagenesis Kit (Stratagene) and verified by DNA sequencing (Source 
BioScience). NetB variants were expressed and purified as described above for wild 
type NetB and protein integrity was assessed by UV and CD measurements at the 
Biomolecular Spectroscopy Centre, King’s College London, UK. 
 
SDS-PAGE analyses 
Protein purity of wild type NetB and variants of NetB was analysed by SDS-PAGE on 
precast 4-12% acrylamide-bisacrylamide gels (Invitrogen). All samples were heated 
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prior to loading at 70 C for 10 min in NuPAGE LDS sample buffer (Invitrogen). Each 
gel lane was loaded with 1 µg of protein. Gels were run in MES running buffer 
(Invitrogen) for 45 min at 200V and stained with SimplyBlue (Invitrogen).  
 
On-cell WesternTM Blotting 
The ability of wild type NetB and variants of NetB to bind to the chicken hepatocellular 
carcinoma epithelial cell line (LMH; ATTC: CRL-2117) was tested by an On-cell 
WesternTM assay using the Odyssey CLx infrared imaging system (Li-Cor). LMH cells 
were grown in Waymouth’s MB 75β/1 medium (Invitrogen) supplemented with 10% 
fetal calf serum at 37°C in a 5% CO2 incubator to 70-80% confluency on 96-well plates 
and fixed with 4% formaldehyde for 20 min at room temperature. After washing the 
cells three times with TBS, cells were incubated with NetB at a concentration of βγ μM 
for 10 min at 37°C in a 5% CO2 incubator. Cells were then washed three times with 
TBS and blocked with Odyssey blocking buffer (Li-Cor) for 1.5 h at room temperature. 
Cells were then incubated with an anti-Xpress antibody (Invitrogen; 1:1,000) overnight 
at 4°C. After washing three times with TBS, cells were incubated with IRdye 800CW 
goat anti-mouse (Li-Cor; 1:800) secondary antibody for 1 h at room temperature. Cells 
were washed three times with TBS and fluorescence was measured by the Odyssey CLx 
infrared scanner (Li-Cor). 
 
Cytotoxic effect of NetB on LMH cells 
The cytotoxic activity of wild type NetB or NetB K41H towards LMH cells was tested 
using the CytoTox96 kit (Promega). LMH cells were grown on 96-well plates as 
described above and incubated with 4 µM, 8 µM or 16 μM of NetB for 2 h at 37°C. 
Control cells were incubated with Waymouth’s medium to determine the base line (0% 
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lysis) or cells were freeze-thawed to determine total cell lysis (100% lysis). Cytotoxicity 
is shown as percentage relative to the controls. 
 
Hemolysis assay 
Hemolysis assays with wild type NetB and variants of NetB were performed using 
human red blood cells (hRBCs) as described previously (Savva et al., 2013). In 
summary, two-fold dilution series of NetB in TBS were made in a 96-well microtiter 
plate and hRBCs (≈ 4.6 x 106 cells/ml) were then added to each well leading to molar 
concentrations of NetB ranging from β0 nM to 5 μM. Hemolysis was determined by 
measuring absorption at 595 nm after 1 h at room temperature with the iMark 
microplate reader (Bio-Rad) and using the Microplate Manager 6.0 software (Bio-Rad). 
The controls consisted of TBS as the negative control for 0% hemolysis and 2% (v/v) 
Triton X-100 as the positive control for 100% hemolysis. Data are shown as the median 
cytotoxic dose (CT50) for causing 50% hemolysis within 1 h. 
 
Osmotic protection assay 
Osmotic protection assays with wild type NetB and NetB K41H were performed using 
polyethylene glycol (PEG) of different molecular sizes. Therefore, hRBCs were mixed 
with PEG 300 or PEG 1000 at a final concentration of 30 mM and incubated with the 
respective CT50 concentrations of wild type NetB or NetB K41H. Percentage osmotic 
protection was calculated based on the cytotoxicity of wild type NetB (0%) in the 
absence of PEG. 
 
Binding and oligomerisation of NetB to liposomes 
Lipids (Avanti polar lipids) were prepared by mixing dioleoylphosphotidylcholine 
(DOPC), egg phosphatidylglycerol (Egg PG) and cholesterol at a ratio of 4:1:5 as 
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described previously (Savva et al., 2013). To allow binding and oligomerisation, wild 
type NetB, NetB K41H or NetB N251A were mixed with liposomes at a protein to lipid 
weight ratio of 2:1 and incubated at 37 C for 1 h. Unbound NetB was removed by 
ultracentrifugation at 100,000 x g for 45 minutes at 4 C using a Beckman TLA 110 
rotor. Subsequently, NetB was extracted from liposomes in TBS buffer containing 40 
mM hexaethylene glycol monodecyl ether (C10E6) and unsolubilised material was 
removed by ultracentrifugation as described above. Detergent-solubilised NetB was 
analysed by SDS-PAGE and run on a 20 ml Superose 6 size-exclusion chromatography 
column (GE Healthcare).  
 
Electron microscopy 
Wild type NetB, NetB K41H or NetB N251A was mixed with liposomes as described 
above and analysed by electron microscopy (EM). Samples were prepared for EM by 
applying 5 l of sample onto carbon-coated grids that had been previously glow-
discharged and incubated for 60 s. Excess liquid was blotted off and grids were stained 
by addition of 5 l of 2% (w/v) aqueous uranyl acetate. Samples were observed on a 
Tecnai F20 EM (FEI) operating at an accelerating voltage of 200 kV. 
 
Calcein release assay 
To measure NetB pore-formation, liposomes were filled with calcein as described 
previously (Savva et al., 2013) and incubated with increasing molar concentrations of 
wild type NetB, NetB K41H and NetB N251A (0.21 µM, 1.05 µM, 5.25 µM and  
10.5 µM) at 37 C for 1 h. The amount of released calcein was measured using a 
FluoroMax-3 fluorometer (Jobin Yvon Horiba) with an excitation and emission 
wavelength of 495 nm and 515 nm, respectively. Calcein release (%) was calculated as 
follows:  
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Calcein release %= (Ffinal-F0)/(Fmax-F0) x 100 
 
Ffinal is the fluorescence measured after incubation with the toxin, F0 is the background 
fluorescence in the absence of toxin and Fmax is the fluorescence after addition of 1% 
(v/v) of Triton X-100. 
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Results 
 
Purification of wild type NetB and variants of NetB 
Expression and purification of variants of NetB resulted in similar protein yields to wild 
type toxin. Purified proteins were analysed by SDS-PAGE and showed a single band 
with an apparent molecular weight of 38 kDa (Figure 1). UV and CD spectroscopy 
analyses revealed that all variants of NetB adopted a similar secondary structure relative 
to wild type toxin and were folded correctly (data not shown). 
 
Binding and toxicity of NetB to LMH cells and hRBCs 
Wild type NetB and NetB variants K41H, K71A, P155A, D156C, D250A and N251A 
were tested for their ability to bind to LMH cells. Binding data revealed that NetB 
K41H was significantly impaired in binding to LMH cells, showing a reduction of 61% 
relative to wild type toxin (Figure 2).  
Next, NetB K41H was tested for cytotoxicity towards LMH cells. In a previous 
study, the dose of wild type NetB required to lyse 50% of LMH cells (CT50) was 
determined as 800 nM (Savva et al., 2013). In this study, LMH cells were incubated 
with wild type NetB or NetB K41H at molar concentrations of 4 µM (4 x CT50), 8 µM 
(10 x CT50) or 16 µM (20 x CT50). A statistically significant reduction in cytotoxicity 
between NetB K41H relative to wild type NetB was shown at all toxin concentrations 
tested and even at the maximum molar concentration tested of 16 µM only 41% of the 
cells were lysed by NetB K41H (Figure 3). 
The hemolytic activities of wild type NetB and NetB variant proteins were 
compared by determining their median hemolytic dose (CT50) towards hRBCs. While 
wild type NetB showed a CT50 of 161 nM, NetB K41H showed a 16-fold reduced 
cytotoxicity towards hRBCs, with a CT50 of 2710 nM (Figure 4). No significant 
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differences in CT50 doses were observed for the other NetB variants relative to wild type 
toxin.  
In order to test if NetB K41H was able to form functional pores, an osmotic 
protection assay using PEG of different molecular sizes was performed. While 
hemolysis of erythrocytes could only be partially blocked by PEG 300, 26% in the case 
of wild type toxin and 15% in the case of NetB K41H, hemolysis was notably blocked 
by PEG 1000 by 79% and 77% for wild type toxin and NetB K41H, respectively 
(Figure 5). 
 
Oligomerisation and pore-formation of NetB 
In order to test oligomerisation and pore-formation, wild type NetB, NetB K41H and 
NetB N251A were mixed with liposomes and oligomer formation was monitored by 
SDS-PAGE. The other variants of NetB were not used in this assay as they did not show 
any differences in oligomerisation relative to wild type toxin in a pre-screen (data not 
shown). NetB protein in the absence of liposomes or mixed with cholesterol only were 
also analysed by SDS-PAGE. Wild type NetB, NetB K41H and NetB N251A ran with 
an apparent molecular weight of 38 kDa in the absence of liposomes (Figure 6, lanes 2, 
5 and 8, respectively) or in the presence of cholesterol only (Figure 6, lanes 4, 7 and 10, 
respectively). However, when these proteins were mixed with liposomes, higher 
molecular weight complexes were detected for wild type NetB (Figure 6, lane 3) and 
NetB N251A (Figure 6, lane 9). While wild type NetB appeared as two bands running 
over 250 kDa, NetB N251A appeared as a smear on the gel with a major band running 
above the high molecular weight complex of wild type toxin. In contrast, no high 
molecular weight complex was detected for NetB K41H when mixed with liposomes 
(Figure 6, lane 6). 
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To further test the ability of wild type NetB, NetB K41H and NetB N251A to 
form high molecular weight complexes on the liposomal surface, detergent extracted 
proteins were analysed by size-exclusion chromatography. The chromatogram of NetB 
K41H showed an altered elution profile relative to wild type NetB and NetB N251A 
(Figure 7). While most of wild type NetB and NetB N251A ran as a high molecular 
weight complex, NetB K41H was mostly present as a low molecular weight complex. 
Electron microscopy (EM) was used to visualise NetB on the surface of 
liposomes. Negatively stained liposomes incubated with wild type NetB or NetB 
N251A showed ring-shaped structures, which measured approximately 10 nm in 
diameter (Figure 8A and 8C, respectively). In contrast, no ring-shaped oligomers were 
observed for NetB K41H, although monomers were present on the liposomal surface 
(Figure 8B; indicated with an arrow). 
A calcein release assay was performed in order to test if wild type NetB, NetB 
K41H or NetB N251A were able to form pores on liposomes. When wild type NetB or 
NetB N251A were incubated with liposomes, calcein was released in a dose-dependent 
manner and over 64% of the loaded calcein was released at a toxin molar concentration 
of 1 µM (Figure 9). However, no calcein release was observed when NetB K41H was 
incubated with liposomes, even at the maximum molar concentration tested of 10 µM. 
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Discussion 
 
In a previous study, we were able to show that amino acid mutations within the rim 
loops of NetB resulted in a significant decrease in toxicity due to reduced binding to 
target cells (Savva et al., 2013). This study used site-directed mutagenesis within the β-
sandwich domain of NetB to identify amino acid residues important for toxin 
oligomerisation and pore-formation. 
NetB K41H showed significantly reduced binding and toxicity towards LMH 
cells relative to wild type toxin. In addition, NetB K41H showed significantly reduced 
hemolysis towards hRBCs. Osmotic protection assays on hRBCs showed that NetB 
K41H toxicity was mediated by the formation of a lytic pore on the surface of the target 
cell. In contrast, no pore-formation was observed when NetB K41H was mixed with 
liposomes, possibly due to different fluidity of the liposomal bilayer. Membrane lipid 
composition and membrane fluidity have been shown to be an important factor for NetB 
oligomerisation and pore-formation (Savva et al., 2013). However, SDS-PAGE 
analyses and EM of liposome-bound NetB K41H indicate that this variant form of NetB 
was still able binding to liposomes. 
According to the solved multimeric NetB structure (Savva et al., 2013), the side 
chains of K41 are located in the monomer-monomer interface and thus may be involved 
in forming a stabilising salt bridge with the adjacent monomer. Amino acid mutation at 
an equivalent position in S. aureus Ȗ-hemolysin (T28D) resulted in a toxin with no pore-
forming activity on liposomes or human leukocytes and only slight hemolytic activity 
towards rabbit RBCs (Meunier et al., 1997). Various point mutations of the equivalent 
amino acid position in S. aureus αHL (H35C, H35I, H35L, H35N, H35P, H35Q, H35R, 
H35S, H35T and H35W) have been shown to significantly reduce hemolytic activity 
towards rat and rabbit RBCs (Walker & Bayley, 1995, Jursch et al., 1994, Menzies & 
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Kernodle, 1994). Valeva and co-workers (Valeva et al., 1997, Valeva et al., 1995) 
demonstrated that H35 is a key residue for transition of S. aureus αHL from the pre-
pore to the transmembrane pore complex by facilitating the insertion of the stem domain 
into the membrane. Position K41 may play a similar role for NetB oligomerisation and 
pore-formation. 
NetB N251A did not show any differences in binding, pore-formation or toxicity 
relative to wild type toxin. However, SDS-PAGE analyses showed a different profile of 
NetB N251A relative to wild type toxin when mixed with liposomes. While wild type 
toxin ran as two protein bands on SDS-PAGE, likely representing the monomeric (38 
kDa) and heptameric (266 kDa) forms of NetB (Savva et al., 2013), NetB N251A was 
able to form higher molecular weight complexes, indicating that NetB N251A may be 
arranged differently to the wild type multimer. However, we were not able to detect 
multimeric forms of NetB N251A which differed from wild type toxin using size-
exclusion chromatography, determine any difference in pore-size by EM or measure an 
altered pore-formation activity by the calcein release assay relative to wild type toxin. 
Taken the close proximity of the N251 amino acid residue to the C-terminal 
region of the protein into account, N251 may play an important role for NetB 
oligomerisation. In S. aureus αHL the C-terminal region has been shown to be 
associated with important functions in toxin oligomerisation and transition between the 
membrane-bound heptamer to the fully assembled functional pore-complex (Walker et 
al., 1995, Walker et al., 1992). Mutation of the equivalent amino acid in S. aureus αHL 
(D254) has been shown to influence binding, hemolytic activity and oligomerisation of 
the toxin (Walker & Bayley, 1995). 
NetB variants K71A, P155A, D156C and D250A did not show altered binding 
to LMH cells or hemolysis on hRBCs. Previous studies revealed that mutation of  
S. aureus αHL (D152C) abolished lytic activity towards rat RBCs (Walker & Bayley, 
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1995) and mutation of the corresponding residue in C. perfringens beta toxin (D167N) 
made the toxin unstable (Steinthorsdottir et al., 1998). Surprisingly, mutation of the 
corresponding amino acid in NetB (D156C) did not affect activity, suggesting that this 
residue plays a different role in NetB. 
In a previous study, we showed that vaccination of chicken with NetB W262A 
was able to induce a specific immune response to NetB and significantly protect 
animals against NE (Fernandes da Costa et al., 2013). In a similar manner, NetB K41H 
may have the potential to be protective when used as a genetic toxoid vaccine. A  
S. aureus αHL mutant protein in the equivalent amino acid position (H35L) has been 
tested in an intraperitoneal murine model and showed no lethal activity (Menzies & 
Kernodle, 1996). In addition, passive immunisation of mice with rabbit antiserum 
against αHL Hγ5L led to significant protection against lethal challenge of wild type 
toxin. A recent study confirmed protection against S. aureus mediated pneumonia by 
immunisation with αHL Hγ5L (Ragle & Wardenburg, 2009, Wardenbeurg & 
Schneewind, 2008). 
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Figure 1. SDS-PAGE analyses of wild type NetB and variants of NetB. 
After protein purification, wild type NetB and NetB variants were analysed by SDS-PAGE. Lane 1: 
protein marker (molecular mass is indicated in kDa to the left); lane 2: wild type NetB; lane 3: NetB 
K41H; lane 4: NetB K71A; lane 5: NetB P155A; lane 6: NetB D156C; lane 7: NetB D250A; lane 8: NetB 
N251A.  
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Figure 2. Binding of wild type NetB and variants of NetB to LMH cells. 
LMH cells were grown on 96-well plates and incubated with wild type NetB or variants of NetB (βγ μM) 
for 10 min at 37°C. The degree of binding is shown relative to wild type toxin (100%). Graph represents 
data from four replicates in three independent experiments (data are means ± SEM; n=3). Asterisks 
indicate a statistically significant difference (***: p<0.001; 1-way ANOVA) relative to wild type NetB. 
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Figure 3. Comparison of the cytotoxic effect of wild type NetB and NetB K41H towards LMH cells.  
LMH cells were grown on 96-well plates and incubated with wild type NetB or NetB K41H at a 
concentration of 4 µM, 8 µM, or 16 µM for 2 h at 37°C. Cytotoxicity is shown relative to the signal of 
untreated (0%) and lysed cells (100%). Graph represents data from three replicates in three independent 
experiments (data are means ± SEM; n=3). Asterisks indicate a statistically significant difference  
(***: p<0.001; 2-way ANOVA) relative to wild type toxin. 
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Figure 4. Hemolysis of hRBCs by wild type NetB and variants of NetB. 
Two-fold dilution series of wild type or variants of NetB were incubated with hRBCs at molar 
concentrations ranging from 20 nM to 10 μM. The required dose to lyse 50% of the cells (CT50) was 
determined after incubation of NetB variants for 1 h at 37°C. Graph represents data from three 
independent experiments (data are means ± SEM; n=3). Asterisks indicate a statistically significant 
difference (***: p<0.001; 1-way ANOVA) relative to wild type NetB. 
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Figure 5. Osmotic protection assay with wild type NetB and NetB K41H on hRBCs. 
To test the ability of wild type NetB or NetB K41H to form pores on hRBCs, cells were incubated with 
the respective CT50 concentrations of wild type NetB or NetB K41H and PEG 300 or PEG 1000 were 
added at a molar concentration of 30 mM. Percentage of osmotic protection was calculated based on the 
cytotoxicity in the absence of PEG (0%). Graph represents data from three replicates in three independent 
experiments (data are means ± SEM; n=3). 
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Figure 6. SDS-PAGE analyses of liposome-bound wild type NetB, NetB K41H and NetB N251A. 
Wild type NetB, NetB K41H and NetB N251A were mixed with liposomes and analysed by SDS-PAGE 
(lanes 3, 6 and 9). In addition, NetB was run on SDS-PAGE in the absence of liposomes (lanes 2, 5 and 
8) as well as mixed with cholesterol only (lanes 4, 7 and 10). Lane 1: protein marker (molecular mass is 
indicated in kDa to the left); lane 2: wild type NetB; lane 3: wild type NetB with liposomes; lane 4: wild 
type NetB with cholesterol; lane 5: NetB K41H; lane 6: NetB K41H with liposomes; lane 7: NetB K41H 
with cholesterol; lane 8: NetB N251A; lane 9: NetB N251A with liposomes; lane 10: NetB N251A with 
cholesterol. 
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Figure 7. Size-exclusion chromatography of liposome-bound wild type NetB, NetB K41H and NetB 
N251A.  
Wild type NetB, NetB K41H and NetB N251A were mixed with liposomes and run on a Superose-6 size-
exclusion chromatography column.  
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Figure 8. Electron microscopy of liposome-bound wild type NetB, NetB K41H and NetB N251A. 
Wild type NetB, NetB K41H and NetB N251A were mixed with liposomes and samples negatively 
stained with 2% (w/v) aqueous uranyl acetate and observed using a Philips T12 transmission electron 
microscope. A: wild type NetB; B: NetB K41H (white arrow indicate toxin on the liposomal surface);  
C: NetB N251A. 
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Figure 9. Calcein release assay of wild type NetB, NetB K41H and NetB N251A. 
Calcein loaded liposomes were incubated with wild type NetB, NetB K41H and NetB N251A at various 
molar concentrations and percentage of calcein release was measured after 1 h at 37 C. Graph represents 
data from three replicates in three independent experiments (data are means ± SEM; n=3). 
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Etx and NetB are both produced by C. perfringens but play roles in very 
different diseases (Keyburn et al., 2008, Songer, 1996). While Etx has been shown to be 
the key virulence factor for enterotoxemia in sheep and goats, NetB has been associated 
with avian NE. Both toxins are secreted into the gut and able to cause damage of the 
host organism remote from the site of bacterial growth (Uzal et al., 2004, Van 
Immerseel et al., 2004). While Etx lesions are mainly found in cerebral, cardiac and 
pulmonary tissue, NetB lesions have been predominantly reported in the small intestines 
but also in kidneys, liver and cecum. Based on their structural organisation and 
molecular mode of action, Etx and NetB have been classified as -PFTs (Cole et al., 
2004, Keyburn et al., 2008). This study aimed to study the structure-function 
relationship of Etx and NetB in more detail. In order to work with a less toxic Etx, a 
genetic variant with a mutation at position 149 (Etx H149A) was used. 
The protein structure of Etx H149A was solved to a resolution of 2.4 Å and 
showed that the H149A mutation does not alter the structural organisation of the 
receptor binding region in domain I and thus confirming the suitability of Etx H149A as 
a platform for further receptor binding studies. In addition, a novel glycan ( -octyl-
glucoside) binding site was identified in domain III. A recent study on lysenin from 
Eisenia fetida, also a member of the aerolysin-like PFTs family, has shown a 
sphingomyelin recognition site in an equivalent region to the putative -octyl-glucoside 
binding site found in Etx (De Colibus et al., 2012). However, lysenin binding is not 
only mediated by residues located within the sphingomyelin binding pocket in domain I 
but also by residues in domain III (Kiyokawa et al., 2005, Kiyokawa et al., 2004). As a 
result, lysenin interaction with the target cell membrane has been suggested to be a two-
stage process, in which binding of the toxin is first mediated by domain I and 
subsequently by interactions of domain III, facilitating an improved anchorage of the 
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toxin to the cell membrane (De Colibus et al., 2012). A similar mechanism might be 
used by Etx. 
The crystal structure of the NetB heptamer was solved to a resolution of 3.9 Å 
and represents the first high-resolution structure of a proteinaceous pore from  
C. perfringens. The protein structure represents the NetB membrane-inserted form 
comprising seven toxin monomers arranged in a cylindrical fashion. Thereby, each 
monomer contributes one β-hairpin to a 14-stranded β-barrel pore. The ring-shaped 
complex resembles a mushroom and can be classified into the following three domains: 
cap, stem and rim. The multimeric crystal structure of NetB shows high structural 
similarity to α-HL from S. aureus (Song et al., 1996), the prototypical member of this 
related family of β-PFTs. However, the NetB pore lumen displayed different surface 
charge characteristics relative to α-HL. Whereas the α-HL pore was shown to be anion 
selective (Noskov et al., 2004), this study indicated that the NetB formed pore is rather 
cation selective. In addition, the rim domain showed some interesting sequence and 
structural divergence resulting in a distinct binding specificity of NetB relative to α-HL. 
In particular, a phosphatidylcholine binding pocket present in α-HL could not be 
identified in NetB. Consistent with this, NetB did not interact efficiently with 
phosphatidylcholine but rather with cholesterol. NetB was able to interact with 
cholesterol even in the absence of any other lipids and its presence in membrane 
bilayers resulted in enhanced toxin activity. Cholesterol has also been shown to play an 
important role for the toxicity of other β-PFTs. In the case of α-HL, cholesterol has been 
shown to improve the exposure of phosphatidylcholine headgroups leading to enhanced 
toxin interaction with the membrane (Valeva et al., 2006, Forti & Menestrina, 1989). 
For CDCs, the β-sandwich domain has been shown to interact specifically with 
membrane cholesterol (Soltani et al., 2007). These interactions are mediated by a 
tryptophan-rich region located at the bottom of the β-sandwich domain (Ramachandran 
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et al., 2002). The eukaryotic cytolysin equinatoxin II from Actinia equina, an α-PFT 
classified into the actinoporin family, is able to specifically interact with membrane 
sphingomyelin (Bakrac et al., 2008). Sticholysin II from Stichodactyla helian is an 
actinoporin which has been shown to exhibit a phosphatidylcholine binding pocket for 
cell membrane contacts (Mancheno et al., 2003). An interaction with 
phosphatidylcholines has also been suggested for the S. aureus bicomponent Ȗ-
hemolysin as toxin activity was significantly increased in the presence of this membrane 
component (Potrich et al., 2009, Monma et al., 2004). C. perfringens δ-toxin has been 
reported to specifically interact with gangliosides, a lipid derivative (Jolivet-Reynaud et 
al., 1989). Cholesterol may also play an active role during membrane insertion and pore 
assembly of NetB. So far, a proteinaceous receptor has not been identified for NetB. In 
this study, NetB was able to form pores even in artificial bilayers lacking any proteins, 
suggesting that a protein receptor may play only a minor role in NetB mediated toxicity. 
The multimeric crystal structure of NetB revealed a heptameric arrangement of 
the membrane-spanning pore complex. Although a multimeric protein structure has not 
been determined for Etx so far, previous studies indicate that Etx may also form a 
heptameric pore (Nagahama et al., 2006, Miyata et al., 2001). Across small β-PFTs, this 
seems to be the most commonly described pore-conformation and has been identified 
for α-HL from S. aureus, aerolysin from A. hydrophila and cytolysin from V. cholerae 
(Song et al., 1996, Dutta et al., 2009, Parker et al., 1994). An octameric pore 
arrangement has been identified for Ȗ-hemolysin from S. aureus (Yamashita et al., 
2011). In contrast, CDCs, such as perfringolysin O from C. perfringens, form large 
pores via the assembly of up to 50 monomers (Heuck et al., 2001, Tweten, 2005). 
However, structural comparison studies among members of β-PFTs revealed that even 
distantly related toxins, sharing only minor sequence similarities, show similar pore-
forming mechanisms and it is remarkable how this strategy is used across diverse 
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bacterial species and even in eukaryotes to damage target host cells (Anderluh & Lakey, 
2008).  
Site-directed mutagenesis led to the identification of key amino acid residues for 
Etx and NetB mediated toxicity. Mutagenesis within domain I of Etx H149A (Y30A 
and Y196A) showed significant reduction in binding and toxicity towards MDCK cells 
relative to wild type Etx H149A. However, the same mutations did not show any affect 
in binding of Etx H149A to ACHN cells and thus suggesting that a different receptor 
may be involved mediating binding of Etx to this type of cells. Although Etx shows a 
remarkable in vitro specificity to only a very few cell lines, a specific proteinaceous 
receptor has not been identified yet. Amino acid mutations within the rim loops of NetB 
(Y78A, Y187A, H188A, Y191A, R200A, Y202A, W257A and W262A) had a 
significant effect on cell binding and toxicity towards target cells relative to wild type 
toxin, with NetB W262A showing the greatest reduction. In addition, amino acid 
substitutions within the β-sandwich domain of NetB revealed residues important for 
toxin oligomerisation and pore-formation. In particular, NetB K41H showed 
significantly less efficient pore-formation and NetB N251A showed altered 
oligomerisation characteristics relative to wild type NetB.  
In accordance to the data from this study, and with previous studies on β-PFTs 
(Gouaux, 1997, Parker & Feil, 2005, Geny & Popoff, 2006, Iacovache et al., 2010), the 
following NetB mode of action is suggested (Figure 1). First, NetB is secreted by  
C. perfringens as a water-soluble monomer and diffuses to the target cell membrane. 
Here, membrane interactions are mediated via surface-exposed residues at the bottom of 
the β-sandwich domain and membrane-bound monomers oligomerise to a heptameric 
complex. Cholesterol may play an important role during toxin binding and 
oligomerisation on target cell membranes. Membrane penetration is achieved by 
unfolding of individual β-hairpins in each monomer towards the membrane. These 
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structural rearrangements lead to the formation of a membrane-spanning β-barrel pore 
complex and to cell lysis, as a result of membrane disruption. 
 
 
Figure 1. Schematic representation of the NetB mode of action.  
After secretion of the water-soluble monomeric NetB by C. perfringens, NetB diffuses to the target cell 
and is able to bind to its membrane surface. After oligomerisation of the membrane-bound monomers, the 
toxin inserts into the membrane and forms a cell-lytic pore. 
 
This study has also considered the potential of a NetB genetic (W262A) and 
formaldehyde NetB toxoid to be used as vaccine candidates against NE. Animals 
immunised with either antigen showed an increased antibody response to NetB and 
significantly reduced occurrence of disease in an experimental in vivo NE chicken 
model. While 48% of the birds were NE-positive in the control groups, only 15% and 
11% were NE-positive in animals immunised with formaldehyde NetB toxoid or NetB 
W262A, respectively. In the past, toxoid vaccinations have been used with success to 
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provide protection against many bacterial toxin mediated diseases (Rappuoli et al., 
1995, Del Giudice et al., 1998). 
Collectively, this study provides profound new insights into the molecular and 
structural toxicity of Etx and NetB. This data established the role of domain I in binding 
of Etx to MDCK cells and confirmed the suitability of Etx-H149A for further receptor 
binding studies. The identification of an additional binding site in domain III will be 
helpful for the development of control measures against Etx in the future. The solved 
crystal structure of the heptameric NetB will help to understand the channel forming 
properties of this toxin in more detail. In addition, key residues for membrane binding, 
oligomerisation and pore-formation were identified. Relating to the development of a 
vaccine against NE, this study showed the potential of NetB toxoids to be used to 
control this disease more effectively in the future. 
However, many questions on these two pore-forming proteins, and for other β-
PFTs alike, still remain unanswered. Little is known on the folding pathway from the 
water-soluble form to the membrane-bound form. How are hydrophobic binding 
pockets generated in order to interact with membranes? Another intriguing question is 
how the toxin monomers assemble to an oligomeric complex on the membrane surface. 
Is it by a precise chronological addition of monomers or is the oligomer formed by the 
accumulation of multimeric intermediate populations? Which intra- and inter-monomer 
interactions are involved in this assembly? After formation of the multimeric pore 
complex, what drives the penetration of β-hairpins into the membrane? How is this step 
coordinated? Is there a signal that triggers membrane insertion? Does penetration take 
place as a concerted action of the monomers or in a sequential mode? How are the 
membrane lipids arranged around the pore and which are the conformational changes 
that generate hydrophobic surfaces in order to facilitate membrane insertion? Is 
membrane disruption the only way leading to cell lysis or may toxins stimulate 
220 
 
intracellular apoptotic pathways simply by binding to the cell surface or by activating 
specific receptors involved in these processes? Concerning membrane receptors, which 
role do they play during binding and assembly of the toxins into a pore complex?  
Many difficulties in understanding the insertion and folding processes of PFTs 
are primarily due to the fact that assembly intermediates are often missing. A common 
approach has been in identifying toxin mutants stuck in a certain conformational state. 
Thereby, certain protein regions or amino acid positions can be attributed to a specific 
function. A different approach to understand folding and oligomerisation of these toxins 
could be to monitor these processes by high resolution microscopy. Increased 
knowledge in this particular field will help to understand the binding and assembly of 
these fascinating PFTs in more detail. Future studies will also focus on specific toxin-
receptor interactions and facilitate improved control measures to be devised against 
NetB and Etx associated diseases. 
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Abstract 
 
Clostridium perfringens İ-toxin is produced by toxinotypes B and D strains. The toxin 
is the etiologic agent of dysentery in newborn lambs, but is also associated with enteritis 
and enterotoxaemia in goats, calves and foals. It is also considered to be a potential 
biowarfare or bioterrorism agent by the U.S. Government Centres for Disease Control 
and Prevention. The relatively inactive 32.9 kDa prototoxin is converted to active 
mature toxin by proteolytic cleavage, either by digestive proteases of the host, such as 
trypsin and chymotrypsin, or by C. perfringens -protease. In vivo, the toxin appears to 
target the brain and kidneys, but relatively few cell lines are susceptible to the toxin, and 
most work has been carried out using Madin-Darby Canine Kidney (MDCK) cells. The 
binding of İ-toxin to MDCK cells and rat synaptosomal membranes is associated with 
the formation of a stable, high molecular weight complex. The crystal structure of  
İ-toxin reveals similarity to aerolysin from Aeromonas hydrophila, parasporin-2 from 
Bacillus thuringiensis, and a lectin from Laetiporus sulphurous. Like these toxins,  
İ-toxin appears to form heptameric pores in target cell membranes. The exquisite 
specificity of the toxin for specific cell types suggests that it binds to a receptor found 
only on these cells. 
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Introduction 
 
The Clostridium genus encompasses more than 80 species that form a diverse group of 
rod-shaped, Gram-positive bacteria with the ability to form spores [1]. These organisms 
are principally obligate anaerobes, although some species are able to survive in the 
presence of trace amounts of oxygen [2, 3]. Clostridia are omnipresent bacteria that can 
be found in the environment, particularly in soil and water, as well as in decomposing 
animal and plant matter. In addition, some clostridial species can be found in the 
gastrointestinal tract of humans and animals where they form part of the common gut 
flora. However, under certain circumstances some of these species are able to cause 
severe diseases in humans and domestic animals by the production of a variety of toxins 
[4].  
Clostridium perfringens is one of the most pathogenic species in the Clostridium 
genus as it is able to produce at least 17 toxins [1, 5]. Depending on their ability to 
produce the four typing toxins (α-, β-, İ-, and Ț-toxins), C. perfringens strains are 
classified into five toxinotypes (Table 1) [6, 7]. In addition to the typing toxins, the 
bacterium is able to produce a number of toxins not used for typing, such as β2, į, ș, , 
Ȝ, ȝ, Ȟ and enterotoxin [8, 9]. As bacterial toxins often act in concert to cause virulence, 
their individual significance and roles in disease can be difficult to interpret. 
İ-toxin is produced by C. perfringens toxinotypes B and D. C. perfringens type 
B, which also produces -toxin, is the etiologic agent of dysentery in newborn lambs, 
but is also associated with enteritis and enterotoxaemia in goats, calves and foals (Table 
2) [5, 10]. C. perfringens type D affects mainly sheep and lambs on rich diets, but also 
causes infections in goats and calves (Table 2) [5, 10]. The most important factor in 
initiating disease is the disruption of the microbial balance in the gut due to overeating, 
which leads to the passage of large amounts of undigested carbohydrates from the 
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rumen into the intestine. Here, C. perfringens is able to proliferate in large numbers and 
produce İ-toxin. The overproduction of toxin causes increased intestinal permeability, 
facilitating the toxin’s entry into the bloodstream and its spread into various organs 
including the brain, lungs and kidneys, thereby causing severe oedema [6]. While the 
infection of the central nervous system results in neurological disorder, the fatal effects 
on the organs often lead to sudden death [11]. 
The toxin is considered to be a potential biowarfare or bioterrorism agent by the 
U.S. Government Centres for Disease Control and Prevention [12]. Although the use of 
biological weapons in conventional warfare has been banned by the Biological and 
Toxic Weapons Convention, initiated by the United States in 1972, Western states are 
particularly concerned about their availability for terrorist groups aiming to threaten 
state security [13]. The fact that the 50% lethal dose (LD50) of İ-toxin in mice is  
50 ng/kg [14] underpins the potential to use this toxin as a bioterrorist weapon, and 
highlights the need to understand the molecular basis of toxicity in order to develop an 
effective vaccine.  
 
Molecular biology of ε-toxin 
The İ-toxin gene, etx, is located on plasmids in both toxinotypes B and D [15]. In 
toxinotype B isolates, the etx gene is carried on a ~65 kb plasmid that may also carry the 
cpb2 gene for 2-toxin [16, 17], while the cpb gene that encodes -toxin resides on a 
separate plasmid. In toxinotype D isolates, the etx gene is present on plasmids ranging 
from 48-110 kb [18]. Interestingly, the larger plasmids have been found to carry up to 
three different toxin-encoding genes (etx, cpe and cpb2) [18]. 
A common theme in both toxinotypes is the association of the etx gene with 
insertion sequences. The transposable element IS1151 has been found upstream of the 
etx gene in plasmids from both toxinotypes, though in opposite orientations [16]. This 
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association has led to speculation about possible virulence gene mobilization and 
exchange between plasmids. Support for this hypothesis was provided by the 
identification of circular transposition intermediates containing IS406-etx-IS1151 [18]. 
These findings have implications for the evolution of C. perfringens and help to explain 
why some plasmids carry multiple toxin genes. Additional evidence for genetic 
exchange among toxinotypes is provided by the finding that the tcp locus, required for 
conjugation [19], is present in some etx plasmids from both toxinotype B and D isolates 
[17, 18]. Hughes and co-workers demonstrated conjugative transfer of an etx plasmid 
from a toxinotype D to a type A isolate, essentially converting type A to type D, both 
genotypically and phenotypically [20]. 
In all strains, İ-toxin is expressed with a signal sequence of 32 amino acids that 
directs export of the prototoxin from C. perfringens [21]. Sequencing of etxB and etxD 
revealed only two nucleotide differences in the open reading frames. The first change, at 
position 762, does not result in an amino acid substitution. The second change, at 
position 962, results in a substitution from serine, in etxB, to tyrosine in etxD [22]. The 
upstream regions of the etxB and etxD genes are not identical, and have different 
putative –10 and –35 promoter regions [22]. This suggests that expression of these 
genes may be regulated in different ways in type B and type D strains of C. perfringens. 
This possibility is supported by the observation that the strain from which the etxD gene 
was isolated (NCTC 8346) produced ten times more -toxin than the strain from which 
the etxB gene was isolated (NCTC 8533) [22]. 
The relatively inactive secreted prototoxin of 296 amino acids (32.9 kDa) is 
converted to the fully active mature toxin by proteolytic cleavage in the gut lumen, 
either by digestive proteases of the host, such as trypsin and chymotrypsin [23], or by  
C. perfringens -protease [14, 24]. Proteolytic activation of the toxin can also be 
achieved in the laboratory by controlled enzyme digestion [25].  
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Depending on the protease, proteolytic cleavage results in the removal of 10-13 
amino-terminal and 22-29 carboxy-terminal amino acids (Fig. 1) [14, 23]. Maximal 
activation of the toxin occurs with a combination of trypsin and chymotrypsin, resulting 
in the loss of 13 N-terminal residues and 29 C-terminal residues, producing a mature 
toxin that is >1000-fold more toxic than the prototoxin [26], with an LD50 of 50-65 
ng/kg in mice [14, 27]. This makes İ-toxin the most potent clostridial toxin after 
botulinum and tetanus neurotoxins. If trypsin alone is used for activation, only 22 
residues are removed from the C-terminus, resulting in a lower toxicity in mice, with an 
LD50 of 320 ng/kg [14]. If C. perfringens -protease is used for activation, the C-
terminus is cleaved at the same position as chymotrypsin but leaving three extra 
residues at the N-terminus, resulting in activity close to maximal, with an LD50 of 110 
ng/kg [14]. Proteolytic cleavage also causes a marked shift in pI, from 8.02 in the 
prototoxin to 5.36 in the mature toxin; though an additional moiety with a pI of 5.74, 
thought to correspond to partially activated toxin, can also be detected [26].  
The primary structure of İ-toxin bears no sequence similarity to any protein with 
a known structure in the current protein data bank (www.rcsb.org/pdb) as detectable by 
sequence comparison methods. However, the amino acid sequence of İ-toxin shows 
some homology to the Bacillus sphaericus mosquitocidal toxins Mtx2 and Mtx3, with 
26% and 23% sequence identity, respectively. The B. sphaericus toxins are also 
activated by proteolytic cleavage [28, 29], giving further support to the idea that they 
have a similar function to -toxin. In addition, there is a similar level of sequence 
identity to a number of putative bacterial proteins of unknown function, identified by 
Genome Sequencing projects, including a number of proteins from Bacillus 
thuringiensis (UniProt ID: C3GC23 or C3FC62). 
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Effects of ε-toxin on cultured cells 
Over the past few decades, a number of cell lines have been tested in order to identify a 
suitable in vitro model for the study of İ-toxin. The Madin-Darby Canine Kidney 
(MDCK) cell line of epithelial origin, derived from the distal collecting tubule, was 
initially identified to be toxin-sensitive by microscopic examination of intoxicated cells 
[30]. Cytotoxicity assays on a further 11 kidney cell lines of animal origin failed to 
identify additional cell lines sensitive to the toxin [31]. Cytotoxicity assays on 17 
human cell lines (originating from kidney, brain, skin, bone, respiratory and intestinal 
tracts) identified the Caucasian renal leiomyoblastoma (G-402) cell line to be toxin-
sensitive, albeit to a lesser extent than the MDCK cell line [32].  
In εDCK cells the dose of İ-toxin needed to kill 50% of cells (CT50) is reported 
to be 15 ng/ml [31]. Intoxicated cells undergo morphological changes including 
swelling and formation of membrane blebs [33]. The rapid death of cells exposed to the 
toxin [34] results in the formation of a large membrane complex on the target cell 
surface [33], leading to pore-formation, an efflux of K+, and an influx of Na+ and Cl- 
ions [35]. In addition, cytotoxicity is temperature- and pH-dependent [36] and is 
potentiated by EDTA [37]. 
Recently, the cytotoxic effect of İ-toxin was demonstrated in a highly 
differentiated murine renal cortical collecting duct principal cell line, mpkCCDcl4 [38]. 
These cells retain the specific ion transport properties of the distal collecting duct cells, 
from which they are derived [38]. In mpkCCDcl4 cells, toxin-induced intracellular Ca2+ 
rise and ATP depletion-mediated cell death occurred even under conditions that 
prevented toxin oligomerisation, and thus, pore-formation. 
Some primary cells are also susceptible to the toxin. For example, guinea pig 
peritoneal macrophages (GPPM) exposed to the toxin show blistering of nuclear 
membrane, ill-defined chromatin and swollen cytoplasm without structure [39]. Mixed 
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glial primary cell cultures, isolated from mice brains, are also toxin-sensitive [40]. 
Primary cultures of mice cerebellar cortex identified granule cells targeted and affected 
by İ-toxin [41], leading to membrane severing, Ca2+ influx and glutamate efflux [41]. 
Primary cultures of human renal tubular epithelial cells (HRTEC) also showed toxin-
induced swelling of cells and formation of membrane blebs [42]. 
 
Effects of ε-toxin on animals and tissues  
Enterotoxaemia in naturally infected animals is usually characterised by enterocolitis in 
goats and systemic lesions in sheep. It is postulated that proteolytic activation of the 
toxin in the gastrointestinal tract compromises the intestinal barrier of intoxicated 
animals, allowing the dissemination of toxin via the bloodstream to the main target 
organs of the kidneys and brain. The mechanism of İ-toxin absorption from the 
gastrointestinal tract is not well defined. Histological analysis of ligated intestinal loops 
of sheep and goats exposed to İ-toxin revealed necrosis of the colonic epithelium in 
both species, suggesting that alteration of large intestinal permeability might play a role 
in toxin absorption [43]. In mice and rats, transmission electron microscopy studies 
revealed that the toxin alters the small intestinal permeability predominantly by opening 
the mucosa tight junction, indicating that the small intestine might also have a role in 
toxin absorption [44].  
Previous studies suggested that toxin-induced oedema of the brain is due to the 
damaging action of the toxin on vascular endothelial cells [45]. Toxin-induced increase 
in vascular permeability in the brain was initially visualised by the use of vascular 
tracers, such as horseradish peroxidise (HRP) [46] or radiolabelled serum albumin [47]. 
More recently, direct visualisation of toxin induced endothelial damage was enabled by 
the use of green fluorescent protein (GFP)-tagged toxin in an acutely intoxicated mice 
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model [40], and by the use of a single-perfused microvessel model of rat mesentery 
[48].  
The use of recombinant GFP-tagged toxin also enabled the direct visualisation 
of its organ distribution. Fluorescence microscopy analysis of cryostat slices from 
various organs of toxin injected mice demonstrated specific, displaceable binding of 
GFP-tagged toxin to blood vessels of the brain and to distal tubules of kidneys [49]. 
Specific binding of GFP-tagged toxin to cryostat slices from rat, sheep, cow and human 
kidneys was also demonstrated [49]. Similar results were obtained with brain slices 
from mice, sheep and cattle [50]. Immunofluorescence of brain slices also identified 
toxin binding sites in defined regions of the mouse cerebellar cortex [41]. 
 
Evidence for neurotoxicity 
The terminal phase of enterotoxaemia is characterized by severe neurological disorders 
that include opisthotonus, seizures and agonal struggling, both in natural hosts and in 
experimental animal models [51]. Several studies provide evidence that neurological 
damage in intoxicated animals is induced by increased vascular permeability in brain 
blood vessels, leading to vasogenic oedema, a common feature of animals suffering 
from C. perfringens enterotoxaemia. There is also evidence that the toxin acts directly 
on neuronal tissues of intoxicated animals. For example, in mice and rat brains, 
intoxication causes both selective and extensive neurotoxicity, depending on the dose of 
toxin administered [52, 53]. Extensive neuronal damage was observed in the rat brain 
after intravenous toxin administration at a minimal lethal dose, while sub-lethal dose 
caused neuronal damage predominantly in the hippocampus, including the mossy fibre 
layers, that was not due to alteration of cerebral blood flow [53]. Subacute or chronic 
intoxication of rats also produced degeneration and necrosis of neuronal cells [54].  
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In intravenously injected mice, pre-injection of prototoxin inhibited preferential 
accumulation and lethal activity of radiolabelled toxin in the brain, indicating that the 
toxin specifically binds to, and acts on, the brain [55]. High affinity binding of 
radiolabelled toxin to rat brain homogenates and synaptosomal membrane fractions also 
suggested the presence of specific binding sites in brain tissue [56]. Pre-treatment of 
synaptosomal membrane fractions with pronase, heat and neuraminidase decreased 
toxin binding, indicating that the interaction of toxin with cell membranes in the brain is 
facilitated by a sialoglycoprotein [56]. Pre-treatment of synaptosomal membrane 
fractions with the presynaptic neurotoxin, β-bungarotoxin, also inhibited toxin binding 
in a dose-dependent manner [56].  
A number of studies suggest that İ-toxin exhibits neurotoxicity towards the brain 
by stimulating neurotransmitter release. In mice, the lethal activity of the toxin was 
reduced by dopamine receptor antagonists and by drugs which directly or indirectly 
inhibit dopamine release, indicating that the toxin specifically stimulates release of 
dopamine from dopaminergic nerve endings [57]. In another study, prior injection of 
either a pre-synaptic glutamate release inhibitor or a glutamate receptor antagonist 
protected the rat hippocampus from toxin-induced neuronal damage, indicating that the 
toxin specifically stimulates glutamate release [53]. Stimulated release of glutamate was 
also demonstrated in the mouse hippocampus after intravenous administration of the 
toxin, leading to seizure and neuronal damage [58]. Recent electrophysiological and 
pharmacological analysis of cultured mouse cerebellar slices demonstrated that 
stimulation of glutamate release is due to the toxin’s direct action on granule cell 
somata [41].  
The identity of the cells targeted by the toxin remains a debatable point. 
δonchamp’s study [41] found no evidence that the toxin has a direct effect on 
glutamatergic nerve terminals. This is in contrast to previous biochemical studies 
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performed on rat brain synaptosomal membrane fractions, where binding of 
radiolabelled toxin to rat synaptosomes was associated with the formation of a stable, 
high molecular weight complex, leading to pore-formation [27, 56, 59]. Dorca-
Arevalo’s recent study [50] also disputes the direct action of GFP-tagged epsilon toxin 
on nerve terminals, based on the failure of the toxin to trigger glutamate release from 
toxin treated mouse brain synaptosomal fractions. In this study, synaptosomal 
preparations were found to be contaminated by myelin structures, identified as the main 
toxin binding sites in these preparations [50].  
 
Crystal structure of -toxin 
The 3D structure of -toxin has been determined [60] by multiwavelength anomalous 
dispersion (www.rcsb.org/pdb, PDB ID: 1UYJ). The crystal structure revealed that  
İ-toxin is a very elongated molecule (100 Å x 20 Å x 20 Å) and is composed of mainly 
-sheets (Fig. 2). The toxin structure can be divided into three domains. Domain I 
contains an -helix and a three-stranded anti-parallel sheet, upon which the large helix 
lies. The second domain is a -sandwich, containing a five-stranded sheet and a β-
hairpin (both of which are anti-parallel). The third domain is a -sandwich comprised of 
one four-stranded sheet and one three-stranded sheet, the latter of which contains the 
only parallel strand in the structure.  
The overall fold of the İ-toxin structure shows similarity to aerolysin from the 
Gram-negative bacterium Aeromonas hydrophila [61], to parasporin-2 (PS) from 
Bacillus thuringiensis [62], and to a pore-forming lectin, LSL, from Laetiporus 
sulphurous [63]. Despite the low identity (<20%) between the primary sequences of all 
the above proteins, the structures show remarkably similar -sheet arrangements (Fig. 
2) in their two C-terminal domains (domains III and IV in aerolysin, and domains II and 
III in the others). All these proteins form pores, though aerolysin and İ-toxin are 
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predicted to be heptameric [64], while LSL is thought to be hexameric. PS is known to 
oligomerise at cell surfaces, though the size of the oligomers has not been accurately 
determined [65]. Aerolysin, -toxin and PS are all secreted as prototoxins and activated 
by the proteolytic removal of N- and C-terminal sequences. 
There is greater structural variation between the N-terminal domains of the 
above proteins than between their C-terminal domains. The N-terminal domains are 
expected to be important for substrate or receptor binding. In aerolysin, the N-terminal 
domain has been postulated to be responsible for the initial interaction with cells [66]. 
Aerolysin binds to glycosylphosphatidylinositol (GPI)-anchored proteins that are found 
in detergent resistant membranes (DRMs) via domain II. The crystal structure of an 
oligomerising, but not pore-forming, mannose-6-phosphate bound aerolysin is now 
available (PDB ID: 3C0O). Domains I of -toxin and PS (Fig. 2) are similar, and have 
some limited similarity to aerolysin. It has been suggested that this domain performs a 
similar function in İ-toxin [60] and PS [62]. However, none of the residues involved in 
sugar-binding in aerolysin are present in -toxin or PS. Therefore, it seems likely that 
these proteins have a different cell-surface receptor. In complete contrast, domain I of 
LSL has a -trefoil lectin fold (Fig. 2), in which lactose (Lac) and N-Acetyl-D-
lactosamine (LacNAc) have been observed crystallographically. It is probable that the 
major reported differences in the target cell specificities of aerolysin and İ-toxin, and 
the different function of LSL, is the result of the different structures and properties of 
these domains. 
The second and third domains of İ-toxin exhibit obvious structural similarity to 
the third and fourth domains of aerolysin, and to the second and third domains of LSL 
and PS. As described previously, domain II is composed of a five-stranded sheet with 
an amphipathic β-hairpin (residues 124-146) lying against it, while domain III is a -
sandwich composed of four- and three-stranded β-sheets. This amphipathic β-hairpin in 
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İ-toxin has been predicted to form the membrane insertion domain, due to its alternating 
hydrophilic-hydrophobic character [60]. The hairpin was studied by Knapp and co-
workers [67]. The group showed that certain residues in the hairpin were accessible to 
methanethiosulphate (MTS) reagents, which resulted in reduced pore conductance of 
planar bilayer-embedded İ-toxin, suggesting these residues must be facing the lumen of 
the pore. In addition, Pellish and McClain [68] showed that creating disulphide bonds 
between pairs of introduced cysteines (one in the amphipathic loop and one in an 
adjacent strand) prevented conformation changes in the amphipathic loop, thus 
preventing pore-formation but not receptor binding or oligomerisation, confirming that 
these residues are important for pore-formation. The amphipathic pattern is present in 
other -pore forming toxins ( -PFTs), including aerolysin, LSL and PS (Fig. 3). The 
corresponding hairpin in domain III of aerolysin was shown to form the membrane pore 
[69]. Alternating residues on either side of the hairpin were accessible to MTS probes 
added to the trans-side of planar bilayers, consistent with these residues lining the 
lumen of the pore. Interestingly, a hydrophobic loop connecting the two amphipathic 
sides of the hairpin was inaccessible, indicating that it is buried in the bilayer. This 
hydrophobic sequence is proposed to drive membrane insertion, and possibly act as a 
rivet, stabilizing the pore. However, this effect was not seen in -toxin, where turn 
residues could be accessed from the trans-side by antibodies [67]. In Clostridium 
septicum -toxin, a protein with significant sequence homology to aerolysin, the region 
equivalent to this hairpin was tested for membrane insertion using sequential cysteine 
mutation, modified with a fluorescent probe sensitive to changes from an aqueous to a 
lipid environment [70]. This technique showed that, alternately, these residues point 
into a lipid then aqueous environment when bound to a membrane, indicating insertion 
of the two-stranded sheets in a similar manner to Staphylococcus aureus -toxin.  
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The final domain of İ-toxin has been associated with heptamerisation [27]. In 
the precursor forms of both İ-toxin and aerolysin the C-terminal peptides appear to 
block oligomerisation. The EM structure of the water-soluble, non-pore-forming 
heptamer formed by an aerolysin mutant, Y221G, shows that the interface between a 
pair of monomers in the heptamer is made up of one face from one monomer and the 
opposite face from the other [71], as is the case for any ring formed of monomers. If the 
C-terminal peptide is not removed by activation, it would be located in a similar 
position between monomers in the oligomer, thus blocking interaction. 
 
Pore formation by ε-toxin  
The binding of İ-toxin to MDCK cells (and rat synaptosomal membranes) is associated 
with the formation of a stable, high molecular weight complex [33, 72]. The formation 
of large complexes has also been observed with the related pore-forming bacterial 
toxins, C. septicum -toxin [70], aerolysin [73] and PS [65]. 
Fully activated İ-toxin is cleaved both at the N- and C-termini. Recombinant 
constructs of the toxin possessing the C-terminal sequence are never observed to form 
large complexes, unlike those missing this sequence [27]. The ability of the -C and  
-N -C toxin derivatives to form a large complex has made it possible to ascertain the 
number of monomers present in the membrane complex. Heterogeneous mixtures of the 
two toxin molecules mixed at various molar ratios produce autoradiographs with six 
intermediary bands, indicating that the complex formed is a heptamer. This is consistent 
with that observed for the related toxin, aerolysin. 
As mentioned, the possible pore-forming ability of -toxin has also been 
investigated via experiments using lipid bilayers. Activated İ-toxin added to bilayer 
membranes causes an increase in conductance across the membrane in a stepwise 
fashion after about two minutes. After about 30 minutes, the increase is of about three 
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orders of magnitude [35]. This stepwise increase indicates not only the presence of 
pores within the membrane after the addition of İ-toxin, but also that these pores are 
long-lived, with no association-dissociation equilibrium. These results showed that 
pores could be formed in the absence of a membrane receptor. Though various lipids 
have been used in these experiments, the toxin has not been shown to have any lipid 
preference [35]. However, lipids with low melting points seem to favour membrane 
insertion under the same experimental conditions [74]. This group reported a 100-fold 
lower sensitivity of the toxin to carboxy-fluorescein loaded liposomes compared to 
MDCK cells. This is not surprising, considering the absence of a receptor in liposomes. 
The same study also demonstrated the existence of heptameric assemblies formed in 
liposomes. However, the heptamers were not stable, as evidenced by the presence of 
intermediate species on a SDS-PAGE gel.  
İ-toxin appears to target the DRMs in membranes. This is also the case for 
aerolysin [75] and PS [65]. Both monomeric and heptameric -toxin accumulates in 
DRMs, and depletion of cholesterol, a major constituent of DRMs, has an inhibitory 
effect on both -toxin [59] and PS. İ-prototoxin, unable to form heptamers, also binds 
mainly to DRMs, indicating that heptamerisation is not a prerequisite for interactions 
with susceptible cells. Therefore, the putative receptor for both İ-prototoxin and İ-toxin 
is thought to be present mainly in the DRMs. All steps, from binding to membrane 
insertion, are thought to occur in DRMs. It has been shown that changes to ganglioside 
content in DRMs affect the binding of İ-toxin [76]. However, there is no direct evidence 
of toxin-binding to ganglioside, and İ-toxin shows high cell specificity. In contrast, the 
related toxin, aerolysin, can interact with many cell types via GPI-anchored proteins. 
Additionally, the residues involved in mannose 6-phosphate binding in aerolysin are not 
conserved in -toxin or PS. Kitada et al. [77] have shown that PS requires a specific 
GPI-anchored protein receptor for efficient cytocidal action, and that this receptor is 
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different to that of aerolysin, despite both being in DRMs. Since the N-terminal 
domains of -toxin and PS are more similar to each other than they are to aerolysin, it 
may be that -toxin acts in a similar manner. As İ-toxin is capable of forming channels 
in lipid bilayers in the absence of a receptor [35], albeit with less efficiency [74], it has 
been suggested that the receptors present in DRMs act to concentrate the toxins, 
allowing heptamerisation [75].  
The size of the pore formed by İ-toxin has also been investigated. Petit and co-
workers [35] suggested a pore size in the 2 nm range, although toxicity associated with 
the polyethylene-glycol used to determine the pore size made the results somewhat 
unreliable. A recent study using polyethylene-glycols of different molecular weights 
suggested the pores formed by İ-toxin to be asymmetrical [78]; the pore size was 
estimated to be 0.4 nm on the side of toxin insertion and 1.0 nm on the opposing side. 
High-throughput screen methods identified some İ-toxin inhibitors that appear to work 
by blocking the pore [79], as they do not work by inhibiting cell-binding or 
oligomerisation, and are effective in cells pre-treated with toxin. 
In summary, the likely mechanism of pore-formation by İ-toxin is predicted to 
be as follows. The prototoxin is secreted by the bacterium and activated, possibly 
locally, by C. perfringens -protease or by host proteases such as trypsin and/or 
chymotrypsin. Receptor binding may occur prior to or after activation. Once activated, 
heptamerisation occurs on the membrane, which may lead to formation of a pre-pore 
complex. This has been observed in cholesterol-dependent cytolysins [80, 81] and in 
Staphylococcus aureus -toxin [82]. In fact, under certain conditions, heptamerisation 
of both aerolysin [71] and İ-toxin [68] is possible without pore-formation. The final step 
of pore-formation might involve unfolding of the amphipathic hairpin and its insertion 
into the membrane to form the walls of the pore comprised of 14 β-strands. 
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Prevention of disease  
A number of commercially available vaccines exist for the prevention of C. perfringens 
enterotoxaemia, and these have been used extensively over the past decades to prevent 
disease in domesticated livestock. The vaccines are typically prepared by treating  
C. perfringens type D culture filtrate with formaldehyde to toxoid components. Because 
relatively crude culture filtrates are used, the vaccines are likely to contain additional 
proteins to the İ-toxoid. Typical immunisation regimens involve an initial course of two 
doses of vaccine, 2-6 weeks apart. Sheep are then boosted annually, whereas goats are 
boosted every 3-4 months [83]. Adjuvants such as aluminium hydroxide are often used. 
These vaccines confer protection in animals if they induce antibody titers equivalent to 
5 international units (IU) of antitoxin [84]. However, the immunogenicity of the  
İ-toxoid in some vaccine preparations has been reported to be poor or variable [85], and 
inflammatory responses following vaccination have been reported to lead to reduced 
food consumption [86]. Attempts to improve vaccine efficacy, using a liposome 
formulation, have reportedly not been successful [83]. 
A method for the reliable production of İ-toxoid vaccines remains one of the 
challenges facing the veterinary vaccine industry. One approach to solving this problem 
would involve using genetic engineering to produce the toxin and then use this 
recombinant protein for toxoiding. The expression of prototoxin or toxin in E. coli has 
been reported [85, 87] with yields of 10 to 12 mg/litre of culture [88]. Prototoxin 
requires trypsin activation [85], but the expression of toxin avoids this requirement [88]. 
After toxoiding with formaldehyde and formulation with an aluminium hydroxide 
adjuvant, a preparation is obtained, which is reported to be immunogenic in rabbits, 
sheep, goats and cattle, and to give rise to >5 IU of antitoxin after two doses [85, 88]. 
This recombinant toxoid was reported to be a superior immunogen compared to the 
commercially available vaccines available in Brazil [85]. 
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An alternative approach to the development of a toxoid vaccine would involve 
generating a gene encoding a non-toxic variant, which can then be expressed in E. coli 
or another easily cultured host. İ-toxin consists of three domains (Fig. 2) that are 
dependent on two strands traversing the entire molecule [60]. Therefore, expression of 
the individual domains of İ-toxin, which are likely to be non-toxic, is not 
straightforward. Site-directed mutants of the toxin have been produced, which show 
markedly reduced toxicity towards MDCK cells, and these could be exploited as 
vaccines [68, 89]. The evaluation of these mutants in mice has not been reported by 
Pelish and McClain [68]. However, the H106P variant protein (H119P, following the 
numbering system for prototoxin without signal peptide) reported by Oyston et al. [89] 
has been shown to be non-toxic to mice. Mice immunised with H106P developed an 
antibody response against İ-toxin. More importantly, these immunised mice were 
protected against a subsequent challenge with 1,000 MLD doses of wild type İ-toxin 
[89]. These findings suggest that H106P could form the basis of a vaccine.  
The reasons why the H106P protein is not toxic are not known. However, it may 
be relevant that chemical modification studies have previously shown that at least one 
histidine is essential for toxicity [90]. However, it is not clear which of the two histidine 
residues in İ-toxin was chemically modified. It is also possible that the mutation of 
histidine to proline at position 10θ caused changes in the structure of İ-toxin, which 
were sufficient to abolish biological activity but not immunological reactivity. In this 
context it may be relevant that antibody against a single epitope on the toxin has been 
shown to protect against İ-toxin [91].  
There has been significant interest in the potential value of antibodies against  
İ-toxin for the prevention of enterotoxaemia caused by İ-toxin. The passive transfer of 
polyclonal antisera against the toxin into newborn lambs has reportedly been achieved 
either by injection [92] or by feeding the animals colostrum that contained antibodies 
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reactive with İ-toxin [93]. More recently, a number of workers have described the 
generation of monoclonal antibodies which are able to protect cultured cells [91, 94, 
95], and in some cases, mice [91, 94], from intoxication. The finding that a single 
monoclonal antibody is able to provide good protection indicates that a single epitope is 
required for the induction of protection. In one study, the location of the epitope 
recognised by the protective monoclonal antibody has been mapped to amino acids 134-
145 (peptide sequence SFANTNTNTNSK), and overlaps the putative membrane 
inserting loop [95]. It is not known whether other neutralising monoclonal antibodies 
recognise this loop. Any of these antibodies could have utility for the prevention or 
treatment of disease.  
An intriguing alternative to the use of antibodies is the use of dominant-negative 
inhibitors of toxicity. This approach involves generating variant forms of İ-toxin which 
are inactive but are still able to oligomerise. In the work reported by Pelish and McClain 
[68], variants were generated in which the putative membrane-insertion loop was locked 
into the folded conformation by the introduction of cysteines, which were then able to 
form disulphide bridges. Mixtures of the variant and wild type toxin, at a ratio of at least 
1:8, were non-toxic towards MDCK cells. Although these mixtures were able to form 
oligomers and bind to cells, they were unable to form heat- and SDS-resistant oligomers 
[68]. It is conceivable that these variant forms of the toxin could be used to limit 
toxicity, but they may need to be given at the same time as exposure to the wild type 
toxin, which would limit their therapeutic value. 
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Conclusions 
All of the evidence indicates that C. perfringens İ-toxin intoxicates cells by forming 
pores in cell membranes, and in this respect the toxin is similar to many other bacterial 
pore-forming toxins. The toxin monomer appears to be structurally related to a range of 
bacterial and eukaryotic pore-forming toxins, although the low degree of sequence 
homology suggests that convergent rather than divergent evolution is responsible for the 
structural similarities. The İ-toxin differs markedly from other pore-forming toxins 
because of its remarkable potency and its exquisite specificity for certain cell types. 
These properties may be linked, and the ability of the toxin to cause lethality in animals 
at low doses might be related to its ability to target neuronal cells. However, the precise 
molecular mechanism(s) by which the toxin causes death, and the mechanisms by which 
the toxin crosses the gut wall and is trafficked to target cells are not known. The 
specificity of the toxin is likely to reflect the ability of the toxin to bind to specific cell 
surface receptors, though the identity of these receptors is still not known. 
Some progress has been made in developing vaccines against İ-toxin, and the 
availability of the crystal structure of the toxin should now allow the protein to be 
rationally modified so that immunological identity is conserved but toxicity is 
abolished. Clearly, an understanding of the structure of the membrane-bound and 
multimeric forms of the toxin will further support work to devise vaccines. The 
development of other interventions to prevent or even reverse toxicity is likely to be 
dependent on a more detailed understanding of the molecular mechanisms of 
intoxication. 
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Tables 
 
 
Table 1: The five toxinotypes of C. perfringens. 
Toxinotype 
Typing toxins 
alpha beta epsilon iota 
A X    
B X X X  
C X X   
D X  X  
E X   X 
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Table 2: Diseases associated with C. perfringens toxinotypes B and D.1 
C. perfringens toxinotype Diseases 
B 
Enterotoxaemia in sheep 
Chronic enteritis in lambs (pine) 
Enteritis in calves, goats and foals 
Dysentery in lambs 
D 
Enterotoxaemia in sheep (pulpy kidney disease, overeating disease), 
calves and goats 
1Based on several reviews [5-7] 
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Figures 
 
 
 
Figure 1: Primary structure of the etx gene product.  
After secretion, the prototoxin is activated by removal of N-and C-terminal peptides at the indicated 
positions. Residue numbers are given according to the numbering system for prototoxin without signal 
peptide. 
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Figure 2: Structures of members of the aerolysin-like, β-pore-forming toxin family as solved by X-
ray crystallography.  
Coloured cyan for N-terminal membrane-interacting and other non-related regions, pale green and pink 
for domains important for oligomerisation and membrane interaction, and red for the β-hairpin predicted 
to insert into the membrane. 
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Figure 3: Structure-based sequence alignment of the β-hairpin for selected members of the 
aerolysin-like, β-pore-forming toxin family. 
Hydrophobic residues are coloured from blue to cyan (blue most hydrophobic), and hydrophilic residues 
are coloured from green to yellow (green most hydrophilic). Alignment was created manually by 
inspection of optimally aligned hairpins, except for C. septicum -toxin, for which the structure is 
unknown, where ClustalW was used to align the entire sequence with that of aerolysin.  Sequence 
numbers are provided for the final amino-acid in the hairpin. Numbering corresponds to PDB file, except 
for C. septicum -toxin, where numbering corresponds to UniProt ID: Q53482. ETX, C. perfringens  
-toxin (1UYJ); AERO: A. hydrophilus aerolysin (1PRE); LSL: L. sulphurous lectin (1W3A); PS2:  
B. thuringiensis parasporin-2 (2ZTB); NONTOX: B. thuringiensis 26 kDa non-toxic protein (2D42); 
ATOX: C. septicum -toxin. Boxing and letter colouring indicate regions of higher sequence 
conservation. 
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Abstract 
 
This study established an expression system for C. perfringens epsilon toxin (Etx) in  
E. coli Rosetta 2. Etx with a mutation at position 149 (Etx H149A) was used to enable 
work with a less toxic protein. First, the etx gene encoding epsilon prototoxin H149A 
(P-Etx H149A) was cloned into the expression vector pET-26b(+). Thereby, the native 
N-terminal signal sequence and propeptide of P-Etx H149A was removed and replaced 
by a PelB leader peptide. In addition, P-Etx H149A was fused to a C-terminal His-tag. 
Expression and purification of P-Etx H149A in E. coli Rosetta 2 resulted in high levels 
of soluble protein. Mass spectrometry analyses of purified P-Etx H149A showed that 
the PelB leader peptide was removed by the expression host. Trypsin-digest of P-Etx 
H149A cleaved the C-terminal His-tag together with the C-terminal peptide and 
generated active Etx H149A. This study will help to pave the way for future 
biochemical and structural studies on Etx. 
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Introduction 
 
Epsilon toxin (Etx) is produced by C. perfringens toxinotypes B and D and has been 
shown to be the main virulence factor causing enterotoxemia in sheep, goats, calves and 
foals (Songer, 1996). Intoxication of animals often occurs rapidly without any 
premonitory signs and may lead to mortality within a short time period (Uzal & Songer, 
2008, Uzal, 2004). 
Etx is secreted by C. perfringens as a relatively inactive prototoxin (P-Etx) with 
a predicted molecular mass of 33 kDa (McDonel, 1980, Hunter et al., 1992). For 
conversion to fully active mature toxin, P-Etx gets either processed by digestive 
proteases of the host, such as trypsin and chymotrypsin, or by C. perfringens Ȝ-protease 
(Bhown & Habeerb, 1977, Minami et al., 1997). Depending on the protease, activation 
of P-Etx leads to the removal of different amino- and carboxy-terminal peptides. 
Proteolytic cleavage by trypsin and chymotrypsin leads to maximal activation of the 
toxin with a LD50 of 50-65 ng/kg in mice (a 1000-fold increase in toxicity relative to P-
Etx), resulting in the removal of 13 amino acids at the N-terminus and 29 amino acids at 
the C-terminus (Minami et al., 1997, Miyata et al., 2001). Activation by trypsin alone 
results in the cleavage of 22 C-terminal residues and a LD50 of 320 ng/kg in mice 
(Minami et al., 1997). C. perfringens -protease removes 29 amino acids at the C-
terminus (same as chymotrypsin) and 10 amino acids at the N-terminus resulting in a 
LD50 of 110 ng/kg in mice (Minami et al., 1997). 
Several attempts have been reported on the production of recombinant Etx. 
Expression of Etx either without the first nine amino acid residues of the native signal 
peptide or without the N-terminal peptide resulted mostly in the production of insoluble 
toxin in the form of inclusion bodies (Goswami et al., 1996, Souza et al., 2010). More 
recently, Zhao and co-workers were able to express and purify active Etx missing the N- 
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and C-terminal peptide (Zhao et al., 2011). The purpose of this study was to establish an 
expression system for Etx in E. coli, being expressed without its native signal sequence 
and propeptide and fused to a C-terminal His-tag which may be removed by trypsin, 
thus activating Etx at the same time. In order to work with a less toxic protein, a variant 
of Etx with a mutation at position 149 (Etx H149A; numbering corresponds to P-Etx 
without the 13 amino acids N-terminal peptide) was used. Etx H149A has been shown a 
6-fold reduction in toxicity relative to wild type toxin (Oyston et al., 1998). 
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Materials and methods 
 
Cloning of epsilon prototoxin (P-Etx H149A) 
The etxD gene encoding epsilon prototoxin with the H149A mutation (P-Etx H149A) 
was subcloned from plasmid pCl0 (Oyston et al., 1998) into the expression vector pET-
26b(+) (Merck, Darmstadt, Germany) using NcoI and XhoI restriction sites and the 
resulting vector designated pET26-b(+)/ P-Etx H149A. Thereby, the native N-terminal 
signal sequence and propeptide of P-Etx H149A was removed (KEISNTVSNEMSK) 
and replaced by a PelB leader peptide to ensure transport of the protein into the 
periplasmic space in an E. coli expression host. In addition, P-Etx H149A was fused 
with a C-terminal His-tag to facilitate its affinity purification.  
 
Expression and purification of P-Etx H149A in E. coli 
E. coli HMS174 (DE3) cells (Merck) or E. coli Rosetta 2 (DE3) cells (Merck) carrying 
the pET-26b(+)/ P-Etx H149A vector were selected as expression hosts. To test the 
effect of different growth conditions on the expression level of P-Etx H149A, bacteria 
were grown in a variety of selected media: Luria-Bertani medium (LB), brain heart 
infusion (BHI), terrific broth (TB) or auto-inducer medium. Protein expression was 
induced either by adding IPTG at a final concentration of 0.5 mM or self-induced in the 
case of auto-inducer medium, at different optical densities (OD595nm = 0.5, 0.6, 0.7 or 
0.8), at different temperatures (20°C or 37°C) and for various time periods (6 h, 12 h,  
18 h, 24 h or 48 h). Bacterial cells were supplemented with kanamycin (50 ȝg/ml) and 
shaken at 300 rpm. In addition, media were supplemented with chloramphenicol  
(34 ȝg/ml) when E. coli Rosetta 2 strain was used for protein expression. After protein 
expression, bacterial cells were harvested by centrifugation and cells lysed 
enzymatically by using BugBuster reagent (Merck). To determine protein solubility, the 
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bacterial lysate was centrifuged for 10 minutes at 8,000 x g and subsequently 
supernatant (soluble fraction) and pellet (insoluble fraction) were resuspended in 
NuPAGE LDS sample buffer (Invitrogen, Paisley, UK) and analysed by SDS-PAGE.  
For P-Etx H149A purification, the soluble fraction was loaded onto His-bind 
chromatography columns (Merck) and toxin purified according to manufacturer’s 
instructions. Subsequently, purified P-Etx H149A was dialysed into Tris-buffered saline 
(TBS; 20 mM Tris pH 7.5, 150 mM NaCl) by using PD-10 desalting columns (GE 
Healthcare Life Sciences, Little Chalfont, UK) and protein concentrations were 
measured with a UV-Vis spectrophotometer (Fisher Scientific, Loughborough, UK). 
 
SDS-PAGE analyses 
Protein samples were analysed by SDS-PAGE on precast 4-12% Bis-Tris NuPAGE gels 
(Invitrogen). All samples were heated prior to loading at 70 C for 10 min in NuPAGE 
LDS sample buffer (Invitrogen). Gels were run using Surelock Xcell apparatus 
(Invitrogen) and NuPAGE MES SDS running buffer (Invitrogen) at 200V for 45 min. 
After electrophoretic separation, proteins were visualised by SimplyBlue (Invitrogen). 
The Perfect Protein Marker 15-150 kDa (Merck) was used as molecular weight 
standard. 
 
Western Blot 
For Western Blot analyses, proteins were transferred onto nitrocellulose membranes 
using the iBlot Dry Blotting System (Invitrogen) after electrophoretic separation. To 
block non-specific antigen binding sites, blots were initially incubated in TBS buffer 
containing 0.1% Tween-20 and 3% BSA (bovine serum albumin) for at least 1 h at 
room temperature or overnight at 4°C. Subsequently, membranes were incubated with 
1:1000 concentration of HRP-conjugated anti-His antibody in TBS buffer containing 
0.1% Tween-20 for 1 h at room temperature. After three washes in the same buffer, the 
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membrane was developed using the Amersham ECL Western Blotting detection reagent 
(GE Healthcare) and photographic films were exposed to time periods ranging from 5 s 
to 10 min, as necessary. The Precision Plus Protein WesternC Standard 25-250 kDa 
(Bio-Rad, Hemel Hempstead, UK) was used as molecular weight marker. 
 
Mass spectrometry analyses 
Samples were prepared for mass spectrometry by an in-gel tryptic digest. Therefore, 
purified P-Etx H149A was run on SDS-PAGE and stained with SimplyBlue 
(Invitrogen). Monomeric P-Etx H149A was excised from the gel and destained three 
times with 50% acetonitrile/ 50 mM ammonium bicarbonate for 30 min at 30°C. Gel 
fragments were reduced with 10 mM DTT/ 50 mM ammonium bicarbonate for 45 min 
at 50°C and subsequently alkylated with 50 mM iodoacetamide for 45 min in the dark at 
room temperature. After three washes with 50% acetonitrile/ 50 mM ammonium 
bicarbonate, gel fragments were hydrated in 40 l trypsin (Porcine trypsin; Promega, 
Southampton, UK) and incubated overnight at 37 C. After centrifugation at 10,000 x g 
for 15 min the supernatant was used for mass spectrometry analyses by using a QTOF 
6520 (Agilent, Wokingham, UK) coupled to a 1200 series HPLC-Chip interface system. 
1 µl of sample was loaded onto a high capacity micro C18 reverse phase analytical 
column (Agilent Protein Identification Chip, 75 µm x 150 mm). The enrichment column 
flow rate was set as 3 µl/min and the analytical column flow rate as 0.3 µl/min. Peptides 
were separated using an acetonitrile/ formic acid gradient. The desolvation gas 
temperature was set to 300°C and gas flow rate set as 4 l/min. Scanning was performed 
using the auto MS/MS function at 4 scans/s with a sloped collision energy of 3.7V/  
100 Da and an offset of 5V. Peak extraction and protein identification were carried out 
using Spectrum Mill MS Proteomics Workbench software (Agilent). A hit was regarded 
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as a probable identification when a peptide achieved MS/MS search scores higher than 
5 and score peak intensities (SPI) of over 60%. 
 
Trypsin-activation of P-Etx H149A 
Purified P-Etx H149A was activated by trypsin (TPCK treated from bovine pancreas; 
Sigma-Aldrich, Gillingham, UK) to remove the C-terminal peptide sequence together 
with the C-terminal His-tag. Trypsin was solved in TBS and added to P-Etx H149A at a 
1:100 (w/w) ratio. The reaction was set up for 1 h at room temperature and stopped by 
the addition of Protease Inhibitor Cocktail (EDTA-free; Fisher Scientific). Removal of 
the C-terminal peptide was analysed by SDS-PAGE. 
  
264 
 
Results 
 
E. coli HMS174-pET-26b(+)/ P-Etx H149A was grown in LB to an OD595nm of 0.5 at 
37°C and expression of P-Etx H149A was induced overnight at 20°C by adding IPTG at 
a final concentration of 0.5 mM. Bacterial cells were lysed and soluble and insoluble 
fractions were analysed by SDS-PAGE. Expression in E. coli HMS174 resulted in low 
levels of soluble P-Etx H149A (Figure 1). Subsequently, E. coli Rosetta 2 was selected 
as an expression host and P-Etx H149A expressed as described for E. coli HMS174. 
Expression P-Etx H149A in E. coli Rosetta 2 yielded higher levels of soluble protein 
relative to E. coli HMS174 (Figure 2). Higher levels of soluble P-Etx H149A were 
produced when E. coli Rosetta 2-pET-26b(+)/ P-Etx H149A were grown in auto-
inducer medium at 20°C for 48 h (Figure 3). Subsequent purification of P-Etx H149A 
resulted in a yield of approximately 100 mg per litre of bacterial cell culture. Purified  
P-Etx H149A was analysed by SDS-PAGE and Western Blot and showed two bands 
with apparent molecular weights of approximately 35 kDa and 75 kDa, likely 
representing the monomeric and dimeric forms of Etx, respectively (Figure 4, Figure 5). 
Mass spectrometry analyses of purified P-Etx H149A revealed 62 spectra with 22 
distinct peptides covering 82% (261/315 amino acids) of the P-Etx H149A protein 
sequence (Table 1, Sup. Table 1). Apart from the 23 amino acids long PelB leader 
peptide, seven short sequence regions, rich in arginine and lysine, were not detected. 
Analyses also confirmed the presence of the Etx H149A point mutation. Incubation of 
P-Etx H149A with trypsin, and subsequent analyses by SDS-PAGE, revealed two bands 
with approximately 5 kDa lower molecular weights relative to their uncleaved P-Etx 
H149A counterparts, corresponding to monomeric and dimeric protein (Figure 6).  
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Discussion 
 
Expression of P-Etx H149A in E. coli HMS174 produced mostly insoluble protein, 
suggesting that P-Etx H149A was not correctly folded under these growth conditions 
and likely accumulated as cytosolic aggregates known as inclusion bodies. Changing 
expression host from E. coli HMS174 to E. coli Rosetta 2 resulted in expression of 
higher amounts of soluble P-Etx H149A, while using E. coli Rosetta 2 strain in 
combination with auto-inducer medium at 20°C for 48 h led to the most optimal results. 
The E. coli Rosetta 2 strain is deficient in Lon protease and lacks OmpT (outer 
membrane protease T), which are able to degrade over-expressed proteins. This may 
have enhanced soluble Etx expression in E. coli Rosetta 2.  
In previous studies, expression of Etx either without the first nine amino acids of 
the native signal peptide or without the N-terminal peptide led mostly to accumulation 
of toxin in inclusion bodies (Goswami et al., 1996, Souza et al., 2010). A more recent 
study using active Etx lacking the N-terminal peptide and 23 C-terminal amino acids led 
to expression of soluble Etx and resulted in yields of 35 mg per litre of bacterial cell 
culture (Zhao et al., 2011).  
In this study, Etx H149A was expressed without the N-terminal peptide and 
protein purification resulted in 100 mg of toxin per litre of bacterial cell culture. Mass 
spectrometry analyses of purified P-Etx H149A showed 82% coverage and confirmed 
the removal of the PelB leader sequence by the expression host. Apart from the PelB 
leader peptide, seven short regions could not be detected. As these regions are rich in 
arginine and lysine they were most likely cleaved into several small-sized fragments by 
the in-gel trypsin digest prior to analyses and thus remained undetected by mass 
spectrometry analyses. Purified P-Etx H149A could be activated by trypsin digest, 
which removed the C-terminal peptide together with the C-terminal His-tag. 
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This study allowed the development of an expression system for Etx H149A in 
E. coli Rosetta 2, paving the way for molecular and structural studies on Etx H149A in 
the future.  
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Tables 
 
 
Table 1. Mass spectrometry analyses of P-Etx H149A.  
Mass spectrometry analyses of purified P-Etx H149A covered 82% (261/315 amino acids) of the protein. 
Unmatched peptides are underlined. The pelB leader sequence is highlighted in bold and the position of 
the H149A mutation in grey. 
Protein Sequence of P-Etx H149A 
MKYLLPTAAAGLLLLAAQPAMAMGKASYDNVDTLIEKGRYNTKYNYLKRM
EKYYPNAMAYFDKVTINPQGNDFYINNPKVELDGEPSMNYLEDVYVGKALLT
NDTQQEQKLKSQSFTCKNTDTVTATTTHTVGTSIQATAKFTVPFNETGVSLTTS
YSFANTNTNTNSKEITANVPSQDILVPANTTVEVIAYLKKVNVKGNVKLVGQV
SGSEWGEIPSYLAFPRDGYKFSLSDTVNKSDLNEDGTININGKGNYSAVMGDEL
IVKVRNLNTNNVQEYVIPVDKKEKSNDSNIVKYRSLSIKAPGIKLEHHHHHH 
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Figures 
 
 
 
Figure 1. Expression of P-Etx H149A in E. coli HMS174. 
After expression of P-Etx H149A in E. coli HMS174 (LB medium, overnight, 20°C) soluble and 
insoluble fractions of uninduced (lanes 1 and 2) and induced (lanes 3 and 4) bacterial cell pellets were 
analysed by SDS-PAGE. Lane 1: uninduced control, insoluble fraction; lane 2: uninduced control, soluble 
fraction; lane 3: induced, insoluble fraction; lane 4: induced, soluble fraction; lane 5: protein marker 
(molecular mass is indicated in kDa to the right). Arrow head indicates position of P-Etx H149A in the 
insoluble fraction of the induced bacterial cell culture. 
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Figure 2. Expression of P-Etx H149A in E. coli Rosetta 2.  
After expression of P-Etx H149A in E. coli Rosetta 2 (LB medium, overnight, 20°C) soluble and 
insoluble fractions of uninduced (lanes 1 and 2) and induced (lanes 3 and 4) bacterial cell pellets were 
analysed by SDS-PAGE. Lane 1: uninduced control, insoluble fraction; lane 2: uninduced control, soluble 
fraction; lane 3: induced, insoluble fraction; lane 4: induced, soluble fraction; lane 5: protein marker 
(molecular mass is indicated in kDa to the right). Arrow head indicates position of P-Etx H149A in the 
soluble fraction of the induced bacterial cell culture. 
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Figure 3. Optimised expression of P-Etx H149A in E. coli Rosetta 2.  
After expression of P-Etx H149A in E. coli Rosetta 2 (autoinducer medium, 48 h, 20°C) soluble and 
insoluble fractions of the bacterial cell pellet were analysed by SDS-PAGE. Lane 1: induced, insoluble 
fraction; lane 2: induced, soluble fraction; lane 3: protein marker (molecular mass is indicated in kDa to 
the right). Arrow head indicates position of P-Etx H149A in the soluble fraction. 
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1 2 3 4 5 
 
Figure 4. SDS-PAGE analyses of P-Etx H149A. 
After protein purification, P-Etx H149A was run on SDS-PAGE. Lane 1: protein marker (molecular mass 
is indicated in kDa to the left); lanes 2-5: decreasing amounts of purified P-Etx H149A. 
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Figure 5. Western Blot analyses of P-Etx H149A. 
After purification, P-Etx H149A was analysed by Western Blot. Lane 1: Marker (molecular mass is 
indicated in kDa to the left); lanes 3-6: decreasing amounts of purified P-Etx H149A. 
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Figure 6. SDS-PAGE analyses of trypsin-activated P-Etx H149A. 
After trypsin-activation, uncleaved and cleaved P-Etx H149A were compared on SDS-PAGE. Lane 1: 
protein marker (molecular mass is indicated in kDa to the left); lane 2: uncleaved P-Etx H149A; lane 3: 
cleaved P-Etx H149A. 
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Supplementary information 
 
Supplementary Table 1. Data collection of mass spectrometry analyses of P-Etx H149A. 
Mass spectrometry analyses of purified P-Etx H149A revealed 62 spectra with 22 distinct peptides of the 
P-Etx H149A protein sequence. 
 
Spectrum 
number 
Sequence 
MS/MS  
search score 
Spectral 
intensity (%) 
3 ALLTNDTQQEQK 23.55 98.3 
7 ALLTNDTQQEQK 23.09 98.2 
10 ALLTNDTQQEQK 22.09 88.1 
55 APGIK 9.48 81.7 
8 ASYDNVDTLIEK 22.58 97.4 
12 ASYDNVDTLIEK 21.76 92.9 
25 ASYDNVDTLIEK 17.91 80.1 
57 ASYDNVDTLIEK 8.65 70.5 
59 DGYK 6.74 70.1 
39 EITANVPSQDILVPANTTVEVIAYLK 13.36 78.2 
49 EITANVPSQDILVPANTTVEVIAYLK 11.09 73.3 
52 EITANVPSQDILVPANTTVEVIAYLK 10.55 69.8 
36 EKSNDSNIVK 13.78 87.3 
58 EKSNDSNIVK 8.31 71.6 
62 EKSNDSNIVK 6.02 60.9 
21 FSLSDTVNK 19.03 85.5 
51 FTVPFNETGVSLTTSYSFANTNTNTNSK 10.55 66.1 
16 GNYSAVMGDELIVK 19.72 92.3 
17 GNYSAVMGDELIVK 19.66 91.6 
19 GNYSAVMGDELIVK 19.1 92.6 
31 GNYSAVMGDELIVK 15.48 78 
38 GNYSAVMGDELIVK 13.43 74.7 
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48 GNYSAVMGDELIVK 11.22 65 
54 GNYSAVMGDELIVK 10.21 72.9 
56 GNYSAVMGDELIVK 9.3 89.8 
60 GNYSAVMGDELIVK 6.52 86.8 
20 LEHHHHHH 19.08 88.2 
24 LEHHHHHH 17.96 86.8 
37 LEHHHHHH 13.76 81 
44 LEHHHHHH 11.73 65.8 
2 LVGQVSGSEWGEIPSYLAFPR 24.5 100 
18 LVGQVSGSEWGEIPSYLAFPR 19.59 97.1 
1 NLNTNNVQEYVIPVDK 24.5 100 
35 NLNTNNVQEYVIPVDK 14.24 76.7 
53 NLNTNNVQEYVIPVDK 10.25 67.7 
5 NLNTNNVQEYVIPVDKK 23.2 100 
23 NLNTNNVQEYVIPVDKK 18.59 81.8 
34 NTDTVTATTTHTVGTSIQATAK 14.51 74.4 
42 NTDTVTATTTHTVGTSIQATAK 12.82 75.3 
14 SDLNEDGTININGK 20.62 95.7 
26 SDLNEDGTININGK 17.31 75.4 
28 SDLNEDGTININGK 16.19 89.5 
30 SDLNEDGTININGK 15.68 79.5 
27 SNDSNIVK 16.98 86.3 
33 SNDSNIVK 14.99 85.6 
41 SNDSNIVK 12.87 82 
50 SNDSNIVK 10.82 79.7 
29 SQSFTCK 16.06 74.5 
40 SQSFTCK 13.18 72.6 
43 SQSFTCK 12.1 72.3 
6 VELDGEPSMNYLEDVYVGK 23.18 94.8 
9 VELDGEPSMNYLEDVYVGK 22.23 94.5 
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13 VELDGEPSMNYLEDVYVGK 20.88 90.9 
32 VELDGEPSMNYLEDVYVGK 15.39 86.4 
4 VTINPQGNDFYINNPK 23.28 96.6 
22 VTINPQGNDFYINNPK 18.85 94.6 
45 YNYLK 11.72 88.4 
46 YNYLK 11.52 87.7 
47 YNYLK 11.32 84.8 
61 YNYLKR 6.3 83.1 
11 YYPNAMAYFDK 21.83 95.7 
15 YYPNAMAYFDK 20.46 92 
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